<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Part Fibre Toxicol</journal-id><journal-id journal-id-type="iso-abbrev">Part Fibre Toxicol</journal-id><journal-id journal-id-type="pmc-domain-id">305</journal-id><journal-id journal-id-type="pmc-domain">partfibtox</journal-id><journal-title-group><journal-title>Particle and Fibre Toxicology</journal-title></journal-title-group><issn pub-type="epub">1743-8977</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5697410</article-id><article-id pub-id-type="pmcid-ver">PMC5697410.1</article-id><article-id pub-id-type="pmcaid">5697410</article-id><article-id pub-id-type="pmcaiid">5697410</article-id><article-id pub-id-type="pmid">29157272</article-id><article-id pub-id-type="doi">10.1186/s12989-017-0228-y</article-id><article-id pub-id-type="publisher-id">228</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Meldrum</surname><given-names initials="K">Kirsty</given-names></name><address><email>Kirsty.Meldrum@phe.gov.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Guo</surname><given-names initials="C">Chang</given-names></name><address><email>Chang.Guo@phe.gov.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Marczylo</surname><given-names initials="EL">Emma L.</given-names></name><address><email>Emma.Marczylo@phe.gov.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gant</surname><given-names initials="TW">Timothy W.</given-names></name><address><email>Tim.Gant@phe.gov.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Smith</surname><given-names initials="R">Rachel</given-names></name><address><email>Rachel.Smith@phe.gov.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Leonard</surname><given-names initials="MO">Martin O.</given-names></name><address><phone>+44-12358-25164</phone><email>Martin.Leonard@phe.gov.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2196 8713</institution-id><institution-id institution-id-type="GRID">grid.9004.d</institution-id><institution>Toxicology Department, </institution><institution>Centre for Radiation, Chemical and Environmental Hazards, Public Health England, </institution></institution-wrap>Chilton, Harwell Campus, OX11 0RQ UK </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">283696</issue-id><elocation-id>45</elocation-id><history><date date-type="received"><day>10</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>11</month><year>2017</year></date></event><event event-type="pmc-live"><date><day>01</day><month>12</month><year>2017</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-10 00:25:09.477"><day>10</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12989_2017_Article_228.pdf"/><abstract id="Abs1"><p id="Par1">Asthma is a chronic respiratory disease known for its high susceptibility to environmental exposure. Inadvertent inhalation of engineered or incidental nanomaterials is a concern for human health, particularly for those with underlying disease susceptibility. In this review we provide a comprehensive analysis of those studies focussed on safety assessment of different nanomaterials and their unique characteristics on asthma and allergic airway disease. These include <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> approaches as well as human and population studies. The weight of evidence presented supports a modifying role for nanomaterial exposure on established asthma as well as the development of the condition. Due to the variability in modelling approaches, nanomaterial characterisation and endpoints used for assessment in these studies, there is insufficient information for how one may assign relative hazard potential to individual nanoscale properties. New developments including the adoption of standardised models and focussed <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in silico</italic> approaches have the potential to more reliably identify properties of concern through comparative analysis across robust and select testing systems. Importantly, key to refinement and choice of the most appropriate testing systems is a more complete understanding of how these materials may influence disease at the cellular and molecular level. Detailed mechanistic insight also brings with it opportunities to build important population and exposure susceptibilities into models. Ultimately, such approaches have the potential to more clearly extrapolate relevant toxicological information, which can be used to improve nanomaterial safety assessment for human disease susceptibility.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s12989-017-0228-y) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Asthma</kwd><kwd>Allergy</kwd><kwd>Nanomaterials</kwd><kwd>Nanoparticles</kwd><kwd>Ultrafine Pollutant</kwd><kwd>Inhalation</kwd><kwd>Lung</kwd></kwd-group><funding-group><award-group><funding-source><institution>National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact of Environmental Hazards at King&#8217;s College London in partnership with Public Health England (PHE)</institution></funding-source></award-group><award-group><funding-source><institution>Public Health England PhD Studentship Project Scheme</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par2">Asthma affects over 330 million individuals worldwide and is associated with significant avoidable mortality, morbidity and economic burden [<xref ref-type="bibr" rid="CR1">1</xref>]. In pathophysiological terms, asthma is a chronic inflammatory condition of the airway and is increasingly considered a term to cover a broad spectrum disease category with multiple causes and phenotypes [<xref ref-type="bibr" rid="CR2">2</xref>]. Clinical symptoms include airway obstruction, bronchospasm, wheezing, coughing, shortness of breath and airway hyper-responsiveness (AHR) [<xref ref-type="bibr" rid="CR3">3</xref>]. The most common underlying disease process is chronic inflammation, which encompasses a wide array of resident and immune cell types. As a consequence of this inflammation, airway remodelling occurs with specific changes manifesting as sub-epithelial fibrosis, smooth muscle thickening, neo-vascularisation and epithelial barrier modification. This restructuring together with increased smooth muscle contractility and enhanced mucus secretion cause obstructive events and the clinical symptoms of disease [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par3">There are a number of environmental factors with strong links to the development of asthma, including early <italic toggle="yes">in utero</italic> and childhood exposure to microbes, infection, diet, obesity, vitamin D levels, allergens, chemicals and tobacco smoke [<xref ref-type="bibr" rid="CR8">8</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>]. Exposures, particularly to&#160;allergens, particulates and&#160;chemicals, and respiratory infections also account for the majority of known triggers for obstructive events in asthma [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR18">18</xref>&#8211;<xref ref-type="bibr" rid="CR20">20</xref>]. It has been recognised for some time that certain chemicals can cause asthma and allergic airway disease (AAD) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Properties intrinsic to these chemicals and more recently for particulate exposure, have been suggested to govern their ability to produce adverse effects. Nanomaterials (NMs), including ultrafine particulates, defined as having at least one dimension less than 100nm [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], are recognised as possessing not simply&#160;chemical but also physical characteristics, with the potential to modify disease risk and outcome.</p><p id="Par4">Concerns have been raised regarding the safety of both engineered NMs and incidental ultrafine particulates upon inadvertent exposure in humans [<xref ref-type="bibr" rid="CR25">25</xref>]. Epidemiological approaches to understanding how nanoscale materials affect asthma and AAD have been restricted to a handful of studies with limited power to attribute causal effect. The study of pollutant mixtures has suggested that nanoscale components of fossil fuel combustion products such as diesel exhaust particulates may contribute to asthma and allergic airway disease [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. As chemicals including polycyclic aromatic hydrocarbons and quinones adhered to ultrafine particles are increasingly suggested as the primary factor responsible for adverse effects [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>], it is important to properly define the nanoscale characteristic contribution. Such information also has the potential to increase our understanding of how&#160;engineered nanoscale materials&#160;may impact asthma. As a focus for this review, we will describe current knowledge from human and experimental observations, on how respiratory exposure to nanomaterials with different compositions and characteristics modify asthma and AAD. We will also describe current understanding of the mechanisms through which such modification can occur, and explore important knowledge gaps to allow prioritisation of research focus into the future.</p><p id="Par5">There are different ways in which nanomaterial (NM) effects on asthma can be considered. In terms of experimental modelling, there are those approaches that have examined either na&#239;ve or genetically susceptible animals in the absence of allergen initiated disease. There are other approaches that have used allergen induced inflammation as a conditioning step for disease initiation and used different protocols to examine effects on the development (adjuvancy) or exacerbation of established allergic airway disease. Using the search criteria detailed in Additional file <xref rid="MOESM1" ref-type="media">1</xref> to encompass all aspects of disease susceptibility, we have performed a comprehensive analysis of those studies, which examine the effect of pulmonary exposure to nanoparticles&#160;(NPs), including nano-sized ultrafine pollutants, on humans and experimental models of asthma and AAD. Those studies focussed on medical applications of NMs were excluded from the main analysis and discussed&#160;separately.</p></sec><sec id="Sec2"><title>Experimental models and evidence for modifying effect of nanomaterials</title><p id="Par6">Experimental modelling as a means to identify hazards and develop risk assessment and management approaches is fundamental to how materials are assessed&#160;for potential safety concerns. The majority of such testing is carried out using <italic toggle="yes">in vivo</italic> exposure systems and occasionally incorporates models of disease susceptibility. A number of experimental <italic toggle="yes">in vivo</italic> approaches have been used to assess the impact of NMs on asthma and AAD. In order to interpret these findings as translational information that can be applied to human exposure, we must first describe the pathological features of asthma and its endotype subcategories as measurable endpoints that can be experimentally modelled and assessed.</p><p id="Par7">Current approaches to the categorisation of asthma involve subdivision based on immunological characteristics&#160;as well as clinical symptoms and severity of disease [<xref ref-type="bibr" rid="CR2">2</xref>]. The most common form of asthma found in children and half of adults is atopic in nature and correlates with increased IgE antibody levels and/or a positive skin prick test for allergens such as house dust mite (HDM). Increased IgE levels in atopic conditions are a functional consequence of CD4+ T-cell patterning towards a Th2 phenotype, which switches B-cell antibody production to IgE. In AAD, IgE coated eosinophils, mast cells and basophils are activated upon re-exposure to allergen and an inflammatory response is&#160;initiated. Allergen specific activation of Th2 CD4+ T-cells in lung tissue increases the production of IL-4, IL-5 and IL-13 cytokines. This results in an&#160;increase in&#160;IgE production from B-cells, eosinophil recruitment and goblet cell metaplasia as well as&#160; increased mucus production (MUC5AC), all of which contribute to airway restriction [<xref ref-type="bibr" rid="CR31">31</xref>]. Within the category of a high Th2 asthma endotype, there is a subdivision of disease, which displays eosinophilia and a Th2 cytokine environment in the absence of an adaptive immune response and is often referred to as intrinsic asthma [<xref ref-type="bibr" rid="CR32">32</xref>]. It has been proposed that the newly discovered innate lymphoid ILC2 cells drive this type of disease in response to chronic stimulation from infection, pollution and irritants. Injury to and activation of the epithelial cell layer in the airway is a key feature of Th2 mediated responses with epithelial derived factors including IL-33, TSLP, IL-25 and GM-CSF all suggested to play a role [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par8">Another important endotype typically associated with late onset and more severe forms of asthma is one where there is a predominant neutrophilic inflammation and the presence of a mixed Th1 and Th17 immune response, producing IL-17A, IL-22, IFN&#947; and TNF&#945; among other mediators [<xref ref-type="bibr" rid="CR33">33</xref>]. It is also important to consider overlapping endotypes, where individuals will have varying degrees of inflammation and disease severity, for example combined eosinophilic and neutrophilic disease with a Th2 and Th17 profile [<xref ref-type="bibr" rid="CR34">34</xref>]. Airway obstruction, hyperresponsiveness, remodelling (cellular proliferation &amp; extracellular matrix deposition) and excessive mucus production with goblet cell hyperplasia are common features across all endotypes of asthma and are directly measureable in model systems [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Together with endotype specific endpoints as described above, they can&#160;all be used to model the impact of material exposure on disease outcome.</p><sec id="Sec3"><title>Nanomaterial exposure and the development of allergic airway disease</title><p id="Par9">Models of atopic asthma typically involve sensitisation to allergens such as ovalbumin (OVA) in rodents and testing of materials for their ability to modify allergic inflammation and airway function, and have allowed a greater understanding of key events in asthmatic disease progression. NM testing for their impact on the sensitisation steps in these models aims to examine how such materials may influence the development and severity of new cases of the disease, which includes adjuvant activity and have been summarized in Table <xref rid="Tab1" ref-type="table">1</xref>. One of the earliest studies investigating adjuvant activity of NPs demonstrated that carbon nanoparticles (CNPs) with a smaller size (14nm) and greater surface area aggravated OVA induced allergic inflammation and mucus hypersecretion, while larger sized particles (56nm) of the same material did not [<xref ref-type="bibr" rid="CR37">37</xref>]. Similar adjuvant effects were observed in other studies from this group using the same particles [<xref ref-type="bibr" rid="CR38">38</xref>] [<xref ref-type="bibr" rid="CR39">39</xref>] but there was not always a size dependent distinction for example when examining AHR [<xref ref-type="bibr" rid="CR40">40</xref>]. The adjuvant effects of CNPs have also been observed in studies from other groups [<xref ref-type="bibr" rid="CR41">41</xref>] and display dose dependent effects [<xref ref-type="bibr" rid="CR42">42</xref>] as well as material composition dependent differences when compared to titanium dioxide NPs (TiO<sub>2</sub>NPs) for example [<xref ref-type="bibr" rid="CR43">43</xref>].<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Effect of nanomaterials on development of allergic airway disease <italic toggle="yes">in vivo</italic>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" rowspan="1">Nanomaterial Properties</th><th colspan="4" rowspan="1">Model Characteristics</th><th colspan="10" rowspan="1">Disease Related Endpoints</th></tr><tr><th colspan="1" rowspan="1">
<italic toggle="yes">Material (coating)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Size (nm)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Surface area (m</italic>
<sup><italic toggle="yes">2</italic></sup>
<italic toggle="yes">/g)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Agg Size: nm</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Species (Strain - Gender)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Allergen (Route)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Particle (Route)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Dose</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">AHR (LF test)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">IgE</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Eos</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Neu</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Lym</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">M&#934;</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Total Cells</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Pathophysiological Indicators</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">GCH-MS</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Reference</italic>
</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL5, IL13, MCP1, IL6); nc (IL4)</td><td colspan="1" rowspan="1">&#8593; Goblet cells</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL5, IL4, IL6, MCP1); nc (IL13)</td><td colspan="1" rowspan="1">nc Goblet cells</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (MIP1&#945;, IL2, IL10, TARC)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (MIP1&#945;, TARC), nc (IL2, IL10)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">887</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (PA)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.5 mg/kg x4</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (CXCL1, IL13), nc (IL4)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">30-50</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">11 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; TNF&#945;, IL4, IL5, IL10, INF&#947;</td><td colspan="1" rowspan="1">&#8593; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">14.3</td><td colspan="1" rowspan="1">253.9</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">3.6 mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL4, IL5, IL10, IL13, INF&#947;, TNF&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">30-50</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">3.6 mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-4, IL-5, IL-10, IL-13, IFN-&#947;, TNF&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR72">72</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (CD86, CD80, MHC II, DEC205, CD19)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.61 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (CD86, CD80, MHC II, DEC205, CD19)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&lt;10 &#956;m</td><td colspan="1" rowspan="1">Rat (BN &#8211;m)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">0.5 mg/kg x3</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (INF&#947;, IL1&#946;, TNF&#945;, IL4, IL5, IL13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR238">238</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">49.8</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">11 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (TNF&#945;, IL4, IL5, IL10, IL13) nc(INF-&#947;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td colspan="1" rowspan="1">C<sub>70</sub> Fullerene</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">1.1 mg/kg</td><td colspan="1" rowspan="1">&#8595; (Resist)</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL4, IL5), &#8593; (CYP1B1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td colspan="1" rowspan="1">Fe<sub>2</sub>O<sub>3</sub>
</td><td colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1">39</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">27.7 mg/kg x4</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595; IL4, INF&#947;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr><tr><td colspan="1" rowspan="1">GO</td><td colspan="1" rowspan="1">D 0.6 L 0.02-2&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.2 mg/kg</td><td colspan="1" rowspan="1">&#8593; (Penh)</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595; (IL4, IL13) nc (IL5)</td><td colspan="1" rowspan="1">&#8593; GCH/PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td colspan="1" rowspan="1">Latex</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">13.8 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL18, MIP1&#945;, MCP1); nc (IL5, IL13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR272">272</xref>]</td></tr><tr><td colspan="1" rowspan="1">Latex</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">13.8 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL18, MIP1&#945;, MCP1); nc (IL5, IL13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR272">272</xref>]</td></tr><tr><td colspan="1" rowspan="1">Latex</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">13.8 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593; (IL18, MIP1&#945;, MCP1); nc (IL5, IL13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR272">272</xref>]</td></tr><tr><td colspan="1" rowspan="1">PS (Glycine)</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">11 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL5, IL13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr><tr><td colspan="1" rowspan="1">PS</td><td colspan="1" rowspan="1">59</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">16 mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td colspan="1" rowspan="1">PS</td><td colspan="1" rowspan="1">59</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">16 mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td colspan="1" rowspan="1">PS (Glycine)</td><td colspan="1" rowspan="1">45-49</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">11 mg/kg x2</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL-4, IL-5, IL-13), nc (IFN-&#947;)</td><td colspan="1" rowspan="1">&#8595; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR78">78</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (C57BL/6-f)</td><td colspan="1" rowspan="1">OVA (Inh)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.7 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;(HO1); nc(TNF&#945;,,IL1&#946;, Cxcl2, Ccl2)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (C57BL/6-f)</td><td colspan="1" rowspan="1">OVA (Inh)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.7 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;(HO1); nc(TNF&#945;,,IL1&#946;, Cxcl2, Ccl2)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub> (Al(OH)<sub>3</sub>)</td><td colspan="1" rowspan="1">30-50</td><td colspan="1" rowspan="1">37.1</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (C57BL/6-f)</td><td colspan="1" rowspan="1">OVA (Inh)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.7 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc (HO1, TNF&#945;, IL1&#946;, Cxcl2, Ccl2)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td colspan="1" rowspan="1">ZnO</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">49.6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (C57BL/6-f)</td><td colspan="1" rowspan="1">OVA (Inh)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.7 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc (HO1, TNF&#945;, IL1&#946;, Cxcl2, Ccl2)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td colspan="1" rowspan="1">ZnO (SiO<sub>2</sub>)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (C57BL/6-f)</td><td colspan="1" rowspan="1">OVA (Inh)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.7 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">10-20</td><td colspan="1" rowspan="1">140-180</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Rat (Wistar &#8211;m)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.6 mg/kg x30</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-4), nc (INF-&#947;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (PEG)</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">22.2 mg/Kg x4</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-6, IL-5, IL-1&#946;, IL-4, TNF-&#945;, INF-&#947;</td><td colspan="1" rowspan="1">&#8593; PAS, MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR47">47</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">12.7</td><td colspan="1" rowspan="1">119.6</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">10 mg/kg x6</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-5, IL-13, IL-1&#946;, INF-&#947;</td><td colspan="1" rowspan="1">nc PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (Meso)</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">70.6</td><td colspan="1" rowspan="1">100.5</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">10 mg/kg x6</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-1&#946;, INF-&#947;) nc (IL-5, IL-13)</td><td colspan="1" rowspan="1">&#8593; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (PEG)</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">12.7</td><td colspan="1" rowspan="1">439.1</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">10 mg/kg x6</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593; (INF-&#947;) nc (IL-1&#946;, IL-5, IL-13)</td><td colspan="1" rowspan="1">nc PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">1.5 &#956;m</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A (Nose only)</td><td colspan="1" rowspan="1">193&#956;g, deposited</td><td colspan="1" rowspan="1">nc (resist)</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL-5, IL-6, INF-&#947;, IL-13, IL-4)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub> (SiO<sub>2</sub>)</td><td colspan="1" rowspan="1">10x40</td><td colspan="1" rowspan="1">132</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">10mg/m<sup>3</sup> 2h/d x12d</td><td colspan="1" rowspan="1">&#8595; (Penh)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595; (IL-1&#946;, TNF-&#945;, IL-4, IL-13, IL-10)</td><td colspan="1" rowspan="1">&#8595; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR81">81</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">4-8</td><td colspan="1" rowspan="1">130</td><td colspan="1" rowspan="1">244</td><td colspan="1" rowspan="1">Mice (BALB/c)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">11 mg/kg</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc (IL-5) &#8593; (IL-4, IL-13,IL-6, TNFa)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR273">273</xref>]</td></tr><tr><td colspan="1" rowspan="1">ZnO</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">10.8</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (Balb/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (OA)</td><td colspan="1" rowspan="1">OA</td><td colspan="1" rowspan="1">0.5 mg/kg x2</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-4, IL-5, IL-6, IL-13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td colspan="1" rowspan="1">CNF</td><td colspan="1" rowspan="1">D-35, L-10&#956;m</td><td colspan="1" rowspan="1">103</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">7.4mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (MCP-1, TNF-&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td colspan="1" rowspan="1">CNF</td><td colspan="1" rowspan="1">D- 36, L-5&#956;m</td><td colspan="1" rowspan="1">124</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">7.4mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (MCP-1, TNF-&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td colspan="1" rowspan="1">CNF</td><td colspan="1" rowspan="1">D-70, L-5&#956;m</td><td colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">7.4mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (MCP-1, TNF-&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td colspan="1" rowspan="1">CNF</td><td colspan="1" rowspan="1">D- 83, L-10&#956;m</td><td colspan="1" rowspan="1">61</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">7.4mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (MCP-1, TNF-&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td colspan="1" rowspan="1">SWCNT</td><td colspan="1" rowspan="1">D- 1.1, L-100&#956;m</td><td colspan="1" rowspan="1">543</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">7.4mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (MCP-1, TNF-&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D20-30, L-200&#956;m</td><td colspan="1" rowspan="1">140</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">7.4mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (MCP-1, TNF-&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td colspan="1" rowspan="1">C (PrinteX 90)</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">7.4mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;(MCP-1),<break/>nc (TNF-&#945;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td colspan="1" rowspan="1">SWCNT</td><td colspan="1" rowspan="1">D 1.2-2, L 1-15&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.3 mg/kg x7</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL4, IL33, IL5, IL13, INF&#947;, IL17)</td><td colspan="1" rowspan="1">&#8593; MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td colspan="1" rowspan="1">SWCNT</td><td colspan="1" rowspan="1">D 0.8-1.2, L 0.1-1&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.3 mg/kg x7</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL5, IL13)</td><td colspan="1" rowspan="1">&#8593; MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D ~15 nm, L 1-10&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">1mg/kg</td><td colspan="1" rowspan="1">&#8593; (sRaw)</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-4, IL-5, IL-13, IL-17)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR50">50</xref>]</td></tr><tr><td colspan="1" rowspan="1">SWCNT</td><td colspan="1" rowspan="1">D 0.93-1.63</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Rat (Wistar &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int T)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">2 mg/kg x13</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL4, ROS) &#8595;(INF&#947;)</td><td colspan="1" rowspan="1">&#8593; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D ~15 nm, L 1-10&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">~350 &#956;m</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">HDM (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">12.5mg/kg x10</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; IL-13, TGF-&#946;1, IL-33, TSLP, IL-25</td><td colspan="1" rowspan="1">&#8593; mucin</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D 67, L 0.1-10&#956;m</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int I)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">4.6 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-4, INF-&#947;, IL-33, IL-1&#946;, TARC, MCP-1)</td><td colspan="1" rowspan="1">&#8593; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D 2&#8211;20, L 0.1-10&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (ICR &#8211;m)</td><td colspan="1" rowspan="1">OVA (Int I)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">4.6 mg/kg x6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-4, INF-&#947;, IL-33, MCP-1, IL-1&#946;);</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">33</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">13.8 mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-4, IL-5)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">79</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">13.8 mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc (IL-4, IL-5)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic toggle="yes">Agg</italic> agglomerate, <italic toggle="yes">AHR</italic> airway hyperresponsiveness, <italic toggle="yes">LF</italic> lung function, <italic toggle="yes">Resist</italic> Resistance, <italic toggle="yes">Penh</italic> Enhanced pause, <italic toggle="yes">Eos</italic> eosinophils, <italic toggle="yes">Neu</italic> neutrophils, <italic toggle="yes">Lym</italic> lymphocytes, M&#934; macrophages, <italic toggle="yes">GCH-MS</italic> goblet cell hyperplasia-mucus secretion, &#8722;<italic toggle="yes">m</italic> &#8211;male, <italic toggle="yes">OVA</italic> ovalbumin, <italic toggle="yes">Int T</italic> intratracheal instillation, &#8593; increase, <italic toggle="yes">nc</italic> no change, &#8722; not determined, &#8722;<italic toggle="yes">f</italic> &#8211;female, <italic toggle="yes">PA</italic> pharyngeal aspiration, <italic toggle="yes">Int N</italic> intranasal instillation, <italic toggle="yes">PAS</italic> Periodic acid&#8211;Schiff staining, <italic toggle="yes">BN</italic> Brown Norway, <italic toggle="yes">IP</italic> intraperitoneal injection, &#8595; decrease, <italic toggle="yes">PS</italic> polystyrene, <italic toggle="yes">Inh</italic> inhalation, <italic toggle="yes">PEG</italic> Polyethylene glycol, <italic toggle="yes">Meso</italic> mesoporous, <italic toggle="yes">OA</italic> oropharyngeal aspiration, <italic toggle="yes">A</italic> aerosol, <italic toggle="yes">D</italic> diameter; <italic toggle="yes">L</italic> length; <italic toggle="yes">CNF</italic> carbon nanofiber, <italic toggle="yes">SWCNT</italic> single-walled carbon nanotubes, <italic toggle="yes">MWCNT</italic> multi-walled carbon nanotubes, <italic toggle="yes">HDM</italic> house dust mite</p></table-wrap-foot></table-wrap>
</p><p id="Par10">Comparison to non-nano sized particles has also been carried out within these adjuvant studies and further supports the hypothesis that smaller size and greater surface area have a larger impact on biological reactivity and AAD. This was observed for example, when comparing nano-sized carbon and TiO<sub>2</sub> to sub-micron sized particles of the same material [<xref ref-type="bibr" rid="CR43">43</xref>]. It has also been observed with polystyrene particles (PSP), where nano-sized PSP produced stronger allergic inflammatory responses to OVA than sub-micron or micron sized PSPs [<xref ref-type="bibr" rid="CR44">44</xref>]. Interestingly this study addressed potential gender response differences and observed that while PSPs had adjuvant effects in both male and female mice, there were significantly higher IgE and eosinophilic responses in females when compared to males. Examination of silicon dioxide NPs (SiO<sub>2</sub>NPs) also demonstrated size and dose dependent effects, where 30nm sized SiO<sub>2</sub>NPs increased OVA specific IgE and Th2 type cytokine production while larger sized SiO<sub>2</sub>NPs (70nm) or sub-micron and micron sized silica did not [<xref ref-type="bibr" rid="CR45">45</xref>]. The adjuvant effects of SiO<sub>2</sub>NPs have been well documented with additional studies revealing dose dependent increases in AHR, allergic as well as innate airway inflammation (both Th2 and Th17 related) and mucus hypersecretion [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. A more detailed exploration of how SiO<sub>2</sub>NPs have adjuvant effects was recently carried out using three different types of SiO<sub>2</sub>NPs (unmodified, mesoporous and polyethylene glycol (PEG) conjugated). The strongest adjuvant activity, measured as increased AHR, inflammatory responses and mucus hypersecretion, was found for the mesoporous form of SiO<sub>2</sub>NPs. This form has a similar size to the unmodified SiO<sub>2</sub>NPs but has a much larger surface area. It was argued that surface area is the key component for adjuvant activity. This was further supported by the observation that the PEG-SiO<sub>2</sub>NPs, which had agglomerates four times larger, and thus a lower surface area per mass dose, failed to produce any adjuvant activity [<xref ref-type="bibr" rid="CR48">48</xref>].</p><p id="Par11">Multi-walled carbon nanotubes (MWCNTs) are&#160;a particular concern for human health and&#160;have been observed to worsen the development of AAI with increased IgE, eosinophils, lymphocytes, IL-4 and&#160;mucus hypersecretion&#160;in a mouse model of AAD&#160;[<xref ref-type="bibr" rid="CR49">49</xref>]. This was also accompanied by innate immune responses including increased neutrophils, IL-1&#946; and IL-33 [<xref ref-type="bibr" rid="CR49">49</xref>]. Similar effects for MWCNTs [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] and single walled carbon nanotubes (SWCNTs) [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] were observed in subsequent studies. Intriguingly, an analysis of different carbon NMs revealed that both SWCNTs and MWCNTs produced significantly higher levels of IgE and pulmonary eosinophils than either carbon nanofibres (CNFs) or CNPs. CNFs in general had a lesser impact on inflammatory responses and were correlated to a lower specific&#160;surface area. Different surface areas however were not sufficient to fully explain allergic airway responses, and nanoparticle (NP) characteristics such as thin tubular structure and biopersistance were suggested as more likely factors contributing to adverse effects [<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par12">In addition to size, material type and structure, solubility of NPs has also been proposed as an important factor for the ability to modulate the development of AAD. Comparison of different NPs for their potential to modify IgE responses to OVA in mice, revealed that zinc oxide nanoparticles (ZnONPs) but not SiO<sub>2</sub>NPs or TiO<sub>2</sub>NPs produced an adjuvant effect [<xref ref-type="bibr" rid="CR55">55</xref>].&#160;It was suggested that&#160;the higher solubility of ZnONPs as a contributing factor. Similar to effects independent of allergen, worsening of OVA induced allergic airway inflammation has also been demonstrated in response to ZnONPs but not ZnCl<sub>2</sub> ion treatment [<xref ref-type="bibr" rid="CR56">56</xref>]. Given the suggestion that the nanoparticle intracellular release of Zn ions over a sustained period of time is the key factor for biological effect [<xref ref-type="bibr" rid="CR57">57</xref>], the use of an ionic metal bolus may not be entirely appropriate to replicate all effects.</p></sec><sec id="Sec4"><title>Nanomaterial effects on established allergic airway disease</title><p id="Par13">Modification of pre-existing asthma involves alterations to airway function and inflammatory status. In this section we will summarise current information on how nanomaterials can modify established allergic airway disease <italic toggle="yes">in vivo</italic> (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Effect of nanomaterials on experimental <italic toggle="yes">in vivo</italic> models of established allergic airway disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" rowspan="1">Nanomaterial Properties</th><th colspan="4" rowspan="1">Model Characteristics</th><th colspan="10" rowspan="1">Disease Related Endpoints</th></tr><tr><th colspan="1" rowspan="1">
<italic toggle="yes">Material (coating)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Size (nm)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Surface area (m</italic>
<sup><italic toggle="yes">2</italic></sup>
<italic toggle="yes">/g)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Agg size (nm)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Species (Strain - Gender)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Allergen (Route)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Particle (Route)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Dose</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">AHR (LF test)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">IgE</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Eos</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Neu</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Lym</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">M&#934;</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Total Cells</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Pathophysiological Indicators</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">GCH-MS</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Reference</italic>
</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Ag</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">0.11</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALBc &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">40mg/kg x5d</td><td colspan="1" rowspan="1">&#8595; (Penh)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL-4 IL-5, IL-13, VEGF)</td><td colspan="1" rowspan="1">&#8595; MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ag</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (C57BL/6 &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">40mg/kg x5d</td><td colspan="1" rowspan="1">&#8595; (Penh)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL-4 IL-5, IL-13, NFkB)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ag</td><td colspan="1" rowspan="1">33</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">3.3mg/m<sup>3</sup> x6h/d x7d</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR274">274</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ag</td><td colspan="1" rowspan="1">33</td><td colspan="1" rowspan="1">0.016</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">3.3mg/m<sup>3</sup> x6h x7d</td><td colspan="1" rowspan="1">nc (Penh)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (IL-13) -</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td colspan="1" rowspan="1">Au</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">TDI (dermal)</td><td colspan="1" rowspan="1">OA</td><td colspan="1" rowspan="1">0.8 mg/kg</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8595; (TNF-&#945;, IL-6) nc (MIP-2, MCP-1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR63">63</xref>]</td></tr><tr><td colspan="1" rowspan="1">Au</td><td colspan="1" rowspan="1">6.3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (A/J &#8211;m)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">60&#956;g/Kg x2</td><td colspan="1" rowspan="1">&#8595; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595; (IL-4, IL-13, CCL11, CCL24)</td><td colspan="1" rowspan="1">&#8595; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td colspan="1" rowspan="1">Au</td><td colspan="1" rowspan="1">6.3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (Swiss Webster &#8211;m)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">60&#956;g/Kg x2</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL-5, Il-1&#946;, IL-6, ROS)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">272</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">TDI (dermal)</td><td colspan="1" rowspan="1">OA</td><td colspan="1" rowspan="1">0.8 mg/kg</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (TNF-&#945;, IL-6, MIP-2, MCP-1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR63">63</xref>]</td></tr><tr><td colspan="1" rowspan="1">CuO</td><td colspan="1" rowspan="1">46.67</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">375.8</td><td colspan="1" rowspan="1">Mice 0(BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">100&#956;g/kg x3</td><td colspan="1" rowspan="1">&#8593; (Penh)</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (ROS, IL-5, IL-6, TNF-&#945;, IL-13, IL-4</td><td colspan="1" rowspan="1">&#8593; MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR64">64</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">442</td><td colspan="1" rowspan="1">344-5720</td><td colspan="1" rowspan="1">Mice (C57BL/6 &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">10mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR60">60</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">34.8</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c)</td><td colspan="1" rowspan="1">OVA (A)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">526&#956;g/m<sup>3</sup> x24h</td><td colspan="1" rowspan="1">&#8593; (Penh)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;(IL-13), &#8595;(IL-5), nc (IL-4)</td><td colspan="1" rowspan="1">&#8593; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR61">61</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">53.2</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">504&#956;g/m3 (24h)</td><td colspan="1" rowspan="1">&#8593; (Penh)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-5, IL-13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">35.2</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Dog (Beagle)</td><td colspan="1" rowspan="1">Ragweed (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">232.3&#956;g/m<sup>3</sup>
</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR58">58</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">507&#956;g/m<sup>3</sup> x24h</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;*</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (LTB<sub>4</sub>, PGE<sub>2</sub>), nc (8-isoprostane)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">507&#956;g/m<sup>3</sup> x24h</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (TNF-&#945;), nc (CC16)</td><td colspan="1" rowspan="1">&#8593; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR62">62</xref>]</td></tr><tr><td colspan="1" rowspan="1">&#945;-Fe<sub>2</sub>O<sub>3</sub>
</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">28.98</td><td colspan="1" rowspan="1">950-2000</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">5mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc (TNF-&#945;, Il-1&#946;, IL6)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR275">275</xref>]</td></tr><tr><td colspan="1" rowspan="1">FeO<sub>2</sub>
</td><td colspan="1" rowspan="1">43</td><td colspan="1" rowspan="1">41.95</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">1.1mg/kg x3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IFN-&#947;), nc (IL-4)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR93">93</xref>]</td></tr><tr><td colspan="1" rowspan="1">GO</td><td colspan="1" rowspan="1">D 0.61, L 0.02-2&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">PA</td><td colspan="1" rowspan="1">2.2mg/kg x4</td><td colspan="1" rowspan="1">nc (Penh)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc (IL-4, IL-5, IL-13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">2.7mg/kg</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-13, MCP-1, MIP-1, Tarc); nc (IL-4, INF-&#947;, TNF-&#945;, KC)</td><td colspan="1" rowspan="1">&#8593; MUC5AC PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (PEG)</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">2.7mg/kg</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-4, IL-13, MCP-1, MIP-1, Tarc, KC), nc (INF-&#947;, TNF-&#945;)</td><td colspan="1" rowspan="1">&#8593; MUC5AC PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (PO<sub>4</sub>)</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">2.7mg/kg</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (MIP-1); nc (IL-13, IL-4, INF-&#947;, TNF-&#945;, MCP-1, Tarc, KC)</td><td colspan="1" rowspan="1">nc MUC5AC PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (Amino)</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int T</td><td colspan="1" rowspan="1">2.7mg/kg</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-13, IL-4); &#8595; (Tarc); nc (INF-&#947;, TNF&#945;, MCP1, KC)</td><td colspan="1" rowspan="1">nc MUC5AC PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>
</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">12.7</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">11 mg/kg x3</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (IL-5, IL-13, IL-1&#946;, INF-&#947;)</td><td colspan="1" rowspan="1">nc PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR276">276</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (Meso)</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">70.6</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">11 mg/kg x3</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (IL-5, IL-13, IL-1&#946;, INF-&#947;)</td><td colspan="1" rowspan="1">nc PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR276">276</xref>]</td></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub> (PEG)</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">12.7</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">11 mg/kg x3</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (IL-5, IL-13, IL-1&#946;, INF-&#947;)</td><td colspan="1" rowspan="1">nc PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR276">276</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">168</td><td colspan="1" rowspan="1">Rat (BN &#8211;m)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">9.4mg/m<sup>3</sup> x6h</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (MCP-1, IL-4, IL-6, INF-&#947;)</td><td colspan="1" rowspan="1">&#8595; PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR118">118</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">4200</td><td colspan="1" rowspan="1">Rat (BN &#8211;m)</td><td colspan="1" rowspan="1">OVA (In)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">159 &#956;g, deposited</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR119">119</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">4200</td><td colspan="1" rowspan="1">Rat (DA-m)</td><td colspan="1" rowspan="1">OVA (In)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">168 &#956;g, deposited</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR119">119</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">1.5 &#956;m</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">193 &#956;g, deposited</td><td colspan="1" rowspan="1">&#8595; (Resist)</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8595; (IL-4, IL-13, IL-5,IL-6, INF-&#947;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">1.5 &#956;m</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">32 &#956;g, deposited</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (IL-4, IL-13, IL-5,IL-6, INF-&#947;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>
</td><td colspan="1" rowspan="1">4-8</td><td colspan="1" rowspan="1">130</td><td colspan="1" rowspan="1">244</td><td colspan="1" rowspan="1">Mice (BALB/c)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">5.5 mg/kg x4</td><td colspan="1" rowspan="1">nc (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR273">273</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D &#8211; 9.5, L&#8211; 1.5&#956;m</td><td colspan="1" rowspan="1">250-300</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Rats (BN &#8211;f)</td><td colspan="1" rowspan="1">TMA (dermal)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">22mg/m3 x5h x7d</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR68">68</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D - 20&#8211;30, L-5-10&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">324</td><td colspan="1" rowspan="1">Mice (C57BL/6)</td><td colspan="1" rowspan="1">HDM (Int N)</td><td colspan="1" rowspan="1">O</td><td colspan="1" rowspan="1">2 mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc (IL-1&#946;, IL-13, IL-4, IL-5 CCL20) &#8593;(CCL2, CXCL1/2)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR71">71</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D 30&#8211;50 L 0.3-50&#956;m</td><td colspan="1" rowspan="1">109.29</td><td colspan="1" rowspan="1">&gt;2 &#956;m</td><td colspan="1" rowspan="1">Mice (C57BL/6J)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">OA</td><td colspan="1" rowspan="1">4mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;*</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8595;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc (IL-13, IL-5,, IL-17&#945;) &#8595;(TGF-&#946;1)</td><td colspan="1" rowspan="1">nc PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR70">70</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D 30&#8211;50 L 0.3-50&#956;m</td><td colspan="1" rowspan="1">109.29</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (C57BL/6 &#8211;)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">100mg/m<sup>3</sup>
</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc (IL-13) &#8593; (IL-5, TGF-&#946;1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">D 10&#8211;30 L 0.3-56&#956;m</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Mice (WT &#8211;m)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">OA</td><td colspan="1" rowspan="1">4mg/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (IL-13, IL-1&#946;, TGF-&#946;1, TNF &#8211;&#945;, IL-10)</td><td colspan="1" rowspan="1">nc PAS</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR69">69</xref>]</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic toggle="yes">Agg</italic> agglomerate, <italic toggle="yes">AHR</italic> airway hyperresponsiveness, <italic toggle="yes">LF</italic> lung function, <italic toggle="yes">Resist</italic> Resistance, <italic toggle="yes">Penh</italic> Enhanced pause, <italic toggle="yes">Eos</italic> eosinophils, <italic toggle="yes">Neu</italic> neutrophils, <italic toggle="yes">Lym</italic> lymphocytes, M&#934; macrophages, <italic toggle="yes">GCH-MS</italic> goblet cell hyperplasia-mucus secretion, &#8722;<italic toggle="yes">f</italic> &#8211;female, <italic toggle="yes">OVA</italic> ovalbumin, <italic toggle="yes">IP</italic> intraperitoneal injection, <italic toggle="yes">A</italic> aerosol, &#8595; decrease, <italic toggle="yes">nc</italic> no change, &#8593; increase, &#8722; not determined, &#8722;<italic toggle="yes">m</italic> &#8211;male, <italic toggle="yes">Int N</italic> intranasal instillation, <italic toggle="yes">PA</italic> pharyngeal aspiration, <italic toggle="yes">PAS</italic> Periodic acid&#8211;Schiff staining, <italic toggle="yes">TDI</italic> toluene diisocyanate, <italic toggle="yes">OA</italic> oropharyngeal aspiration, <italic toggle="yes">Int T</italic> intratracheal instillation, <italic toggle="yes">PEG</italic> Polyethylene glycol, <italic toggle="yes">Meso</italic> mesoporous, <italic toggle="yes">BN</italic> Brown Norway, <italic toggle="yes">DA</italic> Dark Agouti, <italic toggle="yes">MWCNT</italic> multi-walled carbon nanotubes, <italic toggle="yes">D</italic> diameter; <italic toggle="yes">L</italic> length, <italic toggle="yes">TMA</italic> trimellitic anhydride, <italic toggle="yes">HDM</italic> house dust mite</p></table-wrap-foot></table-wrap>
</p><p id="Par14">Early investigations into CNPs and their ability to modify pre-existing ragweed pollen induced AAI in the beagle dog, apart from a mild neutrophilic response, did not show any major effects on airway reactivity or immune activation [<xref ref-type="bibr" rid="CR58">58</xref>]. More recent studies demonstrated a neutrophilic response when CNPs were administered in mouse models of OVA induced inflammatory disease [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. In addition, earlier studies from these same authors revealed exacerbation effects of CNPs on AHR, eosinophils, lymphocytes, IL-13 and mucus hypersecretion, which was more severe when CNPs were administered just before, rather than after allergen challenge [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Gold NPs (AuNPs) and TiO<sub>2</sub>NPs have been examined using a model of occupational asthma, where exposure of toluene diisocyanate sensitised mice to either NP resulted in an increase in AAD with AuNPs showing greater effects [<xref ref-type="bibr" rid="CR63">63</xref>]. The doses used in this study were comparably lower than the majority of other similar <italic toggle="yes">in vivo</italic> studies and aimed to reproduce occupational exposure levels.</p><p id="Par15">Copper oxide NPs (CuONPs) displayed noted potency for their ability to exacerbate AHR, mucus hypersecretion and allergic inflammatory markers including IgE, IL-5 and IL-13 in murine OVA induced&#160;AAD, with dose dependent effects observed from 25 to 100&#956;g/kg [<xref ref-type="bibr" rid="CR64">64</xref>]. Graphene oxide (GO) is another NP examined for exacerbation effects in an allergic airway model of exposure. Repeat administration at the challenge phase of the protocol did not significantly modulate allergic endpoints but did cause significant neutrophilia [<xref ref-type="bibr" rid="CR65">65</xref>]. Dose dependent increases in inflammatory cell infiltrates including macrophages and eosinophils were induced by SiO<sub>2</sub>NPs and accompanied by increased Th2 type inflammation and mucin hypersecretion [<xref ref-type="bibr" rid="CR66">66</xref>].</p><p id="Par16">Interestingly, the effects of MWCNTs in their ability to aggravate pre-existing AAD appear modest. Ryman-Rasmussen and colleagues demonstrated no effect on inflammatory cell infiltration at either 1 or 14 days post challenge exposure. There was however a modest increase in IL-5 which was suggested as a potential contributor to fibrotic events observed only with MWCNTs and OVA treatment at day 14 [<xref ref-type="bibr" rid="CR67">67</xref>]. This lack of modifying effect was also observed in a rat model of trimellitic anhydride induced allergy [<xref ref-type="bibr" rid="CR68">68</xref>] and a murine OVA allergy model [<xref ref-type="bibr" rid="CR69">69</xref>] while inhibitory effects were observed for eosinophil and macrophage infiltration in another&#160;study [<xref ref-type="bibr" rid="CR70">70</xref>]. Moderate exacerbation responses were also observed in a HDM model of AAI [<xref ref-type="bibr" rid="CR71">71</xref>].</p></sec></sec><sec id="Sec5"><title>Mechanistic insight into how nanomaterials may influence asthma</title><p id="Par17"> An understanding of how NMs with defined characteristics influence models of asthma and AAD has the potential to identify characteristics or material types that can be linked to molecular and cellular events critical for disease initiation and exacerbation in humans. This information can be used to identify NM &#8220;properties of concern&#8221; but importantly can also be used to improve choices surrounding relevant endpoints of disease, model selection, testing approaches and prediction strategies towards a more complete assessment of NM hazard. In this part of the review we will document those studies, which have explored key mechanistic events in models of asthma and AAD suggested as underpinning NM adverse effects. This will include discussion of not just <italic toggle="yes">in vivo</italic> approaches but those attempts at modelling key events <italic toggle="yes">in vitro</italic> (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3).</p><sec id="Sec6"><title>Direct effects on sensitisation in allergic airway disease</title><p id="Par18">The development of an adaptive immune response to an allergen is central to those with AAD. This process typically involves dendritic cells, which take up antigen, become activated, mature and travel to lymph nodes where they present these antigens to T and B cells to direct their differentiation to specific functional phenotypes.</p><p id="Par19">The influence of NMs on this process has been examined <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic>, with initial studies focussing on the role of the dendritic cell and T-cell interaction. Using adoptively transferred DO11.10 CD4+ T-cells in mice, which respond specifically to OVA peptides presented from antigen presenting cells, CNPs when administered to the lung in combination with OVA induced a proliferative response [<xref ref-type="bibr" rid="CR72">72</xref>]. This T-cell response indicates increased dendritic cell (DC) antigen presentation. The number of myeloid dendritic cells (DCs) as well as the expression of DC maturation markers CD80 and CD86 in the peribronchial lymph nodes of these mice were also increased. Knockout (KO) mice deficient for these dendritic cell co-stimulatory molecules failed to produce the adjuvant effects of CNPs on AAI. A direct maturation effect of CNPs on dendritic cells <italic toggle="yes">in vitro</italic> was also demonstrated, altogether providing strong evidence that the sensitising effects of CNPs in AAD in this KO model arise from direct effects on dendritic cell maturation [<xref ref-type="bibr" rid="CR72">72</xref>]. A size dependent accumulation of antigen presenting cells induced by CNPs in the mouse lung has also been observed, where 14nm but not 56nm sized particles increased the number of cells positive for CD80, CD86 and MHC class II [<xref ref-type="bibr" rid="CR39">39</xref>]. Moreover, this size dependency was observed <italic toggle="yes">in vitro</italic> through the ability of 14nm but not 56nm CNPs to enhance T-cell proliferation in an allogeneic mixed lymphocyte reaction assay [<xref ref-type="bibr" rid="CR73">73</xref>]. Direct effects of CNPs on T-cell differentiation have also been documented. Splenic leukocytes from DO11.10 transgenic mice were incubated with ovalbumin and two different sizes of CNPs (22nm and 39nm) were examined and shown to have little effect on OVA induced T-cell proliferation. However, the smaller CNPs induced the expression of Th2 cytokines including IL-4 and IL-13 to a greater extent than the larger [<xref ref-type="bibr" rid="CR74">74</xref>]. Interestingly, cell free BAL from CNPs instilled mice can induce the maturation of bone marrow derived dendritic cells (CCR7 expression) pointing towards soluble factors released within the lung as also having a role in directing the sensitisation process [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par20">In addition to CNPs other types of nanomaterials have been investigated for their ability to modify dendritic and T-cell responses. Chen and colleagues demonstrated that PEGylated SiO<sub>2</sub>NPs have direct effects on T-cell differentiation signals (IL-2 and IFN&#947;), but this was only observed for CD8+, not CD4+ T-cells [<xref ref-type="bibr" rid="CR75">75</xref>]. The ability of SiO<sub>2</sub>NPs to enhance cross-presentation of dendritic cell antigens to CD8+ T-cells has also been observed [<xref ref-type="bibr" rid="CR76">76</xref>]. Both these studies demonstrate size dependent effects and while no direct effects on allergy related CD4+ T cell differentiation were observed, it is further evidence&#160;that NPs can influence the adaptive immune response.</p><p id="Par21">Studies on the mechanisms through which adjuvant activity of NPs may occur have focussed not only on how cellular behaviour and differentiation can be altered but also on what molecular interactions drive such responses. Early insight stemmed from initial observations that CNPs enhanced AAD, and that this correlated with the level of cellular oxidative damage in lung tissue [<xref ref-type="bibr" rid="CR37">37</xref>]. This oxidative injury has also been observed with SWCNTs as increased lipid peroxidation and 8-hydroxy-2&#8242;-deoxyguanosine staining within the lung [<xref ref-type="bibr" rid="CR52">52</xref>]. These changes were paralleled by an increase in the maturation of bone marrow derived dendritic cells and antigen-specific syngeneic T-cell-stimulating capacity <italic toggle="yes">in vitro</italic>. However, it was not determined which cell type accounted for oxidative injury or what characteristic of the SWCNTs may be responsible for these changes [<xref ref-type="bibr" rid="CR52">52</xref>]. A role for oxidative injury in SWCNTs mediated worsening of AAD development and adjuvant activity was also suggested from the observations that vitamin E co-administration attenuated oxidation biomarkers and the detrimental effects of the NP [<xref ref-type="bibr" rid="CR53">53</xref>]. Again however, there was no suggestion as to the precise cellular and molecular events underlying these observations.</p><p id="Par22">Oxidative surface chemistry and increases in reactive oxidant species (ROS) within living systems are not necessarily directly related but have been put forward to explain differential dendritic cell maturation and T-cell responses. Human primary monocyte derived dendritic cells were exposed to either TiO<sub>2</sub>NPs or cerium dioxide NPs (CeO<sub>2</sub>NPs) identified as having oxidative and reductive surface chemistry respectively. TiO<sub>2</sub>NPs induced cellular injury was accompanied by DC maturation and&#160;increased expression of CD83, CD80, CD86 and CCR7 together with&#160;the induction of IL-12 and TNF-&#945;. CeO<sub>2</sub>NPs on the other hand did not result in any significant changes in cellular viability or maturation markers, but did produce IL-10 and IL-6. T-cell responses to these NP treated dendritic cells (DCs) were also examined, with TiO<sub>2</sub>NPs inducing a profile of Th1 cytokine production (IL-2, IFN-y) and CeO<sub>2</sub>NPs inducing a Th2 response (IL-4, IL-5, IL-10). The authors suggest that the oxidative capacity of TiO<sub>2</sub>NPs was responsible for increased ROS mediated inflammasome activation (IL-1&#946;), DC maturation and differentiation of T-cells towards a Th1 profile. They also suggest, in contrast that the CeO<sub>2</sub>NPs, which induced anti-inflammatory IL-10 and Th2 biased responses, could be attributed to the anti-oxidant surface chemistry of this NP [<xref ref-type="bibr" rid="CR77">77</xref>]. While this is an interesting set of observations, it cannot be ruled out that surface chemistry independent effects played a role.</p><p id="Par23">The effects of PSNPs on AAD have also been attributed to alterations in DC function. These NPs (PS50G; glycine coated 50nm size) when administered 12 days before sensitisation to OVA resulted in an inhibition of AAI, mucus hypersecretion, allergen specific IgE levels and Th2 cytokines in the lung draining lymph nodes [<xref ref-type="bibr" rid="CR78">78</xref>], effects not observed with larger sub-micron sized particles of the same material [<xref ref-type="bibr" rid="CR79">79</xref>]. This inhibition was not attributed to effects on sensitisation but rather DC function at the challenge phase, explained by a reduction in the numbers of allergen-containing CD11b<sup>hi</sup>MHCII<sup>hi</sup> DCs in the lung and CD11c<sup>+</sup>MHCII<sup>hi</sup> DCs in the lung and draining lymph nodes. An additional mechanism was suggested as PS50G abolished the ability of CD11b<sup>+</sup> DCs to induce OVA specific CD4+ T-cell proliferation [<xref ref-type="bibr" rid="CR78">78</xref>]. Further investigation into these effects demonstrated that PS50G induced DC recruitment and maturation through cytokine induction in the lung but with a reduced number of stimulatory DCs translocating to the lymph node [<xref ref-type="bibr" rid="CR79">79</xref>]. Interestingly the authors have suggested that given the timescale of NP administration 12 days before the start of sensitisation, DC refractoriness as a consequence of activation in the absence of OVA may account for the inability to mount an adaptive immune response at the challenge phase [<xref ref-type="bibr" rid="CR78">78</xref>]. Furthermore, it was speculated that evolutionary conserved responses to viral sized particles, which would aim to limit inflammatory reactions not focussed on anti-viral immunity (e.g. Th1 T-cell activation) such as Th2 type adaptive immune responses, may be activated by the nanoscale properties of NPs and contribute to the inhibitory effects. This can be supported by observations that PS50G did not result in inhibition of allergen specific lymph node production of IFN&#947; or have any effect on Th1 anti-viral immunity in an acute lung influenza virus infection model [<xref ref-type="bibr" rid="CR78">78</xref>].</p><p id="Par24">The inhibitory effects of PS50G on AAI also did not extend to inhibition of AHR [<xref ref-type="bibr" rid="CR78">78</xref>]. This disparity between NP effects on allergic inflammation and AHR has been observed for other types of NPs. Graphene oxide (GO) augments AHR, goblet cell hyperplasia and smooth muscle hypertrophy in OVA induced allergic airway disease while at the same time inhibiting Th2 cytokine production, eosinophilia and IgE levels [<xref ref-type="bibr" rid="CR65">65</xref>]. The mechanism put forward to explain this suggested that&#160;increased macrophages within the lung and their production of chitinases such as CHI3L1 contributes&#160;to airway remodelling/hyperresponsiveness and favours the development of Th1 over Th2 type responses.&#160;These observations were&#160;supported by increased levels of OVA specific IgG2a [<xref ref-type="bibr" rid="CR65">65</xref>]. Inhibition of adjuvant activity and AAI has been observed for other nanomaterials, including Fe<sub>2</sub>O<sub>3</sub> [<xref ref-type="bibr" rid="CR80">80</xref>] and SiO<sub>2</sub> coated TiO<sub>2</sub> [<xref ref-type="bibr" rid="CR81">81</xref>] where they were found to have size and dose dependent effects. While the authors speculate that&#160;the mechanism through which this inhibition occurred&#160;involved dendritic cell modification, modulation of the balance of Th1/Th2 T-cell responses and direct effects on regulatory T-cells, no supporting evidence was offered.</p><p id="Par25">Aluminium salts, the most commonly used adjuvant in humans, have been well characterised for their ability to promote the development of adaptive immunity to co-administered allergens, such as OVA, producing a predominant Th2 type immune response [<xref ref-type="bibr" rid="CR82">82</xref>]. The classic understanding of how these adjuvants have their effects has been described in terms of their ability to aggregate antigens, stabilise protein structure, prevent degradation and to provide a pool of material for continuous release to antigen presenting cells [<xref ref-type="bibr" rid="CR83">83</xref>]. However, recent work has suggested that other mechanisms are involved&#160;as a likely consequence of direct cellular injury, including the activation of innate immune responses and the recruitment of inflammatory cells. Activation of the NLRP3 inflammasome as a consequence of particulate lysosomal overload in resident phagocytes (including macrophages and dendritic cells), uric acid release and subsequent caspase-1 activation and release of inflammatory cytokines, such as IL-1&#946;, IL-18 and IL-33, have also been suggested as important events underlying adjuvant activity [<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>].</p><p id="Par26">Given the particulate nature of NPs it is perhaps unsurprising that these same mechanisms have been suggested to underlie NP modifying effects on adjuvancy [<xref ref-type="bibr" rid="CR86">86</xref>]. Particular attention has been given to the potential role of the NLRP3 inflammasome, with nanomaterials including AgNPs, TiO<sub>2</sub>NPs, SiO<sub>2</sub>NPs and CNTs all inducing markers of this pathway&#8217;s activation [<xref ref-type="bibr" rid="CR87">87</xref>&#8211;<xref ref-type="bibr" rid="CR89">89</xref>]. Using gene KO approaches, a direct role for the&#160;NLRP3 inflammasome in mediating the IL-1&#946; response to TiO<sub>2</sub>NPs in macrophages and dendritic cells has been demonstrated. IL-1&#945; but not NLRP3 however, was identified as a major control point for neutrophilic responses after instillation in murine lung [<xref ref-type="bibr" rid="CR90">90</xref>]. Nano sized particulate forms of TiO<sub>2</sub> and SiO<sub>2</sub> were observed to have a greater impact than submicron sized particles of the same material on the&#160;maturation of bone marrow derived dendritic cells. Using KO mice, IL-1&#946; responses to these NPs in dendritic cells were found to be NLRP3 and caspase-1 dependent [<xref ref-type="bibr" rid="CR91">91</xref>]. Mechanistic insight into how NPs may preferentially activate the inflammasome to induce release of IL-1&#946; and IL-18 in dendritic cells stemmed from observations that production of these mediators was greater with 30nm SiO<sub>2</sub>NPs than larger nano or sub-micron sized particles. The authors went on to demonstrate size dependent effects on cellular uptake, ATP release and ROS production and through interventional studies suggest a sequential mechanism involving NP uptake, lysosomal injury, ATP mediated activation of purinergic receptors and NADPH oxidase dependent production of ROS as a terminal signalling event for inflammasome activation [<xref ref-type="bibr" rid="CR92">92</xref>].</p><p id="Par27">Other mechanisms of NP effects on the adaptive immune system include examples where exosomes were induced in the alveolar region after inhalation of magnetic iron NPs. These exosomes incorporate antigen for systemic delivery to antigen presenting cells such as dendritic cells and modulate T-cell differentiation towards a Th1 T-cell phenotype [<xref ref-type="bibr" rid="CR93">93</xref>]. While Th2 and Th17 immune responses are more commonly associated with asthma it is still of considerable interest that modulation of the immune system in this way by NPs can occur. Furthermore, it is interesting to speculate as to whether other types of material can induce exosome formation to direct other types of hypersensitivity reactions.</p><p id="Par28">Th17 inflammation and the neutrophilic response are a significant component within the asthma phenotype particularly in those with severe asthma [<xref ref-type="bibr" rid="CR94">94</xref>, <xref ref-type="bibr" rid="CR95">95</xref>]. Through the use of genetic KO and cell depletion models, evidence points towards a direct role for neutrophils in controlling AHR [<xref ref-type="bibr" rid="CR96">96</xref>]. Whether NP induced neutrophilic responses contribute to AHR and modify Th17 responses is relatively unexplored. One study using the chemical compound ectoine, which preferentially reduced BAL neutrophils (with no changes in other BAL cells), suggested that the protective effects of this compound on CNPs adjuvancy (IgE, Th2 profile) may be attributed to the reduction in neutrophils [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par29">Lastly, the airway epithelium has been observed to play a central role in the development of sensitisation in asthma, mainly through the ability to detect allergens and associated injury and respond by producing signals such as TSLP, GMCSF, IL-25 and IL-33, which target dendritic cells to initiate sensitisation mechanisms [<xref ref-type="bibr" rid="CR97">97</xref>]. Examples of how NPs can impact on this process include an <italic toggle="yes">in vivo</italic> HDM induced allergy model where the airway epithelium was proposed as the primary source for signals governing airway sensitisation in response to MWCNTs [<xref ref-type="bibr" rid="CR51">51</xref>]. Similar suggestions have been made for IL-33 production in&#160;the murine lung by MWCNTs in an OVA induced AAD model [<xref ref-type="bibr" rid="CR49">49</xref>]. 16HBE14o- airway epithelial cell exposure to&#160;CNPs and TiO<sub>2</sub> NPs resulted in an increase in GMCSF, which was suggested as a consequence of either NP&#160;intrinsic capability or cellular induction of oxidative stress depending on the material type, and that this effect was size, surface area and cellular internalisation dependent [<xref ref-type="bibr" rid="CR98">98</xref>]. SiO<sub>2</sub>NPs have also been observed to induce GMCSF from BEAS2B airway epithelial cells [<xref ref-type="bibr" rid="CR99">99</xref>].</p></sec><sec id="Sec7"><title>Insight into the impact of nanomaterials on established allergic airway disease</title><p id="Par30">With the shift to Th2 type adaptive immunity in allergy, B-cell class switching to IgE production and its&#160;subsequent release occurs. This is&#160;followed by FC&#917;RI&#945; receptor binding in cells and tissues resulting in inflammatory responses when allergen is reencountered. In atopic individuals, allergen binding to IgE present on mast cells and basophils induces the release of pre-existing&#160;pro-inflammatory mediators such as histamine, proteases, proteoglycans and cytokines [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]. This process is a central mechanism for how allergen induced asthma exacerbations manifest at a cellular level.</p><p id="Par31">A number of studies have examined how NPs can impact mast cell function. TiO<sub>2</sub>NPs have been demonstrated to induce the degranulation of RBL-2H3 mast cells with the release of histamine, in an oxidative stress and calcium flux signalling dependent manner [<xref ref-type="bibr" rid="CR102">102</xref>]. This effect was observed without any IgE mast cell priming and suggests that these NPs may directly activate mast cells <italic toggle="yes">in vivo</italic> independent of allergen. Similar findings were observed with AgNPs where degranulation of murine bone marrow derived mast cells was also examined for effects independent of IgE. The smaller sized 20nm but not 110nm sized particles resulted in degranulation, which was found to be dependent on scavenger receptor signalling, indicating cellular uptake as important. Extracellular Ag<sup>+</sup> ions did not have any effect [<xref ref-type="bibr" rid="CR103">103</xref>]. Interestingly, pulmonary instillation of CeO<sub>2</sub>NPs induced inflammatory cell and mediator production, which was not observed in mice deficient in mast cells. This study also examined bone marrow derived mast cells and found that CeO<sub>2</sub>NPs induced inflammatory mediator production from IgE/allergen primed cells but did not induce degranulation [<xref ref-type="bibr" rid="CR104">104</xref>]. As observations of the effects of nano-sized materials on asthma exacerbation also include inhibitory or protective effects, it is interesting to note examples where attempts have been made to interrogate how this may occur. Fullerene derivatives have been observed to stabilise mast cells, prevent IgE dependent activation and to attenuate disease parameters in both exacerbation and sensitisation models of asthma [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. These fullerene derivatives possess inherent anti-oxidant capabilities derived from their ability to catalytically scavenge large numbers of oxygen free radicals [<xref ref-type="bibr" rid="CR107">107</xref>] and this&#160;has been suggested as a mechanism through which they elicit their biological effects. This material has also been reported to increase production of P-450 derived cis-epoxyeicosatrienoic acids, eicosanoid metabolites in the lung, which stabilise and prevent IgE mediated mast cell degranulation [<xref ref-type="bibr" rid="CR106">106</xref>]. SWCNTs were also observed to inhibit IgE mediated RBL2H3 degranulation. In this study the authors pointed to structural similarities to fullerene derivatives but in the absence of a demonstrated&#160;ROS scavenging capability of SWCNTs the mechanism underlying this attenuating effect is yet to be determined [<xref ref-type="bibr" rid="CR108">108</xref>]. ZnONPs were found to inhibit OVA induced degranulation of OVA specific IgE primed RBL2H3 cells, which was not observed with larger sized ZnO particles. These effects were correlated with levels of intracellular Zn<sup>2+</sup> ions, and administration of ZnSO<sub>4</sub> also produced an inhibitory effect on mast cell degranulation. ZnONPs have also been observed to inhibit both basal and IgE mediated degranulation of RBL2H3 and bone marrow derived mast cells, which was observed to a much greater extent for the 30nm rather than the 200nm sized particles. In contrast, TiO<sub>2</sub>NPs examined in the same study, produced a modest increase in mast cell degranulation. Observations that smaller particles produced a greater increase in intracellular Zn<sup>2+</sup> ions and a decrease in Ca<sup>2+</sup> concentrations than larger particles was suggested as a mechanism through which degranulation was inhibited [<xref ref-type="bibr" rid="CR109">109</xref>].</p><p id="Par32">Similar to investigations of sensitisation and AAD development, oxidative and electrophilic stress has also been put forward&#160;as a molecular control point for exacerbation of pre-existing AAD. Inhalation of CNPs, for example just prior to allergen challenge <italic toggle="yes">in vivo</italic> resulted in exacerbation of allergic inflammation and AHR, which was attenuated by systemic administration of the anti-oxidant compound N-acetyl cysteine [<xref ref-type="bibr" rid="CR110">110</xref>]. CuONPs have also been reported to increase disease associated ROS levels in a murine model of OVA induced AAI, which correlated with the degree of exacerbation [<xref ref-type="bibr" rid="CR64">64</xref>]. NPs can have pro-oxidant functional groups, can possess redox cycling ability and may generate ROS from perturbation of cellular processes such as the mitochondria. Determining whether a NP has any or all of these characteristics will be important for attempts at classification of materials likely to contribute to asthma exacerbations in humans.</p><p id="Par33">In addition to fullerene derivatives [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>], anti-oxidant capabilities have also been suggested as a mechanism of inhibition of OVA induced AAD by AgNPs [<xref ref-type="bibr" rid="CR111">111</xref>]. The authors in this study&#160;did not identify cellular targets for the attenuating effects on ROS levels and disease parameters, or whether inherent anti-oxidant properties of AgNPs or the prevention of cellular events leading to ROS generation were responsible for the observed inhibitory effects. Using the same model in a follow on study the authors suggest signalling molecules including HIF-1&#945; and RTK signalling as possible contributors [<xref ref-type="bibr" rid="CR112">112</xref>]. In contrast, AgNPs have been observed to induce ROS in cell free [<xref ref-type="bibr" rid="CR113">113</xref>] as well as upon interaction with cellular [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>] systems, and have been demonstrated to induce oxidative stress in&#160;other investigations of OVA induced murine AAD [<xref ref-type="bibr" rid="CR116">116</xref>]. The reasons for these differential effects with AgNPs could be attributed to particle differences such as size, as well as model specific parameters including dose effects. The inhibitory effects of AuNPs on AAD have been reported in a study by Barreto and colleagues, using two different mouse strains, an effect that was associated with a decrease in ROS generation in BAL cells [<xref ref-type="bibr" rid="CR117">117</xref>]. One similarity between these studies on AuNPs and AgNPs was that the smaller primary-sized particles (6nm) of both materials were associated with inhibitory effects, while the larger-sized was&#160;associated with exacerbation effects.</p><p id="Par34">TiO<sub>2</sub>NPs have been observed to reduce AAI in rats with pre-existing disease. Here it was argued that a direct effect on Th2 type inflammation was the mechanism through which this effect manifested. It was also suggested that the lack of&#160;inhibitory effects in other studies, could be attributable to different routes of administration (aerosol versus instillation) causing different agglomeration, deposition patterns and biological responses within the lung [<xref ref-type="bibr" rid="CR118">118</xref>]. Inhibitory effects of TiO<sub>2</sub>NPs on AAI were also observed in different rat strains [<xref ref-type="bibr" rid="CR119">119</xref>]. This was paralleled by TiO<sub>2</sub>NPs induced increases in&#160;neutrophil and lymphocyte pulmonary responses in dark agouti rats, which are predisposed to chronic inflammatory disorders, but not in Brown Norway rats, which are pre-disposed to allergic responses. [<xref ref-type="bibr" rid="CR119">119</xref>]. In&#160;addition to these effects, another study demonstrated that&#160;a single dose of TiO<sub>2</sub>NPs given at the challenge phase resulted in an exacerbation of AAI and AHR. Repeat dose exposure&#160;in the same model, while resulting in reduced allergic inflammatory markers and AHR, resulted in a marked neutrophilic response and body weight loss pointing towards effects associated with general health decline rather than any protective response attributable to the particles [<xref ref-type="bibr" rid="CR120">120</xref>]. The authors also suggest that activation of the inflammasome via ROS generation may contribute to the responses observed in this study.</p><p id="Par35">Surface chemistry has been proposed as an important determinant of NM effects on biological systems. Uncoated SiO<sub>2</sub>NPs were observed to exacerbate AAD in an OVA-induced mouse model. When the NPs were coated with either amino or phosphate groups this exacerbation effect was attenuated. Macrophage activation markers were not induced by the modified particles and it was suggested that recognition and uptake of the NPs by macrophages were attenuated potentially as a result of protein corona differences in the NPs. Other mechanisms suggested for the lack of effect with coated materials include a modified ability to affect the thermodynamic characteristics of lipid monolayers, including lung surfactant and cell membranes [<xref ref-type="bibr" rid="CR66">66</xref>].</p><p id="Par36">Additional mechanisms for how NM may affect those with pre-existing AAD include the ability to enhance the presentation of allergens. The HDM allergen DERP1 when coated onto AuNPs produced stronger basophil activation from allergic patients compared to exposure to the same amount of free allergen and was correlated with protease activity of the&#160;allergen [<xref ref-type="bibr" rid="CR121">121</xref>]. In addition to activation and degranulation of mast cells and basophils as part of exacerbation events, direct effects of NPs on neutrophil and eosinophil responses have also been investigated. Primary human peripheral blood derived neutrophil degranulation was significantly induced by TiO<sub>2</sub>NPs and CeO<sub>2</sub>NPs with ZnONPs producing a more modest effect. Interestingly these effects were more potent than the classical bacterial FMLP agonist [<xref ref-type="bibr" rid="CR122">122</xref>]. A number of other studies have demonstrated activation of neutrophils by NPs, with intracellular events such as calcium signalling proposed as key in the induction of a respiratory burst and inflammatory mediator transcription and release. One such study investigated the sub-lethal impact of different NPs on HL-60 neutrophil like cells and found that AgNPs but not TiO<sub>2</sub>NPs, ZnONPs, CNPs or MWCNTs induced increases in intracellular Ca<sup>2+</sup> levels [<xref ref-type="bibr" rid="CR123">123</xref>]. Direct activation of eosinophils was observed for ZnONPs and 20nm AgNPs but not CeO<sub>2</sub>NPs, TiO<sub>2</sub>NPs and 70nm AgNPs [<xref ref-type="bibr" rid="CR124">124</xref>]. ZnONPs were also observed to have similar effects in primary human eosinophils in another study from the same group [<xref ref-type="bibr" rid="CR125">125</xref>]. Whether such effects are relevant for modulation of exacerbation in AAD has yet to be determined.</p><p id="Par37">Regulation, recruitment and control of immune and inflammatory signalling is becoming more of a focus for how NMs elicit biological responses and contribute to exacerbation of airway disease. Interventional strategies including gene KO approaches have been used to interrogate how particular inflammatory signalling events and pathways contribute to NM exacerbation effects. Using such knockout approaches, MWCNTs were shown to exacerbate OVA induced AAI through a mechanism involving cyclooxygenase 2 (PTGS2) activity, an enzyme that controls levels of prostaglandins, key regulators of immune system responses [<xref ref-type="bibr" rid="CR70">70</xref>]. In addition, the ability of MWCNTs to cause exacerbation of AAI <italic toggle="yes">in vivo</italic> was further enhanced through KO of the STAT1 gene [<xref ref-type="bibr" rid="CR69">69</xref>], a transcription factor important for mediating interferon and Th1 signals, immune cell signals suggested as having protective effects in allergic asthma. Similar to effects on sensitisation, exosome formation in the alveolar region after inhalation of magnetic iron oxide (Fe<sub>2</sub>O<sub>3</sub>) NPs, has also been suggested as a mechanism through which regulation of Th1 T-cell responses are guided in exacerbation of AAI [<xref ref-type="bibr" rid="CR93">93</xref>]. Lastly, MWCNTs administered to mice were found to produce a strong neutrophilic response, which was diminished in animals with pre-existing HDM induced AAI [<xref ref-type="bibr" rid="CR71">71</xref>]. MWCNTs did not alter the level of eosinophils or other Th2 inflammatory markers but did result in a more severe airway fibrosis. Decreased IL-1&#946; levels together with <italic toggle="yes">in vitro</italic> investigations in this study suggest that an allergic inflammatory environment inhibits inflammasome activation through a STAT6 mechanism and that this may be responsible for the exacerbated fibrotic response observed with MWCNTs exposure [<xref ref-type="bibr" rid="CR71">71</xref>].</p></sec><sec id="Sec8"><title>Mechanisms of asthma development and exacerbation independent of allergic sensitisation</title><p id="Par38">Modelling of asthma using rodent allergic airway disease models as the prototypical testing paradigm does not reflect all types of asthmatic disease in humans. Mechanistic insight into how environmental exposures may influence disease is therefore, potentially overshadowed by predominant discussion of how materials affect allergic responses and Th2 type inflammation. A summary of those studies with observations independent of allergy driven disease identified within our search parameters are documented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S1 and S2. Those studies primarily focussed on allergen independent models are summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1, while those observations independent of allergen effects but documented as part of larger allergen driven model studies are summarized in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2.</p><p id="Par39">Some of the earliest studies to investigate the pulmonary effects of nanomaterial exposure did not specifically set out to model the potential impact on disease conditions such as asthma. However observations including neutrophil and inflammatory mediator alterations can be viewed not just in terms of broad pulmonary toxicity effects but as having the potential to influence disease initiation and progression in conditions such as asthma and AAD. One of these early studies set out to compare similar sized metallic NPs after pulmonary instillation in rats. It was demonstrated that the&#160;level of toxicity and neutrophil response was material specific with nickel (Ni) and cobalt (Co) having the greatest effects. It was suggested that the surface chemistry of these materials as expressed in terms of their ability to generate reactive oxygen species, governed specific potency [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. Other factors including NP solubility and surface area have been put forward as the most significant characteristics influencing NP toxicity after pulmonary exposure and have been reviewed extensively elsewhere [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>].</p><p id="Par40">In a clinical setting, treatment strategies targeting Th2 type inflammation reduce allergic exacerbation rates but have little effect on baseline measures of asthma activity such as AHR [<xref ref-type="bibr" rid="CR130">130</xref>]. These and other observations support the suggestion that asthma should be considered as a condition with a fundamental abnormality in smooth muscle function that underlies diminished lung function and AHR [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]. The concept that AHR and allergic inflammation are not exclusively linked is consistent with observations in this review and has been discussed previously. Indeed, direct effects on AHR have been observed in the absence of allergic airway modelling for AgNPs, TiO<sub>2</sub>NPs, SWCNTs and MWCNTs exposures [<xref ref-type="bibr" rid="CR132">132</xref>&#8211;<xref ref-type="bibr" rid="CR136">136</xref>]. While an understanding of how such effects on AHR manifest is unknown at this time, it is clear that smooth muscle cells are likely to have a central role [<xref ref-type="bibr" rid="CR137">137</xref>]. The direct impact of nanomaterials on smooth muscle has been explored to a&#160;limited extent. TiO<sub>2</sub>NPs instillation in mice resulted in changes in lung gene expression consistent with effects on ion homeostasis and smooth muscle contractibility [<xref ref-type="bibr" rid="CR138">138</xref>]. <italic toggle="yes">Ex vivo</italic> examination of AgNP applied directly to rat tracheal rings found that the nanoparticles caused a non-reversible contractile response to acetylcholine [<xref ref-type="bibr" rid="CR139">139</xref>]. It was suggested that these NPs may interact with and modify muscarinic receptors on smooth muscle and induce nitric oxide as a mechanism to directly influence contractility. Additional observations using <italic toggle="yes">ex vivo</italic> smooth muscle preparations have also revealed increased contractility on exposure to SnO<sub>2</sub>NPs and CoFe<sub>2</sub>O<sub>4</sub>NPs [<xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]. <italic toggle="yes">In vitro</italic> modelling of smooth muscle cells and exposure to NPs has also been attempted to a limited extent. AuNPs were observed to directly alter plasma membrane potential and intracellular calcium signalling in human airway smooth muscle cells in a charge dependent manner [<xref ref-type="bibr" rid="CR142">142</xref>]. Intracellular calcium signalling is intimately involved in muscle contraction and suggests such direct modifications by AuNPs could impact contractility and ultimately AHR. An examination of different NP effects on human airway smooth muscle cell mechanical function after direct exposure, using optical magnetic twisting cytometry revealed material specific, dose and size dependent effects [<xref ref-type="bibr" rid="CR143">143</xref>]. These included CuONPs, which inhibited smooth muscle cell stiffness, histamine contractility and isoproterenol relaxation, while larger micron sized CuO particles did not.</p><p id="Par41">In addition to smooth muscle cells, airway remodelling and AHR in asthma are associated with peribronchial fibrosis and fibroblast expansion [<xref ref-type="bibr" rid="CR144">144</xref>]. Nanomaterial influence on this aspect of airway disease has revealed direct effects, including the ability of graphene oxide, NiNPs and MWCNTs to increase extracellular matrix deposition after pulmonary instillation [<xref ref-type="bibr" rid="CR145">145</xref>&#8211;<xref ref-type="bibr" rid="CR148">148</xref>]. This profibrotic effect within the lung has also been observed for CeO<sub>2</sub>NPs, ZnONPs and SWCNTs [<xref ref-type="bibr" rid="CR148">148</xref>&#8211;<xref ref-type="bibr" rid="CR151">151</xref>]. The involvement of the innate immune system may also play a role here. An investigation into MWCNTs effects suggests that airway epithelial signals initiated by inflammasome activation induce fibroblast proliferation and pro-fibrotic gene expression [<xref ref-type="bibr" rid="CR152">152</xref>]. IL-33 is an epithelial cell derived innate immune signal, which can influence type 2 inflammatory events. Knockout (KO) of IL-33 in mice causes an inhibition of the inflammation, peribronchial fibrosis and AHR induced by MWCNTs [<xref ref-type="bibr" rid="CR153">153</xref>]. The STAT1 transcription factor, which is involved in intracellular inflammatory signalling, also contributes to MWCNTs induced airway pro-fibrotic exacerbation in mice [<xref ref-type="bibr" rid="CR69">69</xref>]. Further examination of NP effects in pre-existing allergic airway disease revealed that SWCNTs and MWCNTs also induce airway fibrosis [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. Whether allergic inflammation was necessary for these later effects was not fully investigated. Airway epithelial cells have been argued as central players not only in directing inflammation but also&#160;in the control of fibrotic signalling in response to inhaled material. In addition to fibroblast to myofibroblast transition, epithelial to mesenchymal transition (EMT) in response to MWCNTs exposure has been proposed to contribute to pulmonary fibrosis. [<xref ref-type="bibr" rid="CR154">154</xref>]. Instillation of MWCNTs in the mouse lung also resulted in peribronchial as well as alveolar fibrosis in another study and a role for epithelial mesenchymal transition was also suggested [<xref ref-type="bibr" rid="CR155">155</xref>]. While a significant body of work has focussed on MWCNTs, there is a distinct lack of interrogation of other types of particles for their effects on airway remodelling and fibrosis.</p><p id="Par42">Airway&#160;hyper-responsiveness and excessive mucin production are the principal mechanisms contributing to airway obstruction in asthma. The airway epithelium is the primary site for mucin release and is therefore an essential focus for the examination&#160;of&#160;nanomaterial effects. A recent study investigating the effects of NPs on mucin rheology found that positively charged polystyrene nanoparticles impaired mucin gel swelling causing mucin aggregation [<xref ref-type="bibr" rid="CR156">156</xref>]. It was suggested that NPs with these properties would impinge mucociliary clearance and contribute to adverse disease outcomes in conditions such as asthma. Studies to date have shown induction of mucus secretion accompanied by AHR independent of allergic sensitisation for CuONPs [<xref ref-type="bibr" rid="CR64">64</xref>] and MWCNTs [<xref ref-type="bibr" rid="CR134">134</xref>]. It is unclear&#160;how nanomaterials cause these effects. Whether it is a result of direct action on epithelial cells, secondary signalling events from inflammatory and other resident cells or a combination of all is still unknown. Some insight however has emerged from observations that cytokines including IL-13, Il-17A and IL-1&#946; can induce mucin production from airway epithelial cells. For example, in a rat pulmonary exposure study, it could be argued that TiO<sub>2</sub>NPs induced goblet cell hyperplasia and MUC5AC expression may be attributable to IL-13 produced from mast cells [<xref ref-type="bibr" rid="CR157">157</xref>]. Direct effects on airway epithelial cells through ROS and calcium signalling was also suggested to control TiO<sub>2</sub>NPs induced mucin secretion [<xref ref-type="bibr" rid="CR158">158</xref>]. Additional signalling events that may be important in the control of mucin production include airway epithelial MAPK signalling, an observation documented for CuONPs induced MUC5AC in H292 epithelial cells [<xref ref-type="bibr" rid="CR159">159</xref>].</p><p id="Par43">Airway epithelial cells are a primary target for inhaled material deposition and a control point for the recruitment of inflammatory cells. Chemokines such as IL-8, MCP1 and CCL28 act to recruit cells including neutrophils, monocytes, lymphocytes, eosinophils and dendritic cells. Production of these mediators from airway epithelial cells has been demonstrated in response to NPs including CNPs, TiO<sub>2</sub>NPs, MWCNTs, CeO<sub>2</sub>NPs, SiO<sub>2</sub>NPs, CoNPs and ZnONPs [<xref ref-type="bibr" rid="CR160">160</xref>&#8211;<xref ref-type="bibr" rid="CR167">167</xref>]. A greater understanding of these primary events in nanomaterial exposure and airway response is likely to lead to a more complete mechanistic understanding of the potential to contribute to asthma and airway disease.</p><p id="Par44">Mast cells are an important part not only for atopic but also non-atopic asthma [<xref ref-type="bibr" rid="CR168">168</xref>]. Exposure of mice to MWCNTs resulted in inflammatory responses and pulmonary functional changes similar to those observed in asthma, which were dependent on the presence of mast cells and their ability to respond to IL-33 [<xref ref-type="bibr" rid="CR169">169</xref>]. Additional investigations demonstrated a role for the IL-33/ST2 axis together with IL-13 signalling in MWCNTs induced AHR and inflammatory events, which were independent of T and B cell involvement [<xref ref-type="bibr" rid="CR135">135</xref>]. The authors suggest type 2 innate lymphoid cells (ILC2) recruited to the airways as a consequence of epithelial injury and IL-33 release as the primary events governing adverse effects. As these cells have the ability to produce type 2 cytokines such as IL-4, IL-5 and IL-13 in the absence of any adaptive immune response, they also&#160;represent an important target for how nanomaterials may impact asthma and obstructive airway disease [<xref ref-type="bibr" rid="CR170">170</xref>]. Other innate lymphoid cells such as ILC3 cells, which produce IL-22 and IL-17, through inflammasome activation, may also be important as they have been directly implicated in the mechanisms of AHR induction in the absence of adaptive immunity [<xref ref-type="bibr" rid="CR171">171</xref>].</p><p id="Par45">It is recognised that respiratory tract viral infection, mainly from rhinovirus (RV), is associated with the majority of asthma exacerbations in children and more than half of adults [<xref ref-type="bibr" rid="CR172">172</xref>]. The presence of Th2 type inflammation and asthma has also been associated with reduced antiviral defence in plasmacytoid dendritic cells and the airway epithelium, indicating increased susceptibility to viral mediated exacerbations in those with allergic inflammation [<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR174">174</xref>]. Despite this being a primary mechanism for asthma exacerbation, only a handful of investigations have been directed towards understanding how nanomaterial exposure, including ultrafine components of air pollution, may impact respiratory viral infections relevant for asthma. This is also true for the development of asthma. One of the earliest studies that did investigate&#160;such interactions focussed on mice exposed to CNPs prior to respiratory syncytial virus (RSV) infection [<xref ref-type="bibr" rid="CR175">175</xref>]. This virus causes lower respiratory tract infection and bronchiolitis and the severity of infection has been associated with the development of asthma. Despite alterations in the inflammatory response, including induction of Th2 markers such as IL-13, there were no significant effects of CNPs on RSV replication or viral clearance [<xref ref-type="bibr" rid="CR175">175</xref>]. In a similar study from the same group, CNPs were administered to mice after RSV infection and despite there being no difference in viral titre and clearance, there was an increase in pulmonary inflammation with CNPs, which was correlated to an increase in AHR [<xref ref-type="bibr" rid="CR176">176</xref>]. Similar to CNPs, TiO<sub>2</sub>NPs when administered prior to RSV infection in mice did not alter viral titres but did exacerbate inflammation and pneumonia [<xref ref-type="bibr" rid="CR177">177</xref>]. Gold nanorods interestingly have been observed to inhibit RSV infection levels in mice and airway epithelial cells, which correlated with the induction of antiviral gene expression and modulation of pattern recognition receptors [<xref ref-type="bibr" rid="CR178">178</xref>]. Other nanomaterials including SWCNTs, AgNPs and polystyrene NPs have all demonstrated modifying effects on viral infectivity or inflammatory consequences of respiratory viral infection [<xref ref-type="bibr" rid="CR179">179</xref>&#8211;<xref ref-type="bibr" rid="CR181">181</xref>]. These later studies however did not focus on viruses typically associated with asthma.</p></sec><sec id="Sec9"><title>Insight from nanomedicine approaches to vaccines and allergy</title><p id="Par46">NPs intended for medical use have also been investigated for modulation of sensitisation. PVA coated super-paramagnetic iron oxide nanoparticles (PVA-SPIONs) caused an&#160;inhibition of monocyte derived dendritic cells&#8217; ability to process antigen and stimulate CD4+ T cells, without affecting antigen uptake or markers of maturation. It was suggested that PVA-SPIONs induced reversion to a more immature dendritic cell phenotype involving the regulation of lysosomal function as a potential mechanism of action. PVA-SPIONs have a slightly positive charge and therefore bind proteins with an isoelectric point (pI) of &gt; 5.5. While not tested, it was suggested that NPs may bind proteins with a higher pI involved in antigen processing, such as Cathepsin B, H, L1 and DMB, and subsequently sequester their function, as a mechanism for how they attenuate dendritic cell function [<xref ref-type="bibr" rid="CR182">182</xref>]. The use of NMs in the development of novel vaccines has contributed significantly to our understanding of how NMs direct dendritic cell function and sensitisation to antigen. Supporting a role for particle charge in this process, a number of studies have observed that cationic NPs produce superior adjuvant responses following pulmonary delivery, when compared to anionic particles of the same material. Pulmonary immunization using OVA conjugated cationic rod shaped hydrogel NPs led to increased antibody titres, B-cell expansion and increased activation of CD4+ T-cell populations in the draining lymph nodes. These effects were not observed using anionic particles of the same material. <italic toggle="yes">Ex vivo</italic> treatment of dendritic cells with these cationic conjugated particles induced dendritic cell maturation markers and robust antigen specific T-cell proliferation, effects not observed with anionic particles or with OVA alone [<xref ref-type="bibr" rid="CR183">183</xref>]. In a follow on study from the same group, it was demonstrated that these positively charged NPs are preferentially taken up by dendritic cells (DCs) in contrast to negatively charged NPs, and were associated with an increased expression of the chemokines Ccl2 and Cxcl10, which possibly contribute to recruitment of Th2 promoting CD11b DCs to the lung [<xref ref-type="bibr" rid="CR184">184</xref>]. Using the same approach as the previous hydrogel studies to modify NP surface by the addition of chemical species for negative carboxyl (&#8722;COOH) and positive amino (&#8722;NH2) charge, a study examining the effect of PVA coated AuNPs found that after instillation into the lung, cationic particles were preferentially taken up by all antigen presenting cells including macrophages and DCs. This was accompanied by an increase in CD4+ T-cell OVA proliferative responses in lung draining lymph nodes, an effect not observed with the anionic NPs [<xref ref-type="bibr" rid="CR185">185</xref>].</p><p id="Par47">Interestingly, rapid translocation of NPs to the lymph nodes after pulmonary instillation, suggested as independent of cell mediated transport, in addition to being influenced by charge is highly size dependent [<xref ref-type="bibr" rid="CR186">186</xref>]. Size dependent preferential uptake of NPs by dendritic cells and translocation to lymph nodes was accompanied by enhanced T-cell responses when compared to larger sized particles [<xref ref-type="bibr" rid="CR187">187</xref>]. These studies have suggested an optimal NP uptake size of between 20 and 50nm for lymph node homing migratory DCs and other antigen presenting cells after pulmonary administration. In contrast, other studies have suggested roles for larger particles in adaptive immunity modulation. As part of strategic approaches to improve vaccine development, one study examined how antigen conjugated to particles in the viral size range influenced induction of adaptive immune responses. Intranasal administration of larger 200nm pluronic-stabilized poly(propylene sulphide) NPs (PSPNPs) were observed to deliver OVA antigen more efficiently into both MHC I and II presentation pathways and increase the number of poly functional CD+ T-cells when compared to the smaller 30nm size [<xref ref-type="bibr" rid="CR188">188</xref>]. Moreover, immunisation approaches using different size OVA conjugated PS beads administered intradermally found that larger sized beads (93nm, 101nm &amp; 123nm) induced IL-4 release from spleen derived CD4+ T-cells <italic toggle="yes">ex vivo</italic>, while smaller sized (40nm, 49nm) induced the release of IFN-&#947; from CD8+ T-cells. This size dependent effect on adaptive immunity patterning was suggested to be a direct result of modification of dendritic cells [<xref ref-type="bibr" rid="CR189">189</xref>].</p><p id="Par48">Immunotherapy is an established treatment for allergies. New approaches using viral like particles (VLPs) loaded with TLR ligands such as unmethylated&#160;CpG, targeting antiviral innate immune responses have the potential for more effective treatment in the absence of side effects associated with other strategies [<xref ref-type="bibr" rid="CR190">190</xref>]. It is proposed that the advantages of this approach stem from the nanosized structure of VLPs, allowing transport to lymph nodes where they can be taken up by resident DCs. Processing then allows endosomal TLR9 activation by unmethylated&#160;CpG and the subsequent patterning of T-cells towards a Th1 phenotype, which in turn competes and/or inhibits Th2 type allergic responses [<xref ref-type="bibr" rid="CR190">190</xref>]. It has been suggested that improvements to the nanocarrier approach to delivering unmethylated&#160;CpG within the lung may further enhance the ability of this TLR ligand to modulate and inhibit allergy and to overcome aspects of efficacy of VLPs observed in preclinical and clinical trials. One approach involved conjugation of unmethylated&#160;CpG to the surface of PSPNPs, where intranasal administration prior to sensitisation significantly reduced AAI and IgE levels in a murine model of HDM induced disease [<xref ref-type="bibr" rid="CR191">191</xref>]. It was suggested that surface associated, rather than encapsulated CpG (observed with VLP approaches) may allow a more robust approach to modifying adaptive immunity towards Th1 responses. This mechanism of delivery for these nanomaterial associated pathogen associated molecular patterns (PAMPs), towards antigen processing, presentation and adaptive immune response influence, is one which should be considered carefully as a significant component to allergy development and exacerbation events. Indeed, the bacterial cell component and TLR4 agonist lipopolysaccharide (LPS) is necessary for the induction of metal allergy to Ag when administered as AgNPs [<xref ref-type="bibr" rid="CR192">192</xref>]. Ag<sup>+</sup> ions and metal NPs of low solubility failed to induce allergy under similar conditions. These observations again highlight the importance of nanostructure and co-exposure to pattern recognition receptor (PRR) ligands in allergy development. Interestingly, in addition to being suggested as a central mechanism for how adjuvants can enhance and direct adaptive immune responses [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR85">85</xref>], PRR activation has been observed directly by NPs. TLR4 binding and activation by TiO<sub>2</sub>NPs for example has been observed in pulmonary epithelial cells [<xref ref-type="bibr" rid="CR193">193</xref>] and using a TLR4 KO murine inhalation model system was also demonstrated to mediate ZnONPs pulmonary inflammatory effects [<xref ref-type="bibr" rid="CR194">194</xref>].</p></sec></sec><sec id="Sec10"><title>Ultrafine pollutant nanomaterial exposure and asthma</title><p id="Par49">Air pollution is one of&#160;the greatest non communicable disease related public health concerns. An estimated 3.3 million premature deaths worldwide per year have been attributed to outdoor air pollution with the particulate fraction playing a major role [<xref ref-type="bibr" rid="CR195">195</xref>]. Respiratory health effects are among the primary concerns, with asthma accounting for a large proportion [<xref ref-type="bibr" rid="CR196">196</xref>]. Evidence for an association between air pollution and in particular traffic derived material, and asthma has accumulated over the last decades, with systematic reviews continuing to build a weight of evidence for direct causal effects [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR196">196</xref>&#8211;<xref ref-type="bibr" rid="CR199">199</xref>]. The precise nature of the exposure material(s) and the mechanisms underlying these associations is not complete and further understanding may allow more targeted and efficient strategies to reduce adverse health effects. The ultrafine particulate (UFP) component of pollutant exposure has been highlighted as a particular focus for investigation due to unique physicochemical properties and interactions with biological systems. It is the aim of the discussion in this section, to document evidence for the role ultrafine particulates (UFPs) may play in asthmatic disease and the potential mechanisms involved.</p><sec id="Sec11"><title>Human ultrafine and nanomaterial exposure effects</title><p id="Par50">Most of the information on human exposure to nanoscale materials and their influence on asthma has originated from the study of pollutant ultrafine material. The majority of particles in terms of numbers within urban pollutant particulate matter (PM) are found within the UFP fraction (typically described as &lt;100nm diameter), while most of the mass is found in particles &gt;100nm in size [<xref ref-type="bibr" rid="CR200">200</xref>]. One of the earliest epidemiological studies in asthmatic adults found that associations between the UFP fraction and asthma outcome, assessed using lung function parameters (Peak Expiratory Flow (PEF)), were greater than those of the fraction between 0.1-10&#956;m (PM10) [<xref ref-type="bibr" rid="CR200">200</xref>]. A follow on study from the same research group in an independent adult asthmatic population, found associations between cumulative (up to 14 days) exposure to both fine (&lt;2.5&#956;m (PM2.5)) and UFP fractions and asthma steroid medication use. It was however, difficult to separate out the effect of UFP material on asthma symptoms from other pollutant components, including NO<sub>2</sub> and larger particulates [<xref ref-type="bibr" rid="CR201">201</xref>]. An association between UFP levels and asthma incidence has also been observed in an urban environment but again confounding factors including other pollutants cannot be ruled out [<xref ref-type="bibr" rid="CR202">202</xref>]. A separate series of studies examining air pollutant exposure in a Finnish adult asthmatic population found an association between a larger particle number and decreased lung function (PEF), which they suggested could be attributed to the level of UFPs. Yet, they did stress that the associations could not be entirely separated from the potential effects of other pollutants such as SO<sub>2</sub>, NO<sub>2</sub> and CO [<xref ref-type="bibr" rid="CR203">203</xref>, <xref ref-type="bibr" rid="CR204">204</xref>]. Separation of the UFP effects of air pollutant material on asthma has been observed to some extent, however, in a study examining lung function (forced expiratory volume-one second (FEV<sub>1</sub>)&#160;and forced volume capacity (FVC)) in adult asthma sufferers after a 2hr walk in either high or low air pollutant environments. In this study significant associations between higher levels of atmospheric pollutants and reduced lung function were observed for UFP and carbon content, which were not observed to the same extent for PM2.5 or NO<sub>2</sub> levels. These effects were more pronounced in those volunteers with moderate versus mild asthma [<xref ref-type="bibr" rid="CR205">205</xref>]. Severe asthma sufferers were not recruited in this study. A similar 2hr walking adult volunteer study found associations between lung function decline and higher levels of pollutant material, the effects being greater in those with severe asthma. In this study however it was not possible to separate out the effect&#160;of UFPs from other pollutants [<xref ref-type="bibr" rid="CR206">206</xref>].</p><p id="Par51">Studies in paediatric asthmatic populations have also been carried out. One early examination failed to distinguish any association of UFPs with diminished lung function as distinct&#160;from other pollutant material [<xref ref-type="bibr" rid="CR207">207</xref>]. Indeed, more recent observations have found that nitrogen oxide pollutants, coarse and fine particles but not UFPs in urban air correlated with hospital admissions for asthma in children [<xref ref-type="bibr" rid="CR208">208</xref>]. There are however other studies that do suggest associations between UFPs and reduced lung function/respiratory problems/asthma in children. Paediatric visits to health care facilities for acute asthmatic events requiring prednisolone were significantly associated with UFP levels in the previous 7 days. This association was also found for CO levels but not for larger particles, carbon black, ozone or SO<sub>2</sub> [<xref ref-type="bibr" rid="CR209">209</xref>]. Similarly, a separate study demonstrated paediatric asthma hospital admissions were associated with ambient urban background levels of total&#160;particle numbers, UFPs&#160;(mass) and NO<sub>2</sub> but not PM10&#160;(mass) [<xref ref-type="bibr" rid="CR210">210</xref>]. When examining wheezing in infants, researchers found a positive correlation with increased UFPs in those below 1 year. Caution was expressed, however, over&#160;this observation due to a protective effect observed in over 3 year olds [<xref ref-type="bibr" rid="CR211">211</xref>]. A more recent analysis of asthmatic children, referred to a clinic for respiratory symptoms found that levels of UFPs in breath condensate correlated with wheezing, eosinophilia and breath symptom score [<xref ref-type="bibr" rid="CR212">212</xref>]. Other studies in children have also indicated some correlation with increased levels of UFPs and functional asthma outcomes but again additional confounding factors cannot be ruled out [<xref ref-type="bibr" rid="CR213">213</xref>&#8211;<xref ref-type="bibr" rid="CR216">216</xref>].</p><p id="Par52">Additional investigations to identify the effects of NMs on asthma have centred mainly on experimentally controlled exposure studies in human volunteers. These include a study examining the effect of isolated UFPs collected from a motor vehicle polluted area in the US, which&#160;found decreases in lung function (FEV<sub>1</sub>). There was, however, no difference between asthmatic and control volunteers [<xref ref-type="bibr" rid="CR217">217</xref>]. Other studies have investigated the effects of inhaled CNPs as model UFPs. Allergic asthmatic subjects exposed to CNPs 28 days before allergen challenge demonstrated increased markers of disease including eosinophilia. There was however no alteration in lung function (FEV<sub>1</sub>) [<xref ref-type="bibr" rid="CR218">218</xref>]. Another study found that inhalation of CNPs caused mild small airway dysfunction together with impaired alveolar gas exchange in normal subjects. When examined in asthmatic subjects there were no differences in responses to those observed for normal volunteers [<xref ref-type="bibr" rid="CR219">219</xref>]. An additional study from the same group found that there were some small changes in vasculature function after CNPs exposure but there were no changes in asthmatic symptoms, pulmonary function, or markers of airway inflammation in both asthmatic and control volunteers [<xref ref-type="bibr" rid="CR220">220</xref>]. This study did, however, identify that asthmatic subjects have an increased deposition of NMs after inhalation as compared to control volunteers, an observation also found in other studies [<xref ref-type="bibr" rid="CR221">221</xref>, <xref ref-type="bibr" rid="CR222">222</xref>]. This effect raises the possibility of increased potentially hazardous effects of these materials in asthmatic populations due to higher exposures over the long term.</p><p id="Par53">Despite there being a weight of evidence for adverse effects of UFPs on conditions such as cardiovascular disease in humans [<xref ref-type="bibr" rid="CR223">223</xref>&#8211;<xref ref-type="bibr" rid="CR225">225</xref>], the picture is less clear for asthmatic disease. Much of the epidemiology suffers from a lack of ability to separate the effects of UFPs from other pollutant material, while human volunteer exposure studies are limited and do not offer clear cut evidence for a direct impact. The studies described in this section focus almost completely on the potential for acute exacerbation effects of these nanosized materials. Apart from a study indicating long term and repeated exposure to NP abrasion products from diamond polishing [<xref ref-type="bibr" rid="CR226">226</xref>] and a case report on long term exposure to Nickel NPs [<xref ref-type="bibr" rid="CR227">227</xref>], there are virtually no long term epidemiological analysis of the effects of NPs and their potential to influence the development of asthma.</p></sec><sec id="Sec12"><title>Experimental models of ultrafine air pollutant exposure effects in asthma</title><p id="Par54">Concern for how particulate pollutants and the nanoscale constituents therein, contribute to adverse health effects were raised by early <italic toggle="yes">in vivo</italic> observations that pulmonary exposure of rats to urban PM10 produces an inflammatory response. In one such study the authors demonstrated a greater inflammatory response with CNPs and proposed that the UFP component of PM10 was the main contributor to the effects seen [<xref ref-type="bibr" rid="CR228">228</xref>]. In this section we will summarise those studies that have attempted to examine the effect of the UFP fraction of air pollution on models of asthma exacerbation and development (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Ultrafine pollutant particular matter effects in experimental <italic toggle="yes">in vivo</italic> models of asthma.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3" rowspan="1">Nanomaterial Properties</th><th colspan="4" rowspan="1">Model Characteristics</th><th colspan="9" rowspan="1">Disease Related Endpoints</th><th colspan="1" rowspan="1">Ref</th></tr><tr><th colspan="1" rowspan="1">
<italic toggle="yes">Material</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">1&#176; Size (nm)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Location</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Species (strain)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Allergen (route)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Exposure Route</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Dose</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">AHR (test)</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">IgE</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Eos</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Neu</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Lym</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">M&#934;</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Total cell</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">Gene Expression Markers</italic>
</th><th colspan="1" rowspan="1">
<italic toggle="yes">GCH-MS</italic>
</th><th colspan="1" rowspan="1"/></tr></thead><tbody><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;150</td><td colspan="1" rowspan="1">Los Angeles</td><td colspan="1" rowspan="1">Mice (BALB/c -f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">0.95 &#956;g/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593; (TNF-&#945;, IL-5, IL-13, IL-6, MCP-1, MIPI-&#945;) nc (IL-4, INF-&#947;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR231">231</xref>]</td></tr><tr><td colspan="1" rowspan="1">DCB-230</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Rats (BN&#8211;neonates)</td><td colspan="1" rowspan="1">n/a</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">200 &#956;g/m<sup>3</sup> (20min x7d)</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8595; (IL-18, VEGF, TNF-&#945;, MCP-1, IL-6, IL-1&#946;)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR234">234</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;180</td><td colspan="1" rowspan="1">Downtown Los Angeles</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">0.01 &#956;g/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-12, IL-6, IL-1&#946;) nc (IL-13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR232">232</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;150</td><td colspan="1" rowspan="1">Downtown Los Angeles</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">297 &#8211; 394 &#956;g/m3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-5) nc (IL-13)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR256">256</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;170</td><td colspan="1" rowspan="1">Fresno, CA, USA (Summer Night)</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">HDM (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">45 &#956;g/m3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (HO-1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR229">229</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;170</td><td colspan="1" rowspan="1">Fresno, CA, USA (Winter Day)</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">HDM (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">45 &#956;g/m3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (HO-1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR229">229</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;170</td><td colspan="1" rowspan="1">Fresno, CA, USA (Winter Night)</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">HDM (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">45 &#956;g/m3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc (HO-1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR229">229</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;170</td><td colspan="1" rowspan="1">Fresno, CA, USA (Summer Day)</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;m)</td><td colspan="1" rowspan="1">HDM (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">45 &#956;g/m3</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">&#8593; (HO-1)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR229">229</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;180</td><td colspan="1" rowspan="1">Los Angeles</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (Int N)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">0.04 &#956;g/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-5, IL-13, IL-17a)</td><td colspan="1" rowspan="1">&#8593; sig MUC5AC</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR258">258</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;180</td><td colspan="1" rowspan="1">Los Angeles</td><td colspan="1" rowspan="1">Mice (Il4raR576)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">Int N</td><td colspan="1" rowspan="1">0.18 &#956;g/kg</td><td colspan="1" rowspan="1">&#8593; (Resist)</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593;</td><td colspan="1" rowspan="1">&#8593; (IL-4, IL-13, IL-17, IFN-&#947;, IL-5)</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR259">259</xref>]</td></tr><tr><td colspan="1" rowspan="1">Ultrafine Particles</td><td colspan="1" rowspan="1">&lt;180</td><td colspan="1" rowspan="1">Detroit (upwind/downwind)</td><td colspan="1" rowspan="1">Mice (BALB/c &#8211;f)</td><td colspan="1" rowspan="1">OVA (IP)</td><td colspan="1" rowspan="1">OA</td><td colspan="1" rowspan="1">0.28, 1.4 &#956;g/kg</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">nc</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">&#8593; (IL-5 (1.4 only))</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR257">257</xref>]</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: 1 primary, <italic toggle="yes">AHR</italic> airway hyperresponsiveness, <italic toggle="yes">LF</italic> lung function, <italic toggle="yes">Resist</italic> Resistance, <italic toggle="yes">Eos</italic> eosinophils, <italic toggle="yes">Neu</italic> neutrophils, <italic toggle="yes">Lym</italic> lymphocytes, M&#934; macrophages, <italic toggle="yes">GCH-MS</italic> goblet cell hyperplasia-mucus secretion, &#8722;<italic toggle="yes">f</italic> &#8211;female, <italic toggle="yes">OVA</italic> ovalbumin, <italic toggle="yes">Int N</italic> intranasal instillation, &#8593; increase, <italic toggle="yes">nc</italic> no change; &#8722; not determined, <italic toggle="yes">DCB</italic> combustion-generated ultrafine particles containing environmental persistent free radicals using 1,2-dichlorobenzene, <italic toggle="yes">BN</italic> Brown Norway, <italic toggle="yes">A</italic> aerosol, &#8595; decrease, &#8722; not determined, &#8722;<italic toggle="yes">m</italic> &#8211;male, <italic toggle="yes">HDM</italic> house dust mite, <italic toggle="yes">IP</italic> intraperitoneal injection, <italic toggle="yes">OA</italic> oropharyngeal aspiration</p></table-wrap-foot></table-wrap>
</p><p id="Par55">The UFP fraction of urban PM produced a greater lung inflammatory response than the larger sub-micron-sized fraction, when administered during the sensitisation phase of a HDM murine model of AAD. The effects were correlated with an oxidative stress cellular response [<xref ref-type="bibr" rid="CR229">229</xref>]. Labile chemicals were suggested as responsible for the increases in antigen presentation marker expression on monocytes induced by coarse, fine and ultrafine fractions of freshly collected urban PM [<xref ref-type="bibr" rid="CR230">230</xref>]. Indeed, in a murine OVA model of AAD, the higher level of redox cycling organic chemicals, PAHs and intrinsic oxidative potential within the ultrafine fraction (&lt;150nm) of ambient PM, was put forward as the mechanism for increased adjuvancy observed with these particulates when compared to the larger PM2.5 sized fraction [<xref ref-type="bibr" rid="CR231">231</xref>]. The idea that oxidative potential of ultrafine material is a determining factor for adjuvant behaviour was also supported by another study from the same group, which demonstrated an increase in Th2 inflammation and augmentation of UFP directed adjuvant activity in KO mice lacking the anti-oxidant transcription factor Nrf2 in dendritic cells [<xref ref-type="bibr" rid="CR232">232</xref>]. Moreover, maternal exposure of mice to free radical chemical containing UFPs (engineered flame combustion particulates) resulted in enhanced OVA induced AAD in offspring, including increased AHR, eosinophils and Th2 responses, which was attributable to an imbalance in T-cell development and inhibition of Th1 maturation [<xref ref-type="bibr" rid="CR233">233</xref>]. Using similar particles also containing free radical chemicals, the same group demonstrated increased oxidative injury and AHR in mice. These effects were not observed however when UFPs had the pro-oxidant chemicals removed [<xref ref-type="bibr" rid="CR234">234</xref>].</p><p id="Par56">In another study, these oxidant chemical containing UFPs were observed to induce EMT in infant mouse lungs. The authors suggest that these changes could represent a mechanism through which pollutant material affects airway development and predisposition to conditions such as asthma [<xref ref-type="bibr" rid="CR235">235</xref>]. In a similar study, UFPs high in PAH chemicals were observed to have increased toxicity in neonatal as compared to adult mice. The authors suggest that neonates have an impaired response to environmental exposures that make them susceptible to pollutant oxidant toxicity and that this may impact airway development and predispose to pulmonary disease development [<xref ref-type="bibr" rid="CR236">236</xref>]. The effect of nanoscale properties as opposed to adhered chemicals effects in these studies were not investigated, but given that these materials have carbonaceous properties which also have the potential to induce oxidative stress [<xref ref-type="bibr" rid="CR237">237</xref>] it is possible that the NPs themselves also contribute. Indeed, CNPs as well as OVA and NO<sub>2</sub> have all been observed to reduce the rate of end expiratory lung volume increase in maturing rats, indicating a direct impact on lung development [<xref ref-type="bibr" rid="CR238">238</xref>]. As reduced lung function has been put forward as a contributor for the development of asthma [<xref ref-type="bibr" rid="CR239">239</xref>] and given the observations that air pollution exposure is associated with compromised lung development [<xref ref-type="bibr" rid="CR240">240</xref>, <xref ref-type="bibr" rid="CR241">241</xref>], the potential for both&#160;nanoscale effects and chemical components within pollutant materials to adversely affect lung development, and thus ultimately to influence the development asthma is an important consideration that warrants further investigation.</p><p id="Par57">
<italic toggle="yes">In vitro</italic> models investigating the effects of ultrafine pollutant material on aspects of asthma pathophysiology have focussed mainly on airway epithelial responses. An early study demonstrated that UFPs (&lt;0.18&#956;m), but not the larger-sized fractions of ambient urban PM, induced GMCSF production from primary human bronchial epithelial cells. This effect on GMCSF, which is a cytokine involved in activation of dendritic cells and Th2 type allergic inflammatory responses was not replicated by exposure of cells to similar sized CNPs, with the suggestion that chemicals adhered to the UFPs were responsible for the observed effects [<xref ref-type="bibr" rid="CR242">242</xref>]. Fine and UFP fractions from urban Paris were also found to induce GMCSF from the human bronchial 16HBE14o- epithelial cell line [<xref ref-type="bibr" rid="CR243">243</xref>]. A subsequent study from the same group correlated GMCSF production from airway epithelium with the organic fraction, also suggesting that chemical composition in PM is a major determinant of this response [<xref ref-type="bibr" rid="CR244">244</xref>]. In a separate study also examining Paris urban as well as rural PM, induction of GMCSF was only induced by the smaller UFP and fine fractions and was correlated to the induction of CYP1A1, NQO1 and HO-1, pointing towards chemical induced aryl hydrocarbon receptor activation (indicative of PAH content) and oxidative stress inducing activity as contributory agents [<xref ref-type="bibr" rid="CR245">245</xref>]. A more recent study of Lebanese fine and UFPs also indicated the chemical organic fraction as inducing significant effects <italic toggle="yes">in vitro</italic> [<xref ref-type="bibr" rid="CR246">246</xref>].</p><p id="Par58">Diesel exhaust particulates (DEPs) are estimated to account for a significant proportion of the UFP fraction found in ambient and traffic related air pollution. There is evidence that DEPs levels are associated with exacerbation of pre-existing asthma and more recently evidence also points towards a direct impact on sensitisation and respiratory effects in early life [<xref ref-type="bibr" rid="CR247">247</xref>, <xref ref-type="bibr" rid="CR248">248</xref>]. Indeed, DEPs have been observed to produce adjuvant effects in humans [<xref ref-type="bibr" rid="CR249">249</xref>]. Experimental modelling in mice further supports the hypothesis that respiratory exposure to DEPs can act as an adjuvant [<xref ref-type="bibr" rid="CR250">250</xref>]. Similar to studies of ambient PM in mice, it has been proposed that the chemical content, in particular the PAH content of DEPs, are the major contributor to adjuvant activity [<xref ref-type="bibr" rid="CR251">251</xref>]. In contrast, work carried out by Tanaka and colleagues revealed that exposure of mice to NP rich DEPs, optimised to maintain relevant organic chemical content, resulted in an adjuvant effect on OVA induced AAD. Interestingly, this adjuvant effect remained when particulates were filtered from the exhaust material, implicating gaseous pollutants as the main effector of adjuvancy [<xref ref-type="bibr" rid="CR252">252</xref>]. The examination of gaseous pollutants, such as NO<sub>2</sub> and ozone, for adjuvant effects in experimental AAD has revealed mixed responses [<xref ref-type="bibr" rid="CR253">253</xref>, <xref ref-type="bibr" rid="CR254">254</xref>]. Clarity is still needed regarding the relative contribution of individual pollutant components including the UFP fraction, in complex mixtures.</p><p id="Par59">Exacerbation of AAD, including effects on AHR has been documented in experimental models of ambient PM exposure [<xref ref-type="bibr" rid="CR255">255</xref>]. The extent to which individual size fractions within such material contribute to exacerbation outcomes has also been examined. Exposure of OVA sensitised mice to the PM2.5 fraction collected close to a motorway resulted in an increase in inflammatory responses, which were not observed to the same extent with UFP fraction exposures [<xref ref-type="bibr" rid="CR256">256</xref>]. Another study examining near road collected PM and exacerbation of inflammatory events in OVA sensitised mice found that the PM10 and PM2.5 fractions resulted in a greater inflammatory cell response than the UFP fraction, with responses more pronounced in samples with a higher level of traffic related material [<xref ref-type="bibr" rid="CR257">257</xref>]. The UFP fraction of near motorway PM has been observed to exacerbate OVA induced AAD in mice but this study did not examine other fractions of PM to allow size comparisons to be made [<xref ref-type="bibr" rid="CR258">258</xref>]. Both the fine (PM2.5) and UFP fractions of traffic associated PM were found to exacerbate AAD in OVA sensitised mice through a mechanisms involving JAG1 and the NOTCH signalling pathway, events which were not observed with carbon black fine particle exposure [<xref ref-type="bibr" rid="CR259">259</xref>]. This study also examined antigen presentation aspects and T-cell responses <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> and through interventional and knockout strategies demonstrated that UFP induced exacerbation of AAD, including IgE responses was mediated through the aryl hydrocarbon receptor. The authors proposed that since UFPs have chemicals associated with them including PAHs, which are potent ligands for the aryl hydrocarbon receptor, that such receptor activation drives JAG1 expression in dendritic cells and consequently allows enhancement of T-cell responses to aggravate AAD [<xref ref-type="bibr" rid="CR259">259</xref>].</p><p id="Par60">Additional aspects of exacerbation impacts have been discussed as a consequence of PM and UFP exposure, including inhibition of macrophage phagocytosis and clearance of microorganisms [<xref ref-type="bibr" rid="CR260">260</xref>]. Interestingly, a recent study demonstrated that neonates exposed to model ultrafine particulates with high oxidant potential enhanced the severity of influenza virus infection [<xref ref-type="bibr" rid="CR261">261</xref>]. Whether similar effects occur for other respiratory viral infections, including asthma associated rhinovirus and RSV exacerbations, is currently unknown.</p></sec></sec><sec id="Sec13"><title>Knowledge gaps and future directions</title><p id="Par61">Broadly speaking from the studies summarised in this review, there appears to be evidence for an impact of NMs on asthma and AAD. There are however many significant knowledge gaps that need to be addressed in order to build any weight of evidence towards a confident assignment of hazard potential relevant for human exposure. Specifically there is an urgent need for much more detailed and mechanistic information surrounding the vast collection of different types of NM and their properties and how they may each affect the range of different manifestations of asthma and AAD observed in humans. There is also a need for study designs to be tailored towards more human relevant exposure scenarios, in order to increase confidence in testing being relevant for human disease. Only a handful of nanomaterial inhalation studies have been carried out&#160;to date. These studies capture relevant particle dynamics, properties and deposition patterns, not properly accounted for when the nanomaterial is administered in solution. Future efforts should encourage inhalation exposures coupled with real world dose equivalents to minimise translational uncertainties. Furthermore, there is a lack of information on long term exposures to NMs. New studies together with the development of new approaches, including <italic toggle="yes">in vitro</italic> and mechanistic insight to address&#160;these knowledge gaps are to be encouraged.</p><sec id="Sec14"><title>Nanomaterial characteristics as a predictor for adverse effects</title><p id="Par62">The application of appropriate NM characterisation approaches&#160;is at the forefront of&#160;addressing knowledge gaps. This is fundamental to accurately attribute nanoscale properties to biological interaction and toxicological outcome. The extent to which NM characterisation was carried out across the studies in this review can be considered substantially inadequate in the vast majority of cases. Adoption of guidance proposals for minimum sets of NM characterisation requirements previously proposed in regulatory and other broader contexts [<xref ref-type="bibr" rid="CR262">262</xref>, <xref ref-type="bibr" rid="CR263">263</xref>] would greatly enhance the power to assign hazard potential in future work.</p><p id="Par63">How one may confidently assign particular characteristics of NMs to specific adverse outcome endpoints, is a substantial challenge and has only been attempted on a limited scale.&#160;Initial attempts were&#160;made to compare nanoparticle composition and characteristics across studies&#160;in this review. However, it was ultimately judged unworkable as the variabilities in models used; including, exposure protocol, material dose and route, time points and endpoints of disease, among many other parameters, including the extent of NM characterisation, made it impossible to reliably compare. Therefore the only realistic comparisons that can be made to assign NM characteristics to adverse effects with any degree of confidence are from&#160;those studies, which focussed on addressing NM characteristics within a specific study. These studies are summarised in Table <xref rid="Tab4" ref-type="table">4</xref>.<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Summary studies of <italic toggle="yes">in vivo</italic> exposures and focussed investigation of engineered nanomaterial characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1">Material Type</th><th colspan="4" rowspan="1">Models of Asthma and Allergic Airway Disease</th><th colspan="8" rowspan="1">Nanomaterial Characteristics Specifically Investigated for Effects in Models of Asthma and Allergic Airway Disease</th></tr><tr><th colspan="3" rowspan="1">Allergen Exposure Models of AAD</th><th rowspan="2" colspan="1">Pulmonary Exposure</th><th rowspan="2" colspan="1">Primary Size</th><th rowspan="2" colspan="1">Solubility</th><th rowspan="2" colspan="1">Shape/Structure</th><th rowspan="2" colspan="1">Agg size</th><th rowspan="2" colspan="1">Charge</th><th rowspan="2" colspan="1">Composition</th><th rowspan="2" colspan="1">Surface Area</th><th rowspan="2" colspan="1">Surface Chemistry/Coating</th></tr><tr><th colspan="1" rowspan="1">ALLERGEN INDEP</th><th colspan="1" rowspan="1">SENSITISATION</th><th colspan="1" rowspan="1">EXACERBATION</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">CNPs</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR41">41</xref>] [<xref ref-type="bibr" rid="CR40">40</xref>] [<xref ref-type="bibr" rid="CR60">60</xref>] [<xref ref-type="bibr" rid="CR37">37</xref>] [<xref ref-type="bibr" rid="CR38">38</xref>] [<xref ref-type="bibr" rid="CR59">59</xref>] [<xref ref-type="bibr" rid="CR58">58</xref>] [<xref ref-type="bibr" rid="CR62">62</xref>] [<xref ref-type="bibr" rid="CR238">238</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR37">37</xref>] [<xref ref-type="bibr" rid="CR38">38</xref>] [<xref ref-type="bibr" rid="CR39">39</xref>] [<xref ref-type="bibr" rid="CR40">40</xref>] [<xref ref-type="bibr" rid="CR41">41</xref>] [<xref ref-type="bibr" rid="CR42">42</xref>] [<xref ref-type="bibr" rid="CR43">43</xref>] [<xref ref-type="bibr" rid="CR54">54</xref>] [<xref ref-type="bibr" rid="CR72">72</xref>] [<xref ref-type="bibr" rid="CR238">238</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR58">58</xref>] [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>] [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>] [<xref ref-type="bibr" rid="CR110">110</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR127">127</xref>] [<xref ref-type="bibr" rid="CR277">277</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR37">37</xref>] [<xref ref-type="bibr" rid="CR38">38</xref>] [<xref ref-type="bibr" rid="CR39">39</xref>] [<xref ref-type="bibr" rid="CR40">40</xref>] [<xref ref-type="bibr" rid="CR42">42</xref>] [<xref ref-type="bibr" rid="CR54">54</xref>] [<xref ref-type="bibr" rid="CR40">40</xref>] [<xref ref-type="bibr" rid="CR37">37</xref>] [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR43">43</xref>] [<xref ref-type="bibr" rid="CR127">127</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">MWCNT</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR169">169</xref>] [<xref ref-type="bibr" rid="CR134">134</xref>] [<xref ref-type="bibr" rid="CR135">135</xref>] [<xref ref-type="bibr" rid="CR50">50</xref>] [<xref ref-type="bibr" rid="CR278">278</xref>] [<xref ref-type="bibr" rid="CR67">67</xref>] [<xref ref-type="bibr" rid="CR69">69</xref>] [<xref ref-type="bibr" rid="CR70">70</xref>] [<xref ref-type="bibr" rid="CR51">51</xref>] [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR49">49</xref>] [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR67">67</xref>] [<xref ref-type="bibr" rid="CR68">68</xref>] [<xref ref-type="bibr" rid="CR69">69</xref>] [<xref ref-type="bibr" rid="CR70">70</xref>] [<xref ref-type="bibr" rid="CR71">71</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR147">147</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR49">49</xref>] [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR49">49</xref>] [<xref ref-type="bibr" rid="CR54">54</xref>] [<xref ref-type="bibr" rid="CR134">134</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">SWCNT</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR136">136</xref>] [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>] [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>] [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">CNF</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR54">54</xref>]</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">AgNP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR132">132</xref>] [<xref ref-type="bibr" rid="CR111">111</xref>] [<xref ref-type="bibr" rid="CR116">116</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR111">111</xref>] [<xref ref-type="bibr" rid="CR112">112</xref>] [<xref ref-type="bibr" rid="CR116">116</xref>] [<xref ref-type="bibr" rid="CR274">274</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR132">132</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR132">132</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR132">132</xref>]</td></tr><tr><td colspan="1" rowspan="1">AuNP</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR63">63</xref>] [<xref ref-type="bibr" rid="CR117">117</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR63">63</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Co<sub>3</sub>O<sub>4</sub>NP</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR126">126</xref>] [<xref ref-type="bibr" rid="CR127">127</xref>] [<xref ref-type="bibr" rid="CR279">279</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR126">126</xref>] [<xref ref-type="bibr" rid="CR127">127</xref>] [<xref ref-type="bibr" rid="CR279">279</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">CuONP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR64">64</xref>] [<xref ref-type="bibr" rid="CR64">64</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR64">64</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR279">279</xref>] [<xref ref-type="bibr" rid="CR280">280</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR280">280</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR279">279</xref>] [<xref ref-type="bibr" rid="CR280">280</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">NiONP</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR126">126</xref>] [<xref ref-type="bibr" rid="CR127">127</xref>] [<xref ref-type="bibr" rid="CR279">279</xref>] [<xref ref-type="bibr" rid="CR280">280</xref>] [<xref ref-type="bibr" rid="CR281">281</xref>] [<xref ref-type="bibr" rid="CR282">282</xref>] [<xref ref-type="bibr" rid="CR146">146</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR280">280</xref>] [<xref ref-type="bibr" rid="CR281">281</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR126">126</xref>] [<xref ref-type="bibr" rid="CR127">127</xref>] [<xref ref-type="bibr" rid="CR279">279</xref>] [<xref ref-type="bibr" rid="CR280">280</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">TiO<sub>2</sub>NP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR119">119</xref>] [<xref ref-type="bibr" rid="CR133">133</xref>] [<xref ref-type="bibr" rid="CR81">81</xref>] [<xref ref-type="bibr" rid="CR119">119</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR43">43</xref>] [<xref ref-type="bibr" rid="CR55">55</xref>] [<xref ref-type="bibr" rid="CR120">120</xref>] [<xref ref-type="bibr" rid="CR81">81</xref>] [<xref ref-type="bibr" rid="CR273">273</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR63">63</xref>] [<xref ref-type="bibr" rid="CR120">120</xref>] [<xref ref-type="bibr" rid="CR118">118</xref>] [<xref ref-type="bibr" rid="CR119">119</xref>] [<xref ref-type="bibr" rid="CR273">273</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR126">126</xref>] [<xref ref-type="bibr" rid="CR127">127</xref>] [<xref ref-type="bibr" rid="CR283">283</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR43">43</xref>] [<xref ref-type="bibr" rid="CR55">55</xref>] [<xref ref-type="bibr" rid="CR63">63</xref>] [<xref ref-type="bibr" rid="CR126">126</xref>] [<xref ref-type="bibr" rid="CR127">127</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">CeO<sub>2</sub>NP</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR104">104</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">ZnONP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR56">56</xref>] [<xref ref-type="bibr" rid="CR56">56</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>] [<xref ref-type="bibr" rid="CR56">56</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR280">280</xref>] [<xref ref-type="bibr" rid="CR194">194</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>] [<xref ref-type="bibr" rid="CR56">56</xref>] [<xref ref-type="bibr" rid="CR280">280</xref>] [<xref ref-type="bibr" rid="CR194">194</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>] [<xref ref-type="bibr" rid="CR280">280</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td colspan="1" rowspan="1">Fullerene</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR106">106</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">FeNP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR275">275</xref>] [<xref ref-type="bibr" rid="CR80">80</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR80">80</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR275">275</xref>] [<xref ref-type="bibr" rid="CR93">93</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">GONP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR65">65</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR65">65</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR65">65</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Latex NP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR272">272</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR272">272</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR272">272</xref>] [<xref ref-type="bibr" rid="CR272">272</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">PSPNP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR79">79</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR44">44</xref>] [<xref ref-type="bibr" rid="CR79">79</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR44">44</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">SiO<sub>2</sub>NP</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR48">48</xref>] [<xref ref-type="bibr" rid="CR46">46</xref>] [<xref ref-type="bibr" rid="CR47">47</xref>] [<xref ref-type="bibr" rid="CR276">276</xref>] [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR45">45</xref>] [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>] [<xref ref-type="bibr" rid="CR48">48</xref>] [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR66">66</xref>] [<xref ref-type="bibr" rid="CR276">276</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR45">45</xref>] [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR48">48</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR66">66</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR55">55</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR48">48</xref>] [<xref ref-type="bibr" rid="CR55">55</xref>] [<xref ref-type="bibr" rid="CR276">276</xref>]</td><td colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR48">48</xref>] [<xref ref-type="bibr" rid="CR66">66</xref>] [<xref ref-type="bibr" rid="CR276">276</xref>]</td></tr><tr><td colspan="1" rowspan="1">TOTALS</td><td colspan="1" rowspan="1">42</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">5</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic toggle="yes">Agg</italic> agglomerate, <italic toggle="yes">GO</italic> Graphene Oxide, <italic toggle="yes">MWCNT</italic> multi-walled carbon nanotubes, <italic toggle="yes">SWCNT</italic> Single-walled carbon nanotubes, <italic toggle="yes">CNF</italic> Carbon Nanofibres</p></table-wrap-foot></table-wrap>
</p><p id="Par64">Size dependent effects have been observed for sensitisation, inflammation and airway disease parameters. This cannot however be said to be a universal effect for all materials and disease situations (due to lack of ability to compare across studies). Interestingly, smaller-sized NMs such as AgNPs and ZnONPs were observed to have more of an impact on mast cells and eosinophils <italic toggle="yes">in vitro</italic> when compared to larger sized particles of the same material. In addition, smaller primary-sized particles of both AuNPs and AgNPs materials were associated with inhibitory effects on AAD, while larger-sized particles were associated with exacerbation effects. While it is interesting to speculate as to whether there is a common&#160;size dependent mechanism involved here, the observations are too few and the models used too variable to reliably say. Importantly, no <italic toggle="yes">in vivo</italic> studies have reported the role of nanomaterial size on exacerbation effects in AAD. This is&#160;a significant knowledge gap in our understanding.</p><p id="Par65">Agglomeration size whether in aerosol or instillation fluid was not documented to the same extent as primary NP size. Agglomeration size and its potential to influence disease is an often overlooked and little discussed characteristic that may influence tissue&#160;distribution and cellular interaction. In addition, how the transition to and from agglomerate state(s) affects biological interaction and localisation (including subcellular) and whether this behaviour is material and/or nano property dependent is unknown.</p><p id="Par66">Solubility, surface charge and surface coating of NPs have been a focus for a number of studies and have demonstrated potential mechanisms and concerns. However these too would be considered of insufficient weight to attribute hazard with any great confidence to any specific property or material. The nature of the biological corona surrounding NPs as they interact with living tissue has been put forward as an important factor determining toxicological impact [<xref ref-type="bibr" rid="CR264">264</xref>, <xref ref-type="bibr" rid="CR265">265</xref>]. To what degree this is true and to what extent material type and associated properties influences this, remains to be determined.</p><p id="Par67">In terms of NP composition, attempts can be made at some general observations, albeit with obvious caveats. CNTs would appear to have a strong adjuvant activity and a detrimental impact on AAD when exposure occurs during sensitisation. In contrast, the effect of CNTs on exacerbation is absent or present to a lesser extent. In some studies, CNTs have been associated with an increase in Th2 type inflammation in the absence of adaptive immune responses, indicating a possible concern for exacerbation of intrinsic type asthma. Whether such categorisation based on asthma endotype can be made confidently, is possibly premature but is something that should be considered in the future. In addition, whether these observations can be linked to the high aspect ratio of CNTs is unknown but also worth further investigation. Some materials like titanium and fullerenes are associated more with inhibitory effects on AAD than others. In addition, there are a number of materials that have not been tested in different types of exposure settings. For example AuNPs, AgNPs and CuONPs have all been tested for their ability to affect pre-existing AAD but not for any effect on sensitisation and the development of AAD. SWCNTs on the other hand have been examined for adjuvant effects but not investigated for any impact on pre-existing disease.</p><p id="Par68">Surface area is a critical factor for pulmonary toxicity of NMs, particularly soluble metal NPs [<xref ref-type="bibr" rid="CR266">266</xref>]. Much more work is needed to investigate this NM characteristic as a determinant of adverse effects of NMs in asthma and AAD. Concerted efforts to categorise NMs according to&#160;their adverse effects by reference to their characteristics such as&#160;size, solubility, surface reactivity, shape (e.g. high aspect ratio, spherical, fibres, platelet-like) and metal content among other characteristics is a particular focus for nanotoxicology. While the lack of NM characterisation data, together with model variability, in&#160;the studies in this review currently limits attempts to link adverse effects to these groupings, it is imperative to prioritise such approaches for future work.</p></sec><sec id="Sec15"><title>Model selection, comparability across studies and protocol standardisation</title><p id="Par69">There is a large variability in the types of protocol and disease-associated endpoints used to assess adverse effects relevant for asthma and AAD, which make it extremely difficult to directly compare results across studies. Adoption of a standardised set of protocols, addressing these concerns would allow more confident comparisons to be made across studies. We have summarised those approaches used to date in terms of model set-up and characteristics, target cells and tissues, key events in disease manifestation as well as molecular endpoints of adverse effects (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) in order to highlight the immense set of challenges, which need to be addressed if one is to bring forward NM testing approaches to become more informative and relevant for human disease.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Investigation of Hazard Potential of NM in Experimental In Vivo Models of Asthma and AAD: Key Events and Endpoints of Disease</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12989_2017_228_Fig1_HTML.jpg"/></fig>
</p><p id="Par70">Given the diversity of asthma in terms of atopic, non-atopic and mixed forms of the disease together with the different stages of susceptibility (e.g. sensitisation and exacerbation), the ability to compare a defined set of disease indicators specific for the type of disease stage, across studies would aid greatly in further clarifying NM effects within a standardised protocol framework. Importantly, reversible airway obstruction is the primary observation used to diagnose those with asthma, and AHR assessment is used to model this <italic toggle="yes">in vivo</italic>. There is a significant knowledge gap surrounding the effects of NMs on AHR as well as a lack of examination of smooth muscle effects and airway remodelling as underlying causes and targets. This can also be said for mucin production and goblet cell hyperplasia modelling as another overlooked and underreported aspect to airway disease in asthma and NM exposure. Both of these features should be included as a basic requirement for any NM studies examining the&#160;potential impact on asthma and AAD.</p><p id="Par71">There is also an overrepresentation of <italic toggle="yes">in vivo</italic> modelling using ovalbumin sensitisation protocols. The inclusion of more human relevant antigen exposures such as house dust mite may allow for broader capture of effects that may otherwise be protocol type specific. Aerosolised delivery of nanomaterials in test systems is also significantly lacking in studies to date. This is particularly important given that this is the route by which humans are exposed to NM. The&#160;consequences that instillation of NM dispersions have on deposition&#160;patterns, nanomaterial characteristics and biological response is rarely discussed. Moreover, the range of doses applied across all studies is highly variable and how it relates to human exposure levels is not often referred to.</p></sec><sec id="Sec16"><title>Translational relevance for human nanomaterial and pollutant exposure</title><p id="Par72">Information on direct effects of engineered nanomaterials on asthma and AAD in humans is limited and evidence for the potential for adverse effects comes mainly from <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic> experimental modelling. However, inadvertent exposure to airborne PM mainly from traffic related pollution brings with it the concern that nanosized particles contained within this inhaled mixture have particular detrimental health effects including an influence on asthma. Epidemiological studies have suggested a role for the UFP fraction of pollutant material in asthma exacerbation, although the role for confounding factors including other pollutants cannot be entirely excluded. Evidence from experimental modelling also suggests that the UFP fraction from ambient and traffic related pollutant material may play a role in the sensitisation and development of AAD. However, experimental models <italic toggle="yes">in vivo</italic> suggest that the UFP fraction may be less important for exacerbation effects than the larger fractions, particularly the fine (typically PM1 and PM2.5) fractions. This apparent discordance with epidemiological observations necessitates clarification.</p><p id="Par73">Such discussion of ultrafine effects in Asthma and AAD must also be considered in the context of other constituents of air pollutant materials. Across all experimental studies including <italic toggle="yes">in vitro</italic> work, there is strong evidence that the particle associated chemical component, containing PAHs among other organics, rather than the particles themselves are the critical determinant responsible for pollutant particulate mediated biological impact in asthma and AAD. However, given that nanomaterials including carbon nanoparticles can directly impact these same model systems, further investigation is needed to address direct versus indirect particulate effects within a pollutant mixture. It should not be overlooked that more labile and gaseous components of airborne pollution also are likely to have a significant role [<xref ref-type="bibr" rid="CR252">252</xref>].</p><p id="Par74">Population studies have pointed towards genetic susceptibility for air pollutant exposures and asthma outcome. These include exposures such as PM10, PM2.5, ozone and NO<sub>2</sub> and&#160;effects associated with altered asthma outcomes in those with particular single nucleotide polymorphisms in genes such as GSTP1, NQO1 and GSTT1 [<xref ref-type="bibr" rid="CR267">267</xref>&#8211;<xref ref-type="bibr" rid="CR269">269</xref>]. These genes are part of the anti-oxidant defence pathway within the cell, altered function of which may impact susceptible individuals through an inability to mount an appropriate anti-oxidant response. However, gene-environment interactions have not been investigated for associations with the smaller UFP fraction of airborne pollution and represent a significant knowledge gap. This is also true to a degree for engineered NP exposure, although some initial studies comparing different animal strains suggest genetic background is a strong determinant of pulmonary response to inhaled or instilled NMs [<xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR132">132</xref>]. Indeed, a wider analysis of up to 20 different strains of mice for responses to inhaled ZnONPs found that there were up to 10 fold differences in PMN accumulation in the lung [<xref ref-type="bibr" rid="CR270">270</xref>]. Similarly, in a study of 8 different mouse strains, lung inflammation and injury in response to inhaled AgNPs was also found to be&#160;strain dependent [<xref ref-type="bibr" rid="CR271">271</xref>]. These later studies did not focus on models of asthma or AAD but do highlight pulmonary response susceptible populations. Interestingly, no studies to date have been reported examining how genetic background affects NM impact on sensitisation and development of AAD. Other types of susceptibilities that exist and may play a role in how pollutant UFPs and engineered NMs impact asthma include <italic toggle="yes">in utero</italic> exposure, age, gender, diet and co-morbidities, including obesity, and have not been examined to any great extent.</p></sec><sec id="Sec17"><title>Mechanistic understanding and focus for future testing</title><p id="Par75">The development of new and more refined approaches to NM testing for effects on asthma and AAD have begun to incorporate concepts of how mechanistic information can lead to more detailed understanding of the most important molecular targets responsible for pathophysiological change. Identification of molecular initiating events that are coupled to detailed mechanistic understanding and NM characterisation, furthers the potential to more clearly define NM properties of concern. A more complete understanding of events that are responsible for NM effects at a tissue, cellular and molecular level through the use of standardised <italic toggle="yes">in vivo</italic> protocols can also lead to the development of more targeted testing approaches such as those using <italic toggle="yes">in vitro</italic> modelling. While <italic toggle="yes">in vitro</italic> modelling to date has been used to identify adverse effects as they may affect sensitisation and other approaches, these remain abstracted from other cellular and tissue compartments that may have important contribution to the overall NM effect at an organism level. Through greater understanding of <italic toggle="yes">in vivo</italic> targets we can begin to prioritise and standardise <italic toggle="yes">in vitro</italic> tests, which may ultimately replace animal testing. The adoption of <italic toggle="yes">in vitro</italic> systems has many advantages including the ability to greatly increase the number of different NMs that can be tested. Given the many combinations of different material types and characteristics, this is crucial. <italic toggle="yes">In vitro</italic> testing will also allow for testing to be carried in a human rather than an animal system, removing particular concerns regarding species specific effects (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). In addition, technologies including the use of induced pluripotent stem cells (iPSC) to develop <italic toggle="yes">in vitro</italic> testing models will allow for the integration of population diverse as well as human disease specific genetic backgrounds, further optimising towards human relevant testing. Of particular note is the recently funded Marie Curie - Innovative Training Network &#8220;in3&#8221;, which aims to incorporate iPSC models into an overall strategy to develop better models for chemical and NM safety assessment.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Approaches for the Development of a Better Understanding and Prediction of Adverse Effects of NM on Asthma and AAD</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12989_2017_228_Fig2_HTML.jpg"/></fig>
</p><p id="Par76">The recent momentum behind understanding modes of toxicity and development of adverse outcome pathways for xenobiotic effects has the potential to help translate <italic toggle="yes">in vitro</italic> findings to a whole organism level. Additionally, it is the hope that through accrual of data from standardised and higher throughput systems, that <italic toggle="yes">in silico</italic> modelling and read across strategies may develop to a point where experimental testing for new materials can be minimised (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Through a greater and more detailed understanding of how NMs may impact respiratory disease outcome and the identification of adverse effect linked molecular signatures, including epigenetic marks, it is hoped that more informative biomarkers of NM exposure and effect may be developed. These may also be useful for refining epidemiological studies of asthma and NM&#160;or air&#160;pollutant exposure.</p></sec><sec id="Sec18"><title>Microbial exposure</title><p id="Par77">Lastly, it is becoming ever clearer that microbial exposure is a critical factor influencing both the development and exacerbation of asthma and AAD. Exposure to bacterial and fungal diversity within the microbiome has been strongly associated with a reduced development of atopy and asthma [<xref ref-type="bibr" rid="CR8">8</xref>]. Viral infection is also considered a major factor for both the development and exacerbation of disease. These interactions and their biological effects should not be examined in isolation from other environmental exposures such as air pollution. Whether NMs can influence these microbial interactions remains to be fully explored.</p></sec></sec><sec id="Sec19"><title>Conclusions</title><p id="Par78">Within this review we have produced a detailed analysis of studies directed to investigate how nanomaterials including nano-sized pollutant particulates may impact asthma and allergic airway disease. We have identified significant knowledge gaps including a lack of investigations targeted towards understanding how different nanomaterial properties influence disease outcome <italic toggle="yes">in vivo</italic>. Attempts at standardisation for testing may overcome the diverse nature of different disease models and allow meaningful comparison of different nanomaterials and their effects across studies. The development of <italic toggle="yes">in vitro</italic> models as representative of <italic toggle="yes">in vivo</italic> exposure and disease progression is immature, particularly in terms of how nanomaterial effects on airway remodelling may be captured. This is also true for how multiple cell types may interact to produce adverse effects. In terms of human exposure, epidemiological studies are rare for engineered materials and represent another important knowledge gap. Investigations into how pollutant nanomaterials affect asthma and AAD in human populations are far from clear due to the inability to separate co-pollutant effects.</p><p id="Par79">In order to address these knowledge gaps, mechanistic understanding at a cellular and molecular level, of disease pathology as well as NM specific outcomes is required. Some attempts have been made in studies covered in this review. Apart from some direct effects on the process of sensitisation involving dendritic cells and studies examing specific gene function through KO approaches, mechanistic insight is generally lacking. As knowledge progresses in our understanding of human asthma development and exacerbation events, it is important that&#160;cellular and molecular discoveries underlying adverse effects and outcomes are incorporated into model development. This allows for a more targeted and translational approach to testing. With the inclusion of more detailed NM characterisation, this approach also allows for increased power to identify properties of concern that can be linked more readily to relevant endpoints of disease. Specifically, in terms of adjuvant activity and the development of sensitisation to antigen, there is a need to determine how the innate immune response, including airway epithelial, macrophage, mast and dendritic cells handle and respond to different NMs as they are first encountered within the lung. How NM properties including size and surface area impact how antigens attached to their surface are handled by these cells is something to consider as a priority research area. For established AAD, there is also a need to tie down how NMs propagate an allergic response. There is also a need for models to be able to capture information relevant for other asthma endotypes such as intrinsic asthma or severe asthma, where allergy does not play a role. Mechanistic insight should be prominent in our attempts to achieve this. Finally, an understanding of airway remodelling and hyper-reactivity is urgently needed; given these events underlie airway obstruction, arguably the pathological feature with the greatest impact on patient morbidity and mortality. Mechanistic understanding of physical airway responses and in particular how smooth muscle cells, fibroblasts and other airway resident cells react to NM exposure is lacking and should also be encouraged as a priority research area.</p></sec></body><back><app-group><app id="App1"><sec id="Sec20"><title>Additional file</title><p id="Par86">
<media xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="12989_2017_228_MOESM1_ESM.docx" id="MOESM1" orientation="portrait"><label>Additional file 1: Table S1.</label><caption><p>Effects of nanomaterials in non-allergic <italic toggle="yes">in vivo</italic> models of experimental pulmonary exposure. Table S2. Allergen independent effects of nanomaterials in <italic toggle="yes">in vivo</italic> models of experimental pulmonary exposure documented as part of larger allergy driven models of asthma and allergic airway disease. Table S3. <italic toggle="yes">In vitro</italic> models and nanomaterial exposure. (DOCX 295 kb)</p></caption></media>
</p></sec></app></app-group><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s12989-017-0228-y) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not Applicable</p><sec id="FPar1"><title>Funding</title><p id="Par80">This work was part funded through the Public Health England PhD Studentship Project Scheme. This work was also part funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact of Environmental Hazards at King&#8217;s College London in partnership with Public Health England (PHE). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par81">Not Applicable.</p></sec></ack><notes notes-type="author-contribution"><title>Authors' contributions</title><p>All authors have made a significant contribution to the review of published material and writing of this manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par82">Not Applicable.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par83">All authors consent to publication of this review on acceptance by the journal.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par84">The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#8217;s Note</title><p id="Par85">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Network GA. The global asthma report 2014. Auckland: Global Asthma Network; 2014. p. 769. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.globalasthmareport.org">http://www.globalasthmareport.org</ext-link>.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lockey</surname><given-names>RF</given-names></name></person-group><article-title>Asthma phenotypes: an approach to the diagnosis and treatment of asthma</article-title><source>J Allergy Clin Immunol Pract</source><year>2014</year><volume>2</volume><issue>6</issue><fpage>682</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">25439357</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaip.2014.09.008</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>DM</given-names></name><name name-style="western"><surname>O&#8217;Byrne</surname><given-names>PM</given-names></name></person-group><article-title>Recent advances in the pathophysiology of asthma</article-title><source>Chest</source><year>2010</year><volume>137</volume><issue>6</issue><fpage>1417</fpage><lpage>1426</lpage><pub-id pub-id-type="pmid">20525652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.09-1895</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergeron</surname><given-names>C</given-names></name><name name-style="western"><surname>Tulic</surname><given-names>MK</given-names></name><name name-style="western"><surname>Hamid</surname><given-names>Q</given-names></name></person-group><article-title>Airway remodelling in asthma: from benchside to clinical practice</article-title><source>Can Respir J.</source><year>2010</year><volume>17</volume><issue>4</issue><fpage>e85</fpage><lpage>e93</lpage><pub-id pub-id-type="pmid">20808979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2010/318029</pub-id><pub-id pub-id-type="pmcid">PMC2933777</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folli</surname><given-names>C</given-names></name><name name-style="western"><surname>Descalzi</surname><given-names>D</given-names></name><name name-style="western"><surname>Scordamaglia</surname><given-names>F</given-names></name><name name-style="western"><surname>Riccio</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gamalero</surname><given-names>C</given-names></name><name name-style="western"><surname>Canonica</surname><given-names>GW</given-names></name></person-group><article-title>New insights into airway remodelling in asthma and its possible modulation</article-title><source>Curr Opin Allergy Clin Immunol</source><year>2008</year><volume>8</volume><issue>5</issue><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">18769186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ACI.0b013e32830a7086</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walters</surname><given-names>EH</given-names></name><name name-style="western"><surname>Soltani</surname><given-names>A</given-names></name><name name-style="western"><surname>Reid</surname><given-names>DW</given-names></name><name name-style="western"><surname>Ward</surname><given-names>C</given-names></name></person-group><article-title>Vascular remodelling in asthma</article-title><source>Curr Opin Allergy Clin Immunol</source><year>2008</year><volume>8</volume><issue>1</issue><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">18188016</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ACI.0b013e3282f42696</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bara</surname><given-names>I</given-names></name><name name-style="western"><surname>Ozier</surname><given-names>A</given-names></name><name name-style="western"><surname>Tunon de Lara</surname><given-names>JM</given-names></name><name name-style="western"><surname>Marthan</surname><given-names>R</given-names></name><name name-style="western"><surname>Berger</surname><given-names>P</given-names></name></person-group><article-title>Pathophysiology of bronchial smooth muscle remodelling in asthma</article-title><source>Eur Respir J</source><year>2010</year><volume>36</volume><issue>5</issue><fpage>1174</fpage><lpage>1184</lpage><pub-id pub-id-type="pmid">21037369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.00019810</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ege</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>M</given-names></name><name name-style="western"><surname>Normand</surname><given-names>AC</given-names></name><name name-style="western"><surname>Genuneit</surname><given-names>J</given-names></name><name name-style="western"><surname>Cookson</surname><given-names>WO</given-names></name><name name-style="western"><surname>Braun-Fahrlander</surname><given-names>C</given-names></name><etal/></person-group><article-title>Exposure to environmental microorganisms and childhood asthma</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><issue>8</issue><fpage>701</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">21345099</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1007302</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>MR</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>NW</given-names></name><name name-style="western"><surname>Hussell</surname><given-names>T</given-names></name><name name-style="western"><surname>Openshaw</surname><given-names>P</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>SL</given-names></name></person-group><article-title>The microbiology of asthma</article-title><source>Nat Rev Microbiol</source><year>2012</year><volume>10</volume><issue>7</issue><fpage>459</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">22669219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrmicro2801</pub-id><pub-id pub-id-type="pmcid">PMC7097220</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holguin</surname><given-names>F</given-names></name><name name-style="western"><surname>Bleecker</surname><given-names>ER</given-names></name><name name-style="western"><surname>Busse</surname><given-names>WW</given-names></name><name name-style="western"><surname>Calhoun</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Castro</surname><given-names>M</given-names></name><name name-style="western"><surname>Erzurum</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Obesity and asthma: an association modified by age of asthma onset</article-title><source>J Allergy Clin Immunol</source><year>2011</year><volume>127</volume><issue>6</issue><fpage>1486</fpage><lpage>93 e2</lpage><pub-id pub-id-type="pmid">21624618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2011.03.036</pub-id><pub-id pub-id-type="pmcid">PMC3128802</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>G</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>JM</given-names></name><name name-style="western"><surname>Alcorn</surname><given-names>JF</given-names></name><name name-style="western"><surname>Holguin</surname><given-names>F</given-names></name><name name-style="western"><surname>Aujla</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Celedon</surname><given-names>JC</given-names></name></person-group><article-title>Vitamin D and asthma</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>185</volume><issue>2</issue><fpage>124</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">22016447</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201108-1502CI</pub-id><pub-id pub-id-type="pmcid">PMC3297088</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGwin</surname><given-names>G</given-names></name><name name-style="western"><surname>Lienert</surname><given-names>J</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>JI</given-names></name></person-group><article-title>Formaldehyde exposure and asthma in children: a systematic review</article-title><source>Environ Health Perspect</source><year>2010</year><volume>118</volume><issue>3</issue><fpage>313</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">20064771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.0901143</pub-id><pub-id pub-id-type="pmcid">PMC2854756</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaakkola</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Knight</surname><given-names>TL</given-names></name></person-group><article-title>The role of exposure to phthalates from polyvinyl chloride products in the development of asthma and allergies: a systematic review and meta-analysis</article-title><source>Environ Health Perspect</source><year>2008</year><volume>116</volume><issue>7</issue><fpage>845</fpage><lpage>853</lpage><pub-id pub-id-type="pmid">18629304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.10846</pub-id><pub-id pub-id-type="pmcid">PMC2453150</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bornehag</surname><given-names>CG</given-names></name><name name-style="western"><surname>Nanberg</surname><given-names>E</given-names></name></person-group><article-title>Phthalate exposure and asthma in children</article-title><source>Int J Androl</source><year>2010</year><volume>33</volume><issue>2</issue><fpage>333</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">20059582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2605.2009.01023.x</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Liu AH. Something old, something new: indoor endotoxin, allergens and asthma. Paediatr Respir Rev. 2004;5 Suppl A:S65-S71. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/14980246">http://www.ncbi.nlm.nih.gov/pubmed/14980246</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1526-0542(04)90013-9</pub-id><pub-id pub-id-type="pmid">14980246</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahluwalia</surname><given-names>SK</given-names></name><name name-style="western"><surname>Matsui</surname><given-names>EC</given-names></name></person-group><article-title>The indoor environment and its effects on childhood asthma</article-title><source>Curr Opin Allergy Clin Immunol</source><year>2011</year><volume>11</volume><issue>2</issue><fpage>137</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">21301330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ACI.0b013e3283445921</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baena-Cagnani</surname><given-names>CE</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>RM</given-names></name><name name-style="western"><surname>Baena-Cagnani</surname><given-names>R</given-names></name><name name-style="western"><surname>Canonica</surname><given-names>GW</given-names></name></person-group><article-title>Impact of environmental tobacco smoke and active tobacco smoking on the development and outcomes of asthma and rhinitis</article-title><source>Curr Opin Allergy Clin Immunol</source><year>2009</year><volume>9</volume><issue>2</issue><fpage>136</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">19307883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ACI.0b013e3283294038</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arruda</surname><given-names>LK</given-names></name><name name-style="western"><surname>Sole</surname><given-names>D</given-names></name><name name-style="western"><surname>Baena-Cagnani</surname><given-names>CE</given-names></name><name name-style="western"><surname>Naspitz</surname><given-names>CK</given-names></name></person-group><article-title>Risk factors for asthma and atopy</article-title><source>Curr Opin Allergy Clin Immunol</source><year>2005</year><volume>5</volume><issue>2</issue><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">15764906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.all.0000162308.89857.6c</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donaldson</surname><given-names>K</given-names></name><name name-style="western"><surname>Gilmour</surname><given-names>MI</given-names></name><name name-style="western"><surname>MacNee</surname><given-names>W</given-names></name></person-group><article-title>Asthma and PM10</article-title><source>Respir Res</source><year>2000</year><volume>1</volume><issue>1</issue><fpage>12</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">11667958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/rr5</pub-id><pub-id pub-id-type="pmcid">PMC59535</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gowers</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cullinan</surname><given-names>P</given-names></name><name name-style="western"><surname>Ayres</surname><given-names>JG</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>HR</given-names></name><name name-style="western"><surname>Strachan</surname><given-names>DP</given-names></name><name name-style="western"><surname>Holgate</surname><given-names>ST</given-names></name><etal/></person-group><article-title>Does outdoor air pollution induce new cases of asthma? Biological plausibility and evidence; a review</article-title><source>Respirology</source><year>2012</year><volume>17</volume><issue>6</issue><fpage>887</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">22672711</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1440-1843.2012.02195.x</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zammit-Tabona</surname><given-names>M</given-names></name><name name-style="western"><surname>Sherkin</surname><given-names>M</given-names></name><name name-style="western"><surname>Kijek</surname><given-names>K</given-names></name><name name-style="western"><surname>Chan</surname><given-names>H</given-names></name><name name-style="western"><surname>Chan-Yeung</surname><given-names>M</given-names></name></person-group><article-title>Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies</article-title><source>Am Rev Respir Dis</source><year>1983</year><volume>128</volume><issue>2</issue><fpage>226</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">6881681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/arrd.1983.128.2.226</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeiss</surname><given-names>CR</given-names></name></person-group><article-title>Advances in acid anhydride induced occupational asthma</article-title><source>Curr Opin Allergy Clin Immunol</source><year>2002</year><volume>2</volume><issue>2</issue><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11964754</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00130832-200204000-00001</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nowack</surname><given-names>B</given-names></name><name name-style="western"><surname>Bucheli</surname><given-names>TD</given-names></name></person-group><article-title>Occurrence, behavior and effects of nanoparticles in the environment</article-title><source>Environ Pollut</source><year>2007</year><volume>150</volume><issue>1</issue><fpage>5</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17658673</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envpol.2007.06.006</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stone</surname><given-names>V</given-names></name><name name-style="western"><surname>Nowack</surname><given-names>B</given-names></name><name name-style="western"><surname>Baun</surname><given-names>A</given-names></name><name name-style="western"><surname>van den Brink</surname><given-names>N</given-names></name><name name-style="western"><surname>Kammer</surname><given-names>F</given-names></name><name name-style="western"><surname>Dusinska</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation</article-title><source>Sci Total Environ</source><year>2010</year><volume>408</volume><issue>7</issue><fpage>1745</fpage><lpage>1754</lpage><pub-id pub-id-type="pmid">19903569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scitotenv.2009.10.035</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sajid</surname><given-names>M</given-names></name><name name-style="western"><surname>Ilyas</surname><given-names>M</given-names></name><name name-style="western"><surname>Basheer</surname><given-names>C</given-names></name><name name-style="western"><surname>Tariq</surname><given-names>M</given-names></name><name name-style="western"><surname>Daud</surname><given-names>M</given-names></name><name name-style="western"><surname>Baig</surname><given-names>N</given-names></name><etal/></person-group><article-title>Impact of nanoparticles on human and environment: review of toxicity factors, exposures, control strategies, and future prospects</article-title><source>Environ Sci Pollut Res Int</source><year>2015</year><volume>22</volume><issue>6</issue><fpage>4122</fpage><lpage>4143</lpage><pub-id pub-id-type="pmid">25548015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11356-014-3994-1</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Georas</surname><given-names>S</given-names></name><name name-style="western"><surname>Alexis</surname><given-names>N</given-names></name><name name-style="western"><surname>Fritz</surname><given-names>P</given-names></name><name name-style="western"><surname>Xia</surname><given-names>T</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MA</given-names></name><etal/></person-group><article-title>A work group report on ultrafine particles (American Academy of Allergy, Asthma &amp; Immunology): Why ambient ultrafine and engineered nanoparticles should receive special attention for possible adverse health outcomes in human subjects</article-title><source>J Allergy Clin Immunol</source><year>2016</year><volume>138</volume><issue>2</issue><fpage>386</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">27130856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2016.02.023</pub-id><pub-id pub-id-type="pmcid">PMC4976002</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosseini</surname><given-names>A</given-names></name><name name-style="western"><surname>Hirota</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hackett</surname><given-names>TL</given-names></name><name name-style="western"><surname>McNagny</surname><given-names>KM</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Carlsten</surname><given-names>C</given-names></name></person-group><article-title>Morphometric analysis of inflammation in bronchial biopsies following exposure to inhaled diesel exhaust and allergen challenge in atopic subjects</article-title><source>Part Fibre Toxicol.</source><year>2016</year><volume>13</volume><fpage>2</fpage><pub-id pub-id-type="pmid">26758251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-016-0114-z</pub-id><pub-id pub-id-type="pmcid">PMC4711081</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Kumagai Y, Abiko Y, Cong NL. Chemical toxicology of reactive species in the atmosphere: two decades of progress in an electron acceptor and an electrophile. J Toxicol Sci. 2016;41 Special:SP37-SP47; doi:10.2131/jts.41.SP37. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28003638">https://www.ncbi.nlm.nih.gov/pubmed/28003638</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2131/jts.41.SP37</pub-id><pub-id pub-id-type="pmid">28003638</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Meldrum K, Gant TW, Leonard MO. Diesel exhaust particulate associated chemicals attenuate expression of CXCL10 in human primary bronchial epithelial cells. Toxicol In Vitro. 2017; doi:10.1016/j.tiv.2017.06.023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28655636">https://www.ncbi.nlm.nih.gov/pubmed/28655636</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tiv.2017.06.023</pub-id><pub-id pub-id-type="pmid">28655636</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Robinson RK, Birrell MA, Adcock JJ, Wortley MA, Dubuis ED, Chen S, et al. Mechanistic link between diesel exhaust particles and respiratory reflexes. J Allergy Clin Immunol. 2017; doi:10.1016/j.jaci.2017.04.038. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28532657">https://www.ncbi.nlm.nih.gov/pubmed/28532657</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2017.04.038</pub-id><pub-id pub-id-type="pmcid">PMC5840514</pub-id><pub-id pub-id-type="pmid">28532657</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H</given-names></name></person-group><article-title>The immunology of asthma</article-title><source>Nature immunology</source><year>2015</year><volume>16</volume><issue>1</issue><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">25521684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3049</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porter</surname><given-names>PC</given-names></name><name name-style="western"><surname>Lim</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Maskatia</surname><given-names>ZK</given-names></name><name name-style="western"><surname>Mak</surname><given-names>G</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>CL</given-names></name><name name-style="western"><surname>Citardi</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Airway surface mycosis in chronic TH2-associated airway disease</article-title><source>J Allergy Clin Immunol</source><year>2014</year><volume>134</volume><issue>2</issue><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">24928648</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2014.04.028</pub-id><pub-id pub-id-type="pmcid">PMC4119856</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manni</surname><given-names>ML</given-names></name><name name-style="western"><surname>Trudeau</surname><given-names>JB</given-names></name><name name-style="western"><surname>Scheller</surname><given-names>EV</given-names></name><name name-style="western"><surname>Mandalapu</surname><given-names>S</given-names></name><name name-style="western"><surname>Elloso</surname><given-names>MM</given-names></name><name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></name><etal/></person-group><article-title>The complex relationship between inflammation and lung function in severe asthma</article-title><source>Mucosal immunology</source><year>2014</year><volume>7</volume><issue>5</issue><fpage>1186</fpage><lpage>1198</lpage><pub-id pub-id-type="pmid">24549277</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mi.2014.8</pub-id><pub-id pub-id-type="pmcid">PMC4138304</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irvin</surname><given-names>C</given-names></name><name name-style="western"><surname>Zafar</surname><given-names>I</given-names></name><name name-style="western"><surname>Good</surname><given-names>J</given-names></name><name name-style="western"><surname>Rollins</surname><given-names>D</given-names></name><name name-style="western"><surname>Christianson</surname><given-names>C</given-names></name><name name-style="western"><surname>Gorska</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma</article-title><source>J Allergy Clin Immunol</source><year>2014</year><volume>134</volume><issue>5</issue><fpage>1175</fpage><lpage>86 e7</lpage><pub-id pub-id-type="pmid">25042748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2014.05.038</pub-id><pub-id pub-id-type="pmcid">PMC4254017</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saglani</surname><given-names>S</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>CM</given-names></name></person-group><article-title>Novel concepts in airway inflammation and remodelling in asthma</article-title><source>Eur Respir J</source><year>2015</year><volume>46</volume><issue>6</issue><fpage>1796</fpage><lpage>1804</lpage><pub-id pub-id-type="pmid">26541520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.01196-2014</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sagar</surname><given-names>S</given-names></name><name name-style="western"><surname>Akbarshahi</surname><given-names>H</given-names></name><name name-style="western"><surname>Uller</surname><given-names>L</given-names></name></person-group><article-title>Translational value of animal models of asthma: Challenges and promises</article-title><source>Eur J Pharmacol</source><year>2015</year><volume>759</volume><fpage>272</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">25823808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejphar.2015.03.037</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Sakurai</surname><given-names>M</given-names></name><name name-style="western"><surname>Ichinose</surname><given-names>T</given-names></name><name name-style="western"><surname>Sadakane</surname><given-names>K</given-names></name><etal/></person-group><article-title>Effects of nano particles on antigen-related airway inflammation in mice</article-title><source>Respir Res</source><year>2005</year><volume>6</volume><fpage>106</fpage><pub-id pub-id-type="pmid">16164761</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1465-9921-6-106</pub-id><pub-id pub-id-type="pmcid">PMC1242256</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Ichinose</surname><given-names>T</given-names></name><name name-style="western"><surname>Sakurai</surname><given-names>M</given-names></name><name name-style="western"><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title>Effects of nano particles on cytokine expression in murine lung in the absence or presence of allergen</article-title><source>Arch Toxicol</source><year>2006</year><volume>80</volume><issue>9</issue><fpage>614</fpage><lpage>619</lpage><pub-id pub-id-type="pmid">16482471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-006-0075-3</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koike</surname><given-names>E</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>KI</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Sakurai</surname><given-names>M</given-names></name><name name-style="western"><surname>Aoyagi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Pulmonary exposure to carbon black nanoparticles increases the number of antigen-presenting cells in murine lung</article-title><source>Int J Immunopathol Pharmacol</source><year>2008</year><volume>21</volume><issue>1</issue><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">18336729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/039463200802100105</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Sakurai</surname><given-names>M</given-names></name><name name-style="western"><surname>Abe</surname><given-names>S</given-names></name><name name-style="western"><surname>Yoshino</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effects of nanoparticles on lung physiology in the presence or absence of antigen</article-title><source>Int J Immunopathol Pharmacol</source><year>2007</year><volume>20</volume><issue>4</issue><fpage>737</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">18179746</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/039463200702000409</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kroker</surname><given-names>M</given-names></name><name name-style="western"><surname>Sydlik</surname><given-names>U</given-names></name><name name-style="western"><surname>Autengruber</surname><given-names>A</given-names></name><name name-style="western"><surname>Cavelius</surname><given-names>C</given-names></name><name name-style="western"><surname>Weighardt</surname><given-names>H</given-names></name><name name-style="western"><surname>Kraegeloh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Preventing carbon nanoparticle-induced lung inflammation reduces antigen-specific sensitization and subsequent allergic reactions in a mouse model</article-title><source>Part Fibre Toxicol</source><year>2015</year><volume>12</volume><fpage>20</fpage><pub-id pub-id-type="pmid">26141115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-015-0093-5</pub-id><pub-id pub-id-type="pmcid">PMC4491258</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Haar</surname><given-names>C</given-names></name><name name-style="western"><surname>Hassing</surname><given-names>I</given-names></name><name name-style="western"><surname>Bol</surname><given-names>M</given-names></name><name name-style="western"><surname>Bleumink</surname><given-names>R</given-names></name><name name-style="western"><surname>Pieters</surname><given-names>R</given-names></name></person-group><article-title>Ultrafine carbon black particles cause early airway inflammation and have adjuvant activity in a mouse allergic airway disease model</article-title><source>Toxicol Sci</source><year>2005</year><volume>87</volume><issue>2</issue><fpage>409</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">16014737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfi255</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Haar</surname><given-names>C</given-names></name><name name-style="western"><surname>Hassing</surname><given-names>I</given-names></name><name name-style="western"><surname>Bol</surname><given-names>M</given-names></name><name name-style="western"><surname>Bleumink</surname><given-names>R</given-names></name><name name-style="western"><surname>Pieters</surname><given-names>R</given-names></name></person-group><article-title>Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice</article-title><source>Clin Exp Allergy</source><year>2006</year><volume>36</volume><issue>11</issue><fpage>1469</fpage><lpage>1479</lpage><pub-id pub-id-type="pmid">17083358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2222.2006.02586.x</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alberg</surname><given-names>T</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>JS</given-names></name><name name-style="western"><surname>Lovik</surname><given-names>M</given-names></name><name name-style="western"><surname>Nygaard</surname><given-names>UC</given-names></name></person-group><article-title>Particles influence allergic responses in mice--role of gender and particle size</article-title><source>J Toxicol Environ Health Part A</source><year>2014</year><volume>77</volume><issue>5</issue><fpage>281</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">24588227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15287394.2013.863746</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshioka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fujimura</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>K</given-names></name><name name-style="western"><surname>Higashisaka</surname><given-names>K</given-names></name><name name-style="western"><surname>Morishita</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice</article-title><source>Nanoscale research letters</source><year>2011</year><volume>6</volume><issue>1</issue><fpage>195</fpage><pub-id pub-id-type="pmid">21711705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1556-276X-6-195</pub-id><pub-id pub-id-type="pmcid">PMC3211251</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Abrahaley</surname><given-names>T</given-names></name><name name-style="western"><surname>Qin</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Adverse effect of nano-silicon dioxide on lung function of rats with or without ovalbumin immunization</article-title><source>PloS one</source><year>2011</year><volume>6</volume><issue>2</issue><fpage>e17236</fpage><pub-id pub-id-type="pmid">21359146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0017236</pub-id><pub-id pub-id-type="pmcid">PMC3040772</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandenberger</surname><given-names>C</given-names></name><name name-style="western"><surname>Rowley</surname><given-names>NL</given-names></name><name name-style="western"><surname>Jackson-Humbles</surname><given-names>DN</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Bramble</surname><given-names>LA</given-names></name><name name-style="western"><surname>Lewandowski</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice</article-title><source>Part Fibre Toxicol</source><year>2013</year><volume>10</volume><fpage>26</fpage><pub-id pub-id-type="pmid">23815813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-10-26</pub-id><pub-id pub-id-type="pmcid">PMC3729411</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>H</given-names></name><name name-style="western"><surname>Park</surname><given-names>YH</given-names></name><name name-style="western"><surname>Park</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K</given-names></name><name name-style="western"><surname>Um</surname><given-names>K</given-names></name><name name-style="western"><surname>Park</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Toxic and adjuvant effects of silica nanoparticles on ovalbumin-induced allergic airway inflammation in mice</article-title><source>Respir Res</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>60</fpage><pub-id pub-id-type="pmid">27194244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-016-0376-x</pub-id><pub-id pub-id-type="pmcid">PMC4870782</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Koike</surname><given-names>E</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Hirano</surname><given-names>S</given-names></name><name name-style="western"><surname>Nishikawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name></person-group><article-title>Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model</article-title><source>Toxicol Appl Pharmacol</source><year>2009</year><volume>237</volume><issue>3</issue><fpage>306</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">19371758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2009.04.003</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizutani</surname><given-names>N</given-names></name><name name-style="western"><surname>Nabe</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshino</surname><given-names>S</given-names></name></person-group><article-title>Exposure to multiwalled carbon nanotubes and allergen promotes early- and late-phase increases in airway resistance in mice</article-title><source>Biol Pharm Bull</source><year>2012</year><volume>35</volume><issue>12</issue><fpage>2133</fpage><lpage>2140</lpage><pub-id pub-id-type="pmid">23207765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/bpb.b12-00357</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ronzani</surname><given-names>C</given-names></name><name name-style="western"><surname>Casset</surname><given-names>A</given-names></name><name name-style="western"><surname>Pons</surname><given-names>F</given-names></name></person-group><article-title>Exposure to multi-walled carbon nanotubes results in aggravation of airway inflammation and remodeling and in increased production of epithelium-derived innate cytokines in a mouse model of asthma</article-title><source>Arch Toxicol</source><year>2014</year><volume>88</volume><issue>2</issue><fpage>489</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">23948970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-013-1116-3</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Koike</surname><given-names>E</given-names></name><name name-style="western"><surname>Nishikawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name></person-group><article-title>Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: Possible role of oxidative stress</article-title><source>Free Radic Biol Med</source><year>2010</year><volume>48</volume><issue>7</issue><fpage>924</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">20093178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.freeradbiomed.2010.01.013</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Application of vitamin E to antagonize SWCNTs-induced exacerbation of allergic asthma</article-title><source>Sci Rep.</source><year>2014</year><volume>4</volume><fpage>4275</fpage><pub-id pub-id-type="pmid">24589727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep04275</pub-id><pub-id pub-id-type="pmcid">PMC3940970</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nygaard</surname><given-names>UC</given-names></name><name name-style="western"><surname>Samuelsen</surname><given-names>M</given-names></name><name name-style="western"><surname>Marioara</surname><given-names>CD</given-names></name><name name-style="western"><surname>Lovik</surname><given-names>M</given-names></name></person-group><article-title>Carbon nanofibers have IgE adjuvant capacity but are less potent than nanotubes in promoting allergic airway responses</article-title><source>BioMed Res Int</source><year>2013</year><volume>2013</volume><fpage>476010</fpage><pub-id pub-id-type="pmid">24024193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2013/476010</pub-id><pub-id pub-id-type="pmcid">PMC3760273</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horie</surname><given-names>M</given-names></name><name name-style="western"><surname>Stowe</surname><given-names>M</given-names></name><name name-style="western"><surname>Tabei</surname><given-names>M</given-names></name><name name-style="western"><surname>Kuroda</surname><given-names>E</given-names></name></person-group><article-title>Pharyngeal aspiration of metal oxide nanoparticles showed potential of allergy aggravation effect to inhaled ovalbumin</article-title><source>Inhal Toxicol</source><year>2015</year><volume>27</volume><issue>3</issue><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">25864991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2015.1026618</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>KL</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HI</given-names></name><name name-style="western"><surname>Liao</surname><given-names>HS</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>BL</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>TJ</given-names></name></person-group><article-title>Zinc oxide nanoparticles induce eosinophilic airway inflammation in mice</article-title><source>J Hazard Mater</source><year>2015</year><volume>297</volume><fpage>304</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">26010476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhazmat.2015.05.023</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukui</surname><given-names>H</given-names></name><name name-style="western"><surname>Horie</surname><given-names>M</given-names></name><name name-style="western"><surname>Endoh</surname><given-names>S</given-names></name><name name-style="western"><surname>Kato</surname><given-names>H</given-names></name><name name-style="western"><surname>Fujita</surname><given-names>K</given-names></name><name name-style="western"><surname>Nishio</surname><given-names>K</given-names></name><etal/></person-group><article-title>Association of zinc ion release and oxidative stress induced by intratracheal instillation of ZnO nanoparticles to rat lung</article-title><source>Chem Biol Interact</source><year>2012</year><volume>198</volume><issue>1&#8211;3</issue><fpage>29</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">22640810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2012.04.007</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>EG</given-names></name><name name-style="western"><surname>Rudolph</surname><given-names>K</given-names></name><name name-style="western"><surname>Bowen</surname><given-names>LE</given-names></name><name name-style="western"><surname>Muggenburg</surname><given-names>BA</given-names></name><name name-style="western"><surname>Bice</surname><given-names>DE</given-names></name></person-group><article-title>Effect of inhaled ultrafine carbon particles on the allergic airway response in ragweed-sensitized dogs</article-title><source>Inhal Toxicol</source><year>2003</year><volume>15</volume><issue>2</issue><fpage>151</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">12528044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08958370304474</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beck-Speier</surname><given-names>I</given-names></name><name name-style="western"><surname>Karg</surname><given-names>E</given-names></name><name name-style="western"><surname>Behrendt</surname><given-names>H</given-names></name><name name-style="western"><surname>Stoeger</surname><given-names>T</given-names></name><name name-style="western"><surname>Alessandrini</surname><given-names>F</given-names></name></person-group><article-title>Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies</article-title><source>Part Fibre Toxicol</source><year>2012</year><volume>9</volume><fpage>27</fpage><pub-id pub-id-type="pmid">22809365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-9-27</pub-id><pub-id pub-id-type="pmcid">PMC3508980</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unfried</surname><given-names>K</given-names></name><name name-style="western"><surname>Kroker</surname><given-names>M</given-names></name><name name-style="western"><surname>Autengruber</surname><given-names>A</given-names></name><name name-style="western"><surname>Gotic</surname><given-names>M</given-names></name><name name-style="western"><surname>Sydlik</surname><given-names>U</given-names></name></person-group><article-title>The compatible solute ectoine reduces the exacerbating effect of environmental model particles on the immune response of the airways</article-title><source>J Allergy</source><year>2014</year><volume>2014</volume><fpage>708458</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/708458</pub-id><pub-id pub-id-type="pmcid">PMC4005218</pub-id><pub-id pub-id-type="pmid">24822073</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alessandrini</surname><given-names>F</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>H</given-names></name><name name-style="western"><surname>Takenaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Lentner</surname><given-names>B</given-names></name><name name-style="western"><surname>Karg</surname><given-names>E</given-names></name><name name-style="western"><surname>Behrendt</surname><given-names>H</given-names></name><etal/></person-group><article-title>Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung</article-title><source>J Allergy Clin Immunol</source><year>2006</year><volume>117</volume><issue>4</issue><fpage>824</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">16630940</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2005.11.046</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alessandrini</surname><given-names>F</given-names></name><name name-style="western"><surname>Weichenmeier</surname><given-names>I</given-names></name><name name-style="western"><surname>van Miert</surname><given-names>E</given-names></name><name name-style="western"><surname>Takenaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Karg</surname><given-names>E</given-names></name><name name-style="western"><surname>Blume</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effects of ultrafine particles-induced oxidative stress on Clara cells in allergic lung inflammation</article-title><source>Part Fibre Toxicol</source><year>2010</year><volume>7</volume><fpage>11</fpage><pub-id pub-id-type="pmid">20420656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-7-11</pub-id><pub-id pub-id-type="pmcid">PMC2880284</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain</surname><given-names>S</given-names></name><name name-style="western"><surname>Vanoirbeek</surname><given-names>JA</given-names></name><name name-style="western"><surname>Luyts</surname><given-names>K</given-names></name><name name-style="western"><surname>De Vooght</surname><given-names>V</given-names></name><name name-style="western"><surname>Verbeken</surname><given-names>E</given-names></name><name name-style="western"><surname>Thomassen</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Lung exposure to nanoparticles modulates an asthmatic response in a mouse model</article-title><source>Eur Respir J</source><year>2011</year><volume>37</volume><issue>2</issue><fpage>299</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">20530043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.00168509</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>JW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>IC</given-names></name><name name-style="western"><surname>Shin</surname><given-names>NR</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>CM</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>OK</given-names></name><name name-style="western"><surname>Ko</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Copper oxide nanoparticles aggravate airway inflammation and mucus production in asthmatic mice via MAPK signaling</article-title><source>Nanotoxicology</source><year>2016</year><volume>10</volume><issue>4</issue><fpage>445</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">26472121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2015.1078851</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shurin</surname><given-names>MR</given-names></name><name name-style="western"><surname>Yanamala</surname><given-names>N</given-names></name><name name-style="western"><surname>Kisin</surname><given-names>ER</given-names></name><name name-style="western"><surname>Tkach</surname><given-names>AV</given-names></name><name name-style="western"><surname>Shurin</surname><given-names>GV</given-names></name><name name-style="western"><surname>Murray</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Graphene oxide attenuates Th2-type immune responses, but augments airway remodeling and hyperresponsiveness in a murine model of asthma</article-title><source>ACS nano.</source><year>2014</year><volume>8</volume><issue>6</issue><fpage>5585</fpage><lpage>5599</lpage><pub-id pub-id-type="pmid">24847914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/nn406454u</pub-id><pub-id pub-id-type="pmcid">PMC4072415</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marzaioli</surname><given-names>V</given-names></name><name name-style="western"><surname>Aguilar-Pimentel</surname><given-names>JA</given-names></name><name name-style="western"><surname>Weichenmeier</surname><given-names>I</given-names></name><name name-style="western"><surname>Luxenhofer</surname><given-names>G</given-names></name><name name-style="western"><surname>Wiemann</surname><given-names>M</given-names></name><name name-style="western"><surname>Landsiedel</surname><given-names>R</given-names></name><etal/></person-group><article-title>Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties</article-title><source>Int J Nanomedicine</source><year>2014</year><volume>9</volume><fpage>2815</fpage><lpage>2832</lpage><pub-id pub-id-type="pmid">24940059</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S57396</pub-id><pub-id pub-id-type="pmcid">PMC4051720</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryman-Rasmussen</surname><given-names>JP</given-names></name><name name-style="western"><surname>Tewksbury</surname><given-names>EW</given-names></name><name name-style="western"><surname>Moss</surname><given-names>OR</given-names></name><name name-style="western"><surname>Cesta</surname><given-names>MF</given-names></name><name name-style="western"><surname>Wong</surname><given-names>BA</given-names></name><name name-style="western"><surname>Bonner</surname><given-names>JC</given-names></name></person-group><article-title>Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma</article-title><source>Am J Respir Cell Mol Biol</source><year>2009</year><volume>40</volume><issue>3</issue><fpage>349</fpage><lpage>358</lpage><pub-id pub-id-type="pmid">18787175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2008-0276OC</pub-id><pub-id pub-id-type="pmcid">PMC2645533</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staal</surname><given-names>YC</given-names></name><name name-style="western"><surname>van Triel</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Maarschalkerweerd</surname><given-names>TV</given-names></name><name name-style="western"><surname>Arts</surname><given-names>JH</given-names></name><name name-style="western"><surname>Duistermaat</surname><given-names>E</given-names></name><name name-style="western"><surname>Muijser</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inhaled multiwalled carbon nanotubes modulate the immune response of trimellitic anhydride-induced chemical respiratory allergy in brown Norway rats</article-title><source>Toxicol Pathol</source><year>2014</year><volume>42</volume><issue>7</issue><fpage>1130</fpage><lpage>1142</lpage><pub-id pub-id-type="pmid">24705883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0192623313519874</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>EA</given-names></name><name name-style="western"><surname>Sayers</surname><given-names>BC</given-names></name><name name-style="western"><surname>Glista-Baker</surname><given-names>EE</given-names></name><name name-style="western"><surname>Shipkowski</surname><given-names>KA</given-names></name><name name-style="western"><surname>Ihrie</surname><given-names>MD</given-names></name><name name-style="western"><surname>Duke</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Role of signal transducer and activator of transcription 1 in murine allergen-induced airway remodeling and exacerbation by carbon nanotubes</article-title><source>Am J Respir Cell Mol Biol</source><year>2015</year><volume>53</volume><issue>5</issue><fpage>625</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">25807359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2014-0221OC</pub-id><pub-id pub-id-type="pmcid">PMC4742949</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sayers</surname><given-names>BC</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Glista-Baker</surname><given-names>EE</given-names></name><name name-style="western"><surname>Shipley-Phillips</surname><given-names>JK</given-names></name><name name-style="western"><surname>Dackor</surname><given-names>RT</given-names></name><name name-style="western"><surname>Edin</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes</article-title><source>Am J Respir Cell Mol Biol</source><year>2013</year><volume>49</volume><issue>4</issue><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">23642096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2013-0019OC</pub-id><pub-id pub-id-type="pmcid">PMC3824045</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shipkowski</surname><given-names>KA</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>EA</given-names></name><name name-style="western"><surname>Glista-Baker</surname><given-names>EE</given-names></name><name name-style="western"><surname>Sayers</surname><given-names>BC</given-names></name><name name-style="western"><surname>Messenger</surname><given-names>ZJ</given-names></name><etal/></person-group><article-title>An allergic lung microenvironment suppresses carbon nanotube-induced inflammasome activation via STAT6-dependent inhibition of caspase-1</article-title><source>PloS one</source><year>2015</year><volume>10</volume><issue>6</issue><fpage>e0128888</fpage><pub-id pub-id-type="pmid">26091108</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0128888</pub-id><pub-id pub-id-type="pmcid">PMC4474696</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Haar</surname><given-names>C</given-names></name><name name-style="western"><surname>Kool</surname><given-names>M</given-names></name><name name-style="western"><surname>Hassing</surname><given-names>I</given-names></name><name name-style="western"><surname>Bol</surname><given-names>M</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name><name name-style="western"><surname>Pieters</surname><given-names>R</given-names></name></person-group><article-title>Lung dendritic cells are stimulated by ultrafine particles and play a key role in particle adjuvant activity</article-title><source>J Allergy Clin Immunol</source><year>2008</year><volume>121</volume><issue>5</issue><fpage>1246</fpage><lpage>1254</lpage><pub-id pub-id-type="pmid">18313130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2008.01.010</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koike</surname><given-names>E</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>T</given-names></name></person-group><article-title>Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells</article-title><source>Chemosphere</source><year>2008</year><volume>73</volume><issue>3</issue><fpage>371</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">18602660</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2008.05.054</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lefebvre</surname><given-names>DE</given-names></name><name name-style="western"><surname>Pearce</surname><given-names>B</given-names></name><name name-style="western"><surname>Fine</surname><given-names>JH</given-names></name><name name-style="western"><surname>Chomyshyn</surname><given-names>E</given-names></name><name name-style="western"><surname>Ross</surname><given-names>N</given-names></name><name name-style="western"><surname>Halappanavar</surname><given-names>S</given-names></name><etal/></person-group><article-title>In vitro enhancement of mouse T helper 2 cell sensitization to ovalbumin allergen by carbon black nanoparticles</article-title><source>Toxicol Sci</source><year>2014</year><volume>138</volume><issue>2</issue><fpage>322</fpage><lpage>332</lpage><pub-id pub-id-type="pmid">24449417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfu010</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>BL</given-names></name><name name-style="western"><surname>Baker</surname><given-names>GL</given-names></name><name name-style="western"><surname>Kaminski</surname><given-names>NE</given-names></name></person-group><article-title>Induced T cell cytokine production is enhanced by engineered nanoparticles</article-title><source>Nanotoxicology</source><year>2014</year><volume>8</volume><issue>Suppl 1</issue><fpage>11</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">24256152</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2013.848302</pub-id><pub-id pub-id-type="pmcid">PMC4130797</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirai</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshioka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>H</given-names></name><name name-style="western"><surname>Ichihashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name><name name-style="western"><surname>Tochigi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Amorphous silica nanoparticles enhance cross-presentation in murine dendritic cells</article-title><source>Biochem Biophys Res Commun</source><year>2012</year><volume>427</volume><issue>3</issue><fpage>553</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">23022188</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2012.09.095</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schanen</surname><given-names>BC</given-names></name><name name-style="western"><surname>Das</surname><given-names>S</given-names></name><name name-style="western"><surname>Reilly</surname><given-names>CM</given-names></name><name name-style="western"><surname>Warren</surname><given-names>WL</given-names></name><name name-style="western"><surname>Self</surname><given-names>WT</given-names></name><name name-style="western"><surname>Seal</surname><given-names>S</given-names></name><etal/></person-group><article-title>Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles</article-title><source>PloS one</source><year>2013</year><volume>8</volume><issue>5</issue><fpage>e62816</fpage><pub-id pub-id-type="pmid">23667525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0062816</pub-id><pub-id pub-id-type="pmcid">PMC3648566</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hardy</surname><given-names>CL</given-names></name><name name-style="western"><surname>LeMasurier</surname><given-names>JS</given-names></name><name name-style="western"><surname>Belz</surname><given-names>GT</given-names></name><name name-style="western"><surname>Scalzo-Inguanti</surname><given-names>K</given-names></name><name name-style="western"><surname>Yao</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>SD</given-names></name><etal/></person-group><article-title>Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation</article-title><source>J Immunol</source><year>2012</year><volume>188</volume><issue>3</issue><fpage>1431</fpage><lpage>1441</lpage><pub-id pub-id-type="pmid">22190179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1100156</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hardy</surname><given-names>CL</given-names></name><name name-style="western"><surname>Lemasurier</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mohamud</surname><given-names>R</given-names></name><name name-style="western"><surname>Yao</surname><given-names>J</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>SD</given-names></name><name name-style="western"><surname>Rolland</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints</article-title><source>J Immunol</source><year>2013</year><volume>191</volume><issue>10</issue><fpage>5278</fpage><lpage>5290</lpage><pub-id pub-id-type="pmid">24123688</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1203131</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ban</surname><given-names>M</given-names></name><name name-style="western"><surname>Langonne</surname><given-names>I</given-names></name><name name-style="western"><surname>Huguet</surname><given-names>N</given-names></name><name name-style="western"><surname>Guichard</surname><given-names>Y</given-names></name><name name-style="western"><surname>Goutet</surname><given-names>M</given-names></name></person-group><article-title>Iron oxide particles modulate the ovalbumin-induced Th2 immune response in mice</article-title><source>Toxicol Lett</source><year>2013</year><volume>216</volume><issue>1</issue><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">23147377</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2012.11.003</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>EM</given-names></name><name name-style="western"><surname>Pylkkanen</surname><given-names>L</given-names></name><name name-style="western"><surname>Koivisto</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Nykasenoja</surname><given-names>H</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>H</given-names></name><name name-style="western"><surname>Savolainen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inhalation exposure to nanosized and fine TiO2 particles inhibits features of allergic asthma in a murine model</article-title><source>Part Fibre Toxicol</source><year>2010</year><volume>7</volume><fpage>35</fpage><pub-id pub-id-type="pmid">21108815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-7-35</pub-id><pub-id pub-id-type="pmcid">PMC3003234</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grun</surname><given-names>JL</given-names></name><name name-style="western"><surname>Maurer</surname><given-names>PH</given-names></name></person-group><article-title>Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses</article-title><source>Cellular Immunol</source><year>1989</year><volume>121</volume><issue>1</issue><fpage>134</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">2524278</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0008-8749(89)90011-7</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergmann-Leitner</surname><given-names>ES</given-names></name><name name-style="western"><surname>Leitner</surname><given-names>WW</given-names></name></person-group><article-title>Adjuvants in the Driver&#8217;s Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators</article-title><source>Vaccines (Basel)</source><year>2014</year><volume>2</volume><issue>2</issue><fpage>252</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">26344620</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/vaccines2020252</pub-id><pub-id pub-id-type="pmcid">PMC4494256</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrack</surname><given-names>P</given-names></name><name name-style="western"><surname>McKee</surname><given-names>AS</given-names></name><name name-style="western"><surname>Munks</surname><given-names>MW</given-names></name></person-group><article-title>Towards an understanding of the adjuvant action of aluminium</article-title><source>Nat Rev Immunol</source><year>2009</year><volume>9</volume><issue>4</issue><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">19247370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri2510</pub-id><pub-id pub-id-type="pmcid">PMC3147301</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oleszycka</surname><given-names>E</given-names></name><name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name></person-group><article-title>Immunomodulatory properties of the vaccine adjuvant alum</article-title><source>Curr Opin Immunol</source><year>2014</year><volume>28</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">24463269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.coi.2013.12.007</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sayan</surname><given-names>M</given-names></name><name name-style="western"><surname>Mossman</surname><given-names>BT</given-names></name></person-group><article-title>The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases</article-title><source>Part Fibre Toxicol</source><year>2016</year><volume>13</volume><issue>1</issue><fpage>51</fpage><pub-id pub-id-type="pmid">27650313</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-016-0162-4</pub-id><pub-id pub-id-type="pmcid">PMC5029018</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="other">Mishra A, Zheng J, Tang X, Goering PL. Silver Nanoparticle-Induced Autophagic-Lysosomal Disruption and NLRP3-Inflammasome Activation in HepG2 Cells is Size-Dependent. Toxicol Sci. 2016; doi:10.1093/toxsci/kfw011. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/26801583">http://www.ncbi.nlm.nih.gov/pubmed/26801583</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfw011</pub-id><pub-id pub-id-type="pmid">26801583</pub-id></mixed-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baron</surname><given-names>L</given-names></name><name name-style="western"><surname>Gombault</surname><given-names>A</given-names></name><name name-style="western"><surname>Fanny</surname><given-names>M</given-names></name><name name-style="western"><surname>Villeret</surname><given-names>B</given-names></name><name name-style="western"><surname>Savigny</surname><given-names>F</given-names></name><name name-style="western"><surname>Guillou</surname><given-names>N</given-names></name><etal/></person-group><article-title>The NLRP3 inflammasome is activated by nanoparticles through ATP</article-title><source>ADP and adenosine. Cell Death Dis.</source><year>2015</year><volume>6</volume><fpage>e1629</fpage><pub-id pub-id-type="pmid">25654762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cddis.2014.576</pub-id><pub-id pub-id-type="pmcid">PMC4669808</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sager</surname><given-names>TM</given-names></name><name name-style="western"><surname>Wolfarth</surname><given-names>MW</given-names></name><name name-style="western"><surname>Andrew</surname><given-names>M</given-names></name><name name-style="western"><surname>Hubbs</surname><given-names>A</given-names></name><name name-style="western"><surname>Friend</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>TH</given-names></name><etal/></person-group><article-title>Effect of multi-walled carbon nanotube surface modification on bioactivity in the C57BL/6 mouse model</article-title><source>Nanotoxicology</source><year>2014</year><volume>8</volume><issue>3</issue><fpage>317</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">23432020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2013.779757</pub-id><pub-id pub-id-type="pmcid">PMC4669410</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yazdi</surname><given-names>AS</given-names></name><name name-style="western"><surname>Guarda</surname><given-names>G</given-names></name><name name-style="western"><surname>Riteau</surname><given-names>N</given-names></name><name name-style="western"><surname>Drexler</surname><given-names>SK</given-names></name><name name-style="western"><surname>Tardivel</surname><given-names>A</given-names></name><name name-style="western"><surname>Couillin</surname><given-names>I</given-names></name><etal/></person-group><article-title>Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><issue>45</issue><fpage>19449</fpage><lpage>19454</lpage><pub-id pub-id-type="pmid">20974980</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1008155107</pub-id><pub-id pub-id-type="pmcid">PMC2984140</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winter</surname><given-names>M</given-names></name><name name-style="western"><surname>Beer</surname><given-names>HD</given-names></name><name name-style="western"><surname>Hornung</surname><given-names>V</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>U</given-names></name><name name-style="western"><surname>Schins</surname><given-names>RP</given-names></name><name name-style="western"><surname>Forster</surname><given-names>I</given-names></name></person-group><article-title>Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells</article-title><source>Nanotoxicology</source><year>2011</year><volume>5</volume><issue>3</issue><fpage>326</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">20846021</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2010.506957</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakanishi</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsukimoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Tanuma</surname><given-names>S</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name><name name-style="western"><surname>Kojima</surname><given-names>S</given-names></name></person-group><article-title>Silica nanoparticles activate purinergic signaling via P2X7 receptor in dendritic cells, leading to production of pro-inflammatory cytokines</article-title><source>Toxicol In Vitro</source><year>2016</year><volume>35</volume><fpage>202</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">27311643</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tiv.2016.06.003</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Tian</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Nanoparticle-induced exosomes target antigen-presenting cells to initiate Th1-type immune activation</article-title><source>Small.</source><year>2012</year><volume>8</volume><issue>18</issue><fpage>2841</fpage><lpage>2848</lpage><pub-id pub-id-type="pmid">22674628</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.201200381</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><mixed-citation publication-type="other">Ricciardolo FL, Sorbello V, Folino A, Gallo F, Massaglia GM, Favata G, et al. Identification of IL-17F/frequent exacerbator endotype in asthma. J Allergy Clin Immunol. 2016; doi:10.1016/j.jaci.2016.10.034. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27931975">http://www.ncbi.nlm.nih.gov/pubmed/27931975</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2016.10.034</pub-id><pub-id pub-id-type="pmid">27931975</pub-id></mixed-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chesne</surname><given-names>J</given-names></name><name name-style="western"><surname>Braza</surname><given-names>F</given-names></name><name name-style="western"><surname>Mahay</surname><given-names>G</given-names></name><name name-style="western"><surname>Brouard</surname><given-names>S</given-names></name><name name-style="western"><surname>Aronica</surname><given-names>M</given-names></name><name name-style="western"><surname>Magnan</surname><given-names>A</given-names></name></person-group><article-title>IL-17 in severe asthma. Where do we stand?</article-title><source>Am J Respir Crit Care Med</source><year>2014</year><volume>190</volume><issue>10</issue><fpage>1094</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">25162311</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201405-0859PP</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>RH</given-names></name><name name-style="western"><surname>Whitehead</surname><given-names>GS</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>H</given-names></name><name name-style="western"><surname>Free</surname><given-names>ME</given-names></name><name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></name><name name-style="western"><surname>Cook</surname><given-names>DN</given-names></name></person-group><article-title>Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>180</volume><issue>8</issue><fpage>720</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">19661246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200904-0573OC</pub-id><pub-id pub-id-type="pmcid">PMC2778149</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H</given-names></name></person-group><article-title>Allergens and the airway epithelium response: gateway to allergic sensitization</article-title><source>J Allergy Clin Immunol</source><year>2014</year><volume>134</volume><issue>3</issue><fpage>499</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">25171864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2014.06.036</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain</surname><given-names>S</given-names></name><name name-style="western"><surname>Boland</surname><given-names>S</given-names></name><name name-style="western"><surname>Baeza-Squiban</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamel</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomassen</surname><given-names>LC</given-names></name><name name-style="western"><surname>Martens</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount</article-title><source>Toxicology.</source><year>2009</year><volume>260</volume><issue>1&#8211;3</issue><fpage>142</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">19464580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tox.2009.04.001</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gualtieri</surname><given-names>M</given-names></name><name name-style="western"><surname>Skuland</surname><given-names>T</given-names></name><name name-style="western"><surname>Iversen</surname><given-names>TG</given-names></name><name name-style="western"><surname>Lag</surname><given-names>M</given-names></name><name name-style="western"><surname>Schwarze</surname><given-names>P</given-names></name><name name-style="western"><surname>Bilanicova</surname><given-names>D</given-names></name><etal/></person-group><article-title>Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells</article-title><source>Nanotoxicology.</source><year>2012</year><volume>6</volume><issue>7</issue><fpage>700</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">21793771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2011.604441</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Presta</surname><given-names>L</given-names></name><name name-style="western"><surname>Shields</surname><given-names>R</given-names></name><name name-style="western"><surname>O'Connell</surname><given-names>L</given-names></name><name name-style="western"><surname>Lahr</surname><given-names>S</given-names></name><name name-style="western"><surname>Porter</surname><given-names>J</given-names></name><name name-style="western"><surname>Gorman</surname><given-names>C</given-names></name><etal/></person-group><article-title>The binding site on human immunoglobulin E for its high affinity receptor</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><issue>42</issue><fpage>26368</fpage><lpage>26373</lpage><pub-id pub-id-type="pmid">7929356</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>H</given-names></name><name name-style="western"><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>Signalling through the high-affinity IgE receptor Fc epsilonRI</article-title><source>Nature.</source><year>1999</year><volume>402</volume><issue>6760 Suppl</issue><fpage>B24</fpage><lpage>B30</lpage><pub-id pub-id-type="pmid">10586892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/35037021</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>EY</given-names></name><name name-style="western"><surname>Garnica</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Mintz</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CS</given-names></name><name name-style="western"><surname>Chin</surname><given-names>WC</given-names></name></person-group><article-title>A mixture of anatase and rutile TiO(2) nanoparticles induces histamine secretion in mast cells</article-title><source>Part Fibre Toxicol</source><year>2012</year><volume>9</volume><fpage>2</fpage><pub-id pub-id-type="pmid">22260553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-9-2</pub-id><pub-id pub-id-type="pmcid">PMC3275461</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aldossari</surname><given-names>AA</given-names></name><name name-style="western"><surname>Shannahan</surname><given-names>JH</given-names></name><name name-style="western"><surname>Podila</surname><given-names>R</given-names></name><name name-style="western"><surname>Brown</surname><given-names>JM</given-names></name></person-group><article-title>Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation</article-title><source>Toxicol In Vitro</source><year>2015</year><volume>29</volume><issue>1</issue><fpage>195</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">25458489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tiv.2014.10.008</pub-id><pub-id pub-id-type="pmcid">PMC4294974</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wingard</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Walters</surname><given-names>DM</given-names></name><name name-style="western"><surname>Cathey</surname><given-names>BL</given-names></name><name name-style="western"><surname>Hilderbrand</surname><given-names>SC</given-names></name><name name-style="western"><surname>Katwa</surname><given-names>P</given-names></name><name name-style="western"><surname>Lin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation</article-title><source>Nanotoxicology.</source><year>2011</year><volume>5</volume><issue>4</issue><fpage>531</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">21043986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2010.530004</pub-id><pub-id pub-id-type="pmcid">PMC3208763</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>HR</given-names></name><name name-style="western"><surname>Stover</surname><given-names>A</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>G</given-names></name><name name-style="western"><surname>Norton</surname><given-names>SK</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name><etal/></person-group><article-title>Fullerene nanomaterials inhibit the allergic response</article-title><source>J Immunol.</source><year>2007</year><volume>179</volume><issue>1</issue><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">17579089</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.179.1.665</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="other">Norton SK, Wijesinghe DS, Dellinger A, Sturgill J, Zhou Z, Barbour S, et al. Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma. J Allergy Clin Immunol. 2012;130 3:761&#8211;769 e2; doi:10.1016/j.jaci.2012.04.023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22664166">http://www.ncbi.nlm.nih.gov/pubmed/22664166</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2012.04.023</pub-id><pub-id pub-id-type="pmcid">PMC3955256</pub-id><pub-id pub-id-type="pmid">22664166</pub-id></mixed-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Djordjevic</surname><given-names>A</given-names></name><name name-style="western"><surname>Bogdanovic</surname><given-names>G</given-names></name><name name-style="western"><surname>Dobric</surname><given-names>S</given-names></name></person-group><article-title>Fullerenes in biomedicine</article-title><source>J BUON</source><year>2006</year><volume>11</volume><issue>4</issue><fpage>391</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">17309168</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Umemoto</surname><given-names>EY</given-names></name><name name-style="western"><surname>Speck</surname><given-names>M</given-names></name><name name-style="western"><surname>Shimoda</surname><given-names>LM</given-names></name><name name-style="western"><surname>Kahue</surname><given-names>K</given-names></name><name name-style="western"><surname>Sung</surname><given-names>C</given-names></name><name name-style="western"><surname>Stokes</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Single-walled carbon nanotube exposure induces membrane rearrangement and suppression of receptor-mediated signalling pathways in model mast cells</article-title><source>Toxicol Lett</source><year>2014</year><volume>229</volume><issue>1</issue><fpage>198</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">24910985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2014.06.009</pub-id><pub-id pub-id-type="pmcid">PMC4136761</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feltis</surname><given-names>BN</given-names></name><name name-style="western"><surname>Elbaz</surname><given-names>A</given-names></name><name name-style="western"><surname>Wright</surname><given-names>PF</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>GA</given-names></name><name name-style="western"><surname>Turney</surname><given-names>TW</given-names></name><name name-style="western"><surname>Lopata</surname><given-names>AL</given-names></name></person-group><article-title>Characterizing the inhibitory action of zinc oxide nanoparticles on allergic-type mast cell activation</article-title><source>Mol Immunol</source><year>2015</year><volume>66</volume><issue>2</issue><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">25771180</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molimm.2015.02.021</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alessandrini</surname><given-names>F</given-names></name><name name-style="western"><surname>Beck-Speier</surname><given-names>I</given-names></name><name name-style="western"><surname>Krappmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Weichenmeier</surname><given-names>I</given-names></name><name name-style="western"><surname>Takenaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Karg</surname><given-names>E</given-names></name><etal/></person-group><article-title>Role of oxidative stress in ultrafine particle-induced exacerbation of allergic lung inflammation</article-title><source>Am J Respir Crit Care Med.</source><year>2009</year><volume>179</volume><issue>11</issue><fpage>984</fpage><lpage>991</lpage><pub-id pub-id-type="pmid">19264975</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200807-1061OC</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>HS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>KH</given-names></name><name name-style="western"><surname>Jang</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>JW</given-names></name><name name-style="western"><surname>Cha</surname><given-names>HR</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Attenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles</article-title><source>Int J Nanomedicine.</source><year>2010</year><volume>5</volume><fpage>505</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">20957173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/ijn.s11664</pub-id><pub-id pub-id-type="pmcid">PMC2950409</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>JW</given-names></name><name name-style="western"><surname>Cha</surname><given-names>HR</given-names></name><name name-style="western"><surname>Jung</surname><given-names>SY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JE</given-names></name><name name-style="western"><surname>Jung</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation</article-title><source>Int J Nanomedicine</source><year>2012</year><volume>7</volume><fpage>1329</fpage><lpage>1343</lpage><pub-id pub-id-type="pmid">22457593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S27159</pub-id><pub-id pub-id-type="pmcid">PMC3310409</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>D</given-names></name><name name-style="western"><surname>Garg</surname><given-names>S</given-names></name><name name-style="western"><surname>Waite</surname><given-names>TD</given-names></name></person-group><article-title>H2O2-mediated oxidation of zero-valent silver and resultant interactions among silver nanoparticles, silver ions, and reactive oxygen species</article-title><source>Langmuir</source><year>2012</year><volume>28</volume><issue>27</issue><fpage>10266</fpage><lpage>10275</lpage><pub-id pub-id-type="pmid">22616806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/la300929g</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsin</surname><given-names>YH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CF</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>Shih</surname><given-names>TS</given-names></name><name name-style="western"><surname>Lai</surname><given-names>PS</given-names></name><name name-style="western"><surname>Chueh</surname><given-names>PJ</given-names></name></person-group><article-title>The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells</article-title><source>Toxicol lett</source><year>2008</year><volume>179</volume><issue>3</issue><fpage>130</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">18547751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2008.04.015</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piao</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kang</surname><given-names>KA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>IK</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Choi</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis</article-title><source>Toxicology lett</source><year>2011</year><volume>201</volume><issue>1</issue><fpage>92</fpage><lpage>100</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2010.12.010</pub-id><pub-id pub-id-type="pmid">21182908</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuang</surname><given-names>HC</given-names></name><name name-style="western"><surname>Hsiao</surname><given-names>TC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CK</given-names></name><name name-style="western"><surname>Chang</surname><given-names>HH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Allergenicity and toxicology of inhaled silver nanoparticles in allergen-provocation mice models</article-title><source>Int J Nanomedicine</source><year>2013</year><volume>8</volume><fpage>4495</fpage><lpage>4506</lpage><pub-id pub-id-type="pmid">24285922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S52239</pub-id><pub-id pub-id-type="pmcid">PMC3841295</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barreto</surname><given-names>E</given-names></name><name name-style="western"><surname>Serra</surname><given-names>MF</given-names></name><name name-style="western"><surname>Dos Santos</surname><given-names>RV</given-names></name><name name-style="western"><surname>Dos Santos</surname><given-names>CE</given-names></name><name name-style="western"><surname>Hickmann</surname><given-names>J</given-names></name><name name-style="western"><surname>Cotias</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Local Administration of Gold Nanoparticles Prevents Pivotal Pathological Changes in Murine Models of Atopic Asthma</article-title><source>J Biomed Nanotechnol</source><year>2015</year><volume>11</volume><issue>6</issue><fpage>1038</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">26353593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1166/jbn.2015.2024</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scarino</surname><given-names>A</given-names></name><name name-style="western"><surname>Noel</surname><given-names>A</given-names></name><name name-style="western"><surname>Renzi</surname><given-names>PM</given-names></name><name name-style="western"><surname>Cloutier</surname><given-names>Y</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>R</given-names></name><name name-style="western"><surname>Truchon</surname><given-names>G</given-names></name><etal/></person-group><article-title>Impact of emerging pollutants on pulmonary inflammation in asthmatic rats: ethanol vapors and agglomerated TiO2 nanoparticles</article-title><source>Inhal Toxicol</source><year>2012</year><volume>24</volume><issue>8</issue><fpage>528</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">22746402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2012.696741</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gustafsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Jonasson</surname><given-names>S</given-names></name><name name-style="western"><surname>Sandstrom</surname><given-names>T</given-names></name><name name-style="western"><surname>Lorentzen</surname><given-names>JC</given-names></name><name name-style="western"><surname>Bucht</surname><given-names>A</given-names></name></person-group><article-title>Genetic variation influences immune responses in sensitive rats following exposure to TiO2 nanoparticles</article-title><source>Toxicology.</source><year>2014</year><volume>326</volume><fpage>74</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">25456268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tox.2014.10.004</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jonasson</surname><given-names>S</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Koch</surname><given-names>B</given-names></name><name name-style="western"><surname>Bucht</surname><given-names>A</given-names></name></person-group><article-title>Inhalation exposure of nano-scaled titanium dioxide (TiO2) particles alters the inflammatory responses in asthmatic mice</article-title><source>Inhal Toxicol</source><year>2013</year><volume>25</volume><issue>4</issue><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">23480194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2013.770939</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radauer-Preiml</surname><given-names>I</given-names></name><name name-style="western"><surname>Andosch</surname><given-names>A</given-names></name><name name-style="western"><surname>Hawranek</surname><given-names>T</given-names></name><name name-style="western"><surname>Luetz-Meindl</surname><given-names>U</given-names></name><name name-style="western"><surname>Wiederstein</surname><given-names>M</given-names></name><name name-style="western"><surname>Horejs-Hoeck</surname><given-names>J</given-names></name><etal/></person-group><article-title>Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses</article-title><source>Part Fibre Toxicol</source><year>2016</year><volume>13</volume><fpage>3</fpage><pub-id pub-id-type="pmid">26772182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-016-0113-0</pub-id><pub-id pub-id-type="pmcid">PMC4715273</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babin</surname><given-names>K</given-names></name><name name-style="western"><surname>Antoine</surname><given-names>F</given-names></name><name name-style="western"><surname>Goncalves</surname><given-names>DM</given-names></name><name name-style="western"><surname>Girard</surname><given-names>D</given-names></name></person-group><article-title>TiO2, CeO2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils</article-title><source>Toxicol Lett</source><year>2013</year><volume>221</volume><issue>1</issue><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">23726862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2013.05.010</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>H</given-names></name><name name-style="western"><surname>Brown</surname><given-names>DM</given-names></name><name name-style="western"><surname>Kanase</surname><given-names>N</given-names></name><name name-style="western"><surname>Euston</surname><given-names>M</given-names></name><name name-style="western"><surname>Gaiser</surname><given-names>BK</given-names></name><name name-style="western"><surname>Robb</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Mechanism of neutrophil activation and toxicity elicited by engineered nanomaterials</article-title><source>Toxicol In Vitro</source><year>2015</year><volume>29</volume><issue>5</issue><fpage>1172</fpage><lpage>1184</lpage><pub-id pub-id-type="pmid">25962642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tiv.2015.04.021</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><mixed-citation publication-type="other">Vallieres F, Simard JC, Noel C, Murphy-Marion M, Lavastre V, Girard D. Activation of human AML14.3D10 eosinophils by nanoparticles: Modulatory activity on apoptosis and cytokine production. J Immunotoxicol. 2016:1&#8211;10. doi:10.1080/1547691X.2016.1203379. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27404512">http://www.ncbi.nlm.nih.gov/pubmed/27404512</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/1547691X.2016.1203379</pub-id><pub-id pub-id-type="pmid">27404512</pub-id></mixed-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>LR</given-names></name><name name-style="western"><surname>Girard</surname><given-names>D</given-names></name></person-group><article-title>Human eosinophils are direct targets to nanoparticles: Zinc oxide nanoparticles (ZnO) delay apoptosis and increase the production of the pro-inflammatory cytokines IL-1beta and IL-8</article-title><source>Toxicol Lett</source><year>2016</year><volume>259</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">27452280</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2016.07.020</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kusaka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sato</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakakuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Kohyama</surname><given-names>N</given-names></name><name name-style="western"><surname>Donaldson</surname><given-names>K</given-names></name></person-group><article-title>Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: role of free radicals</article-title><source>J Toxicol Environ Health A</source><year>1998</year><volume>53</volume><issue>6</issue><fpage>423</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">9537280</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/009841098159169</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dick</surname><given-names>CA</given-names></name><name name-style="western"><surname>Brown</surname><given-names>DM</given-names></name><name name-style="western"><surname>Donaldson</surname><given-names>K</given-names></name><name name-style="western"><surname>Stone</surname><given-names>V</given-names></name></person-group><article-title>The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types</article-title><source>Inhal Toxicol</source><year>2003</year><volume>15</volume><issue>1</issue><fpage>39</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">12476359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08958370304454</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stone</surname><given-names>V</given-names></name><name name-style="western"><surname>Miller</surname><given-names>MR</given-names></name><name name-style="western"><surname>Clift</surname><given-names>MJD</given-names></name><name name-style="western"><surname>Elder</surname><given-names>A</given-names></name><name name-style="western"><surname>Mills</surname><given-names>NL</given-names></name><name name-style="western"><surname>Moller</surname><given-names>P</given-names></name><etal/></person-group><article-title>Nanomaterials Versus Ambient Ultrafine Particles: An Opportunity to Exchange Toxicology Knowledge</article-title><source>Environ Health Perspect</source><year>2017</year><volume>125</volume><issue>10</issue><fpage>106002</fpage><pub-id pub-id-type="pmid">29017987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/EHP424</pub-id><pub-id pub-id-type="pmcid">PMC5933410</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braakhuis</surname><given-names>HM</given-names></name><name name-style="western"><surname>Oomen</surname><given-names>AG</given-names></name><name name-style="western"><surname>Cassee</surname><given-names>FR</given-names></name></person-group><article-title>Grouping nanomaterials to predict their potential to induce pulmonary inflammation</article-title><source>Toxicol Appl Pharmacol</source><year>2016</year><volume>299</volume><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">26603513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2015.11.009</pub-id></element-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunican</surname><given-names>EM</given-names></name><name name-style="western"><surname>Fahy</surname><given-names>JV</given-names></name></person-group><article-title>The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations</article-title><source>Annals Am Thoracic Soc</source><year>2015</year><volume>12</volume><issue>Suppl 2</issue><fpage>S144</fpage><lpage>S149</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/AnnalsATS.201506-377AW</pub-id><pub-id pub-id-type="pmcid">PMC5467082</pub-id><pub-id pub-id-type="pmid">26595730</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><mixed-citation publication-type="other">An SS, Mitzner W, Tang WY, Ahn K, Yoon AR, Huang J, et al. An inflammation-independent contraction mechanophenotype of airway smooth muscle in asthma. J Allergy Clin Immunol. 2016;138 1:294&#8211;297 e4; doi:10.1016/j.jaci.2015.12.1315. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/26936804">http://www.ncbi.nlm.nih.gov/pubmed/26936804</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2015.12.1315</pub-id><pub-id pub-id-type="pmcid">PMC4931984</pub-id><pub-id pub-id-type="pmid">26936804</pub-id></mixed-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seiffert</surname><given-names>J</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>F</given-names></name><name name-style="western"><surname>Wiegman</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Bey</surname><given-names>L</given-names></name><name name-style="western"><surname>Baker</surname><given-names>W</given-names></name><etal/></person-group><article-title>Pulmonary toxicity of instilled silver nanoparticles: influence of size, coating and rat strain</article-title><source>PloS one</source><year>2015</year><volume>10</volume><issue>3</issue><fpage>e0119726</fpage><pub-id pub-id-type="pmid">25747867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0119726</pub-id><pub-id pub-id-type="pmcid">PMC4352037</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scuri</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>BT</given-names></name><name name-style="western"><surname>Castranova</surname><given-names>V</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>JS</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>VJ</given-names></name><name name-style="western"><surname>Samsell</surname><given-names>L</given-names></name><etal/></person-group><article-title>Effects of titanium dioxide nanoparticle exposure on neuroimmune responses in rat airways</article-title><source>J Toxicol Environ Health A</source><year>2010</year><volume>73</volume><issue>20</issue><fpage>1353</fpage><lpage>1369</lpage><pub-id pub-id-type="pmid">20818535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15287394.2010.497436</pub-id><pub-id pub-id-type="pmcid">PMC3655524</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rydman</surname><given-names>EM</given-names></name><name name-style="western"><surname>Ilves</surname><given-names>M</given-names></name><name name-style="western"><surname>Koivisto</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Kinaret</surname><given-names>PA</given-names></name><name name-style="western"><surname>Fortino</surname><given-names>V</given-names></name><name name-style="western"><surname>Savinko</surname><given-names>TS</given-names></name><etal/></person-group><article-title>Inhalation of rod-like carbon nanotubes causes unconventional allergic airway inflammation</article-title><source>Part Fibre Toxicol</source><year>2014</year><volume>11</volume><fpage>48</fpage><pub-id pub-id-type="pmid">25318534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-014-0048-2</pub-id><pub-id pub-id-type="pmcid">PMC4215016</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beamer</surname><given-names>CA</given-names></name><name name-style="western"><surname>Girtsman</surname><given-names>TA</given-names></name><name name-style="western"><surname>Seaver</surname><given-names>BP</given-names></name><name name-style="western"><surname>Finsaas</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Migliaccio</surname><given-names>CT</given-names></name><name name-style="western"><surname>Perry</surname><given-names>VK</given-names></name><etal/></person-group><article-title>IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung</article-title><source>Nanotoxicology.</source><year>2013</year><volume>7</volume><issue>6</issue><fpage>1070</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">22686327</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2012.702230</pub-id><pub-id pub-id-type="pmcid">PMC4080677</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hsieh</surname><given-names>WY</given-names></name><name name-style="western"><surname>Chou</surname><given-names>CC</given-names></name><name name-style="western"><surname>Ho</surname><given-names>CC</given-names></name><name name-style="western"><surname>Yu</surname><given-names>SL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HY</given-names></name><name name-style="western"><surname>Chou</surname><given-names>HY</given-names></name><etal/></person-group><article-title>Single-walled carbon nanotubes induce airway hyperreactivity and parenchymal injury in mice</article-title><source>Am J Respir Cell Mol Biol</source><year>2012</year><volume>46</volume><issue>2</issue><fpage>257</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">21960547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2011-0010OC</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><mixed-citation publication-type="other">Lauzon AM, Martin JG. Airway hyperresponsiveness; smooth muscle as the principal actor. F1000Research. 2016;5; doi:10.12688/f1000research.7422.1. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/26998246">http://www.ncbi.nlm.nih.gov/pubmed/26998246</ext-link>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.12688/f1000research.7422.1</pub-id><pub-id pub-id-type="pmcid">PMC4786946</pub-id><pub-id pub-id-type="pmid">26998246</pub-id></mixed-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Husain</surname><given-names>M</given-names></name><name name-style="western"><surname>Saber</surname><given-names>AT</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>NR</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>KA</given-names></name><name name-style="western"><surname>Yauk</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation</article-title><source>Toxicol Appl Pharmacol</source><year>2013</year><volume>269</volume><issue>3</issue><fpage>250</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">23557971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2013.03.018</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez</surname><given-names>C</given-names></name><name name-style="western"><surname>Salazar-Garcia</surname><given-names>S</given-names></name><name name-style="western"><surname>Palestino</surname><given-names>G</given-names></name><name name-style="western"><surname>Martinez-Cuevas</surname><given-names>PP</given-names></name><name name-style="western"><surname>Ramirez-Lee</surname><given-names>MA</given-names></name><name name-style="western"><surname>Jurado-Manzano</surname><given-names>BB</given-names></name><etal/></person-group><article-title>Effect of 45 nm silver nanoparticles (AgNPs) upon the smooth muscle of rat trachea: role of nitric oxide</article-title><source>Toxicol Lett</source><year>2011</year><volume>207</volume><issue>3</issue><fpage>306</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">21983655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2011.09.024</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kapilevich</surname><given-names>LV</given-names></name><name name-style="western"><surname>Zaytseva</surname><given-names>TN</given-names></name><name name-style="western"><surname>Nosarev</surname><given-names>AV</given-names></name><name name-style="western"><surname>Agev</surname><given-names>BG</given-names></name><name name-style="western"><surname>Dyakova</surname><given-names>EY</given-names></name><name name-style="western"><surname>Ogorodova</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Contractile reactions of guinea pig airway smooth muscles in the presence of stannum oxide nanosized particles</article-title><source>Bull Exp Biol Med</source><year>2012</year><volume>153</volume><issue>1</issue><fpage>98</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">22808504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10517-012-1653-4</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><mixed-citation publication-type="other">Kapilevich LV, Zaitseva TN, Nosarev AV, D'Iakova E, Petlina ZR, Ogorodova LM, et al. Influence of nanosize particles of cobalt ferrite on contractile responses of smooth muscle segment of airways. Rossiiskii fiziologicheskii zhurnal imeni IM Sechenova. 2012;98 2:228&#8211;35. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22650066">http://www.ncbi.nlm.nih.gov/pubmed/22650066</ext-link>.<pub-id pub-id-type="pmid">22650066</pub-id></mixed-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arvizo</surname><given-names>RR</given-names></name><name name-style="western"><surname>Miranda</surname><given-names>OR</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pabelick</surname><given-names>CM</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>R</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Effect of nanoparticle surface charge at the plasma membrane and beyond</article-title><source>Nano lett</source><year>2010</year><volume>10</volume><issue>7</issue><fpage>2543</fpage><lpage>2548</lpage><pub-id pub-id-type="pmid">20533851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/nl101140t</pub-id><pub-id pub-id-type="pmcid">PMC2925219</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berntsen</surname><given-names>P</given-names></name><name name-style="western"><surname>Park</surname><given-names>CY</given-names></name><name name-style="western"><surname>Rothen-Rutishauser</surname><given-names>B</given-names></name><name name-style="western"><surname>Tsuda</surname><given-names>A</given-names></name><name name-style="western"><surname>Sager</surname><given-names>TM</given-names></name><name name-style="western"><surname>Molina</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Biomechanical effects of environmental and engineered particles on human airway smooth muscle cells</article-title><source>J R Soc Interface</source><year>2010</year><volume>7</volume><issue>Suppl 3</issue><fpage>S331</fpage><lpage>S340</lpage><pub-id pub-id-type="pmid">20356875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1098/rsif.2010.0068.focus</pub-id><pub-id pub-id-type="pmcid">PMC2943881</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benayoun</surname><given-names>L</given-names></name><name name-style="western"><surname>Druilhe</surname><given-names>A</given-names></name><name name-style="western"><surname>Dombret</surname><given-names>MC</given-names></name><name name-style="western"><surname>Aubier</surname><given-names>M</given-names></name><name name-style="western"><surname>Pretolani</surname><given-names>M</given-names></name></person-group><article-title>Airway structural alterations selectively associated with severe asthma</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><issue>10</issue><fpage>1360</fpage><lpage>1368</lpage><pub-id pub-id-type="pmid">12531777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200209-1030OC</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Biodistribution and pulmonary toxicity of intratracheally instilled graphene oxide in mice</article-title><source>NPG Asia Materials</source><year>2013</year><volume>5</volume><issue>4</issue><fpage>e44</fpage></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glista-Baker</surname><given-names>EE</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Sayers</surname><given-names>BC</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>EA</given-names></name><name name-style="western"><surname>Bonner</surname><given-names>JC</given-names></name></person-group><article-title>Nickel nanoparticles cause exaggerated lung and airway remodeling in mice lacking the T-box transcription factor, TBX21 (T-bet)</article-title><source>Part Fibre Toxicol</source><year>2014</year><volume>11</volume><fpage>7</fpage><pub-id pub-id-type="pmid">24499286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-11-7</pub-id><pub-id pub-id-type="pmcid">PMC3931667</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain</surname><given-names>S</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Z</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>AJ</given-names></name><name name-style="western"><surname>DeGraff</surname><given-names>LM</given-names></name><name name-style="western"><surname>George</surname><given-names>M</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Multiwalled Carbon Nanotube Functionalization with High Molecular Weight Hyaluronan Significantly Reduces Pulmonary Injury</article-title><source>ACS nano.</source><year>2016</year><volume>10</volume><issue>8</issue><fpage>7675</fpage><lpage>7688</lpage><pub-id pub-id-type="pmid">27459049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.6b03013</pub-id><pub-id pub-id-type="pmcid">PMC5340294</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Duch</surname><given-names>MC</given-names></name><name name-style="western"><surname>Mansukhani</surname><given-names>N</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liao</surname><given-names>YP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials</article-title><source>ACS Nano</source><year>2015</year><volume>9</volume><issue>3</issue><fpage>3032</fpage><lpage>3043</lpage><pub-id pub-id-type="pmid">25646681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/nn507243w</pub-id><pub-id pub-id-type="pmcid">PMC4539018</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>JY</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>RR</given-names></name><name name-style="western"><surname>Barger</surname><given-names>M</given-names></name><name name-style="western"><surname>Schwegler-Berry</surname><given-names>D</given-names></name><name name-style="western"><surname>Scabilloni</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Induction of pulmonary fibrosis by cerium oxide nanoparticles</article-title><source>Toxicol Appl Pharmacol</source><year>2012</year><volume>262</volume><issue>3</issue><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">22613087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2012.05.005</pub-id><pub-id pub-id-type="pmcid">PMC4697452</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Bishoff</surname><given-names>B</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>RR</given-names></name><name name-style="western"><surname>Barger</surname><given-names>M</given-names></name><name name-style="western"><surname>Schwegler-Berry</surname><given-names>D</given-names></name><name name-style="western"><surname>Castranova</surname><given-names>V</given-names></name></person-group><article-title>Role of epithelial-mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles-induced lung fibrosis</article-title><source>Toxicol Appl Pharmacol.</source><year>2017</year><volume>323</volume><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">28315692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2017.03.015</pub-id><pub-id pub-id-type="pmcid">PMC6341478</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobsen</surname><given-names>NR</given-names></name><name name-style="western"><surname>Stoeger</surname><given-names>T</given-names></name><name name-style="western"><surname>van den Brule</surname><given-names>S</given-names></name><name name-style="western"><surname>Saber</surname><given-names>AT</given-names></name><name name-style="western"><surname>Beyerle</surname><given-names>A</given-names></name><name name-style="western"><surname>Vietti</surname><given-names>G</given-names></name><etal/></person-group><article-title>Acute and subacute pulmonary toxicity and mortality in mice after intratracheal instillation of ZnO nanoparticles in three laboratories</article-title><source>Food Chem Toxicol.</source><year>2015</year><volume>85</volume><fpage>84</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">26260750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fct.2015.08.008</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain</surname><given-names>S</given-names></name><name name-style="western"><surname>Sangtian</surname><given-names>S</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>SM</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Marshburn</surname><given-names>JD</given-names></name><name name-style="western"><surname>Rice</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Inflammasome activation in airway epithelial cells after multi-walled carbon nanotube exposure mediates a profibrotic response in lung fibroblasts</article-title><source>Part Fibre Toxicol</source><year>2014</year><volume>11</volume><fpage>28</fpage><pub-id pub-id-type="pmid">24915862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-11-28</pub-id><pub-id pub-id-type="pmcid">PMC4067690</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Shannahan</surname><given-names>JH</given-names></name><name name-style="western"><surname>Brown</surname><given-names>JM</given-names></name></person-group><article-title>IL-33 modulates chronic airway resistance changes induced by multi-walled carbon nanotubes</article-title><source>Inhal Toxicol</source><year>2014</year><volume>26</volume><issue>4</issue><fpage>240</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">24502429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2014.880202</pub-id><pub-id pub-id-type="pmcid">PMC4631064</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nie</surname><given-names>X</given-names></name><name name-style="western"><surname>Braini</surname><given-names>C</given-names></name><name name-style="western"><surname>Bai</surname><given-names>R</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name></person-group><article-title>Multiwall carbon nanotubes directly promote fibroblast-myofibroblast and epithelial-mesenchymal transitions through the activation of the TGF-beta/Smad signaling pathway</article-title><source>Small.</source><year>2015</year><volume>11</volume><issue>4</issue><fpage>446</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">25255886</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.201303588</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>T</given-names></name><name name-style="western"><surname>Nie</surname><given-names>H</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Pu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway</article-title><source>Toxicol Lett</source><year>2014</year><volume>226</volume><issue>2</issue><fpage>150</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">24530353</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2014.02.004</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>EY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CS</given-names></name><name name-style="western"><surname>Chin</surname><given-names>WC</given-names></name></person-group><article-title>Functionalized positive nanoparticles reduce mucin swelling and dispersion</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>11</issue><fpage>e15434</fpage><pub-id pub-id-type="pmid">21085670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0015434</pub-id><pub-id pub-id-type="pmcid">PMC2978103</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahn</surname><given-names>MH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>CM</given-names></name><name name-style="western"><surname>Park</surname><given-names>CS</given-names></name><name name-style="western"><surname>Park</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Rhim</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>PO</given-names></name><etal/></person-group><article-title>Titanium dioxide particle-induced goblet cell hyperplasia: association with mast cells and IL-13</article-title><source>Respir Res</source><year>2005</year><volume>6</volume><fpage>34</fpage><pub-id pub-id-type="pmid">15829015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1465-9921-6-34</pub-id><pub-id pub-id-type="pmcid">PMC1087883</pub-id></element-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>EY</given-names></name><name name-style="western"><surname>Garnica</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CS</given-names></name><name name-style="western"><surname>Chin</surname><given-names>WC</given-names></name></person-group><article-title>Mucin secretion induced by titanium dioxide nanoparticles</article-title><source>PloS one</source><year>2011</year><volume>6</volume><issue>1</issue><fpage>e16198</fpage><pub-id pub-id-type="pmid">21283816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0016198</pub-id><pub-id pub-id-type="pmcid">PMC3023769</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>JW</given-names></name><name name-style="western"><surname>Park</surname><given-names>JW</given-names></name><name name-style="western"><surname>Shin</surname><given-names>NR</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Cho</surname><given-names>YK</given-names></name><name name-style="western"><surname>Shin</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Copper oxide nanoparticle induces inflammatory response and mucus production via MAPK signaling in human bronchial epithelial cells</article-title><source>Environ Toxicol Pharmacol</source><year>2016</year><volume>43</volume><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">26934431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.etap.2016.02.008</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>YM</given-names></name><name name-style="western"><surname>Reed</surname><given-names>W</given-names></name><name name-style="western"><surname>Lenz</surname><given-names>AG</given-names></name><name name-style="western"><surname>Jaspers</surname><given-names>I</given-names></name><name name-style="western"><surname>Silbajoris</surname><given-names>R</given-names></name><name name-style="western"><surname>Nick</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Ultrafine carbon particles induce interleukin-8 gene transcription and p38 MAPK activation in normal human bronchial epithelial cells</article-title><source>Am J Physiol Lung Cell Mol Physiol.</source><year>2005</year><volume>288</volume><issue>3</issue><fpage>L432</fpage><lpage>L441</lpage><pub-id pub-id-type="pmid">15695543</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00285.2004</pub-id></element-citation></ref><ref id="CR161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Val</surname><given-names>S</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>S</given-names></name><name name-style="western"><surname>Boland</surname><given-names>S</given-names></name><name name-style="western"><surname>Hamel</surname><given-names>R</given-names></name><name name-style="western"><surname>Baeza-Squiban</surname><given-names>A</given-names></name><name name-style="western"><surname>Marano</surname><given-names>F</given-names></name></person-group><article-title>Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts</article-title><source>Inhal Toxicol</source><year>2009</year><volume>21</volume><issue>Suppl 1</issue><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">19558243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08958370902942533</pub-id></element-citation></ref><ref id="CR162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ursini</surname><given-names>CL</given-names></name><name name-style="western"><surname>Maiello</surname><given-names>R</given-names></name><name name-style="western"><surname>Ciervo</surname><given-names>A</given-names></name><name name-style="western"><surname>Fresegna</surname><given-names>AM</given-names></name><name name-style="western"><surname>Buresti</surname><given-names>G</given-names></name><name name-style="western"><surname>Superti</surname><given-names>F</given-names></name><etal/></person-group><article-title>Evaluation of uptake, cytotoxicity and inflammatory effects in respiratory cells exposed to pristine and -OH and -COOH functionalized multi-wall carbon nanotubes</article-title><source>J Appl Toxicol</source><year>2016</year><volume>36</volume><issue>3</issue><fpage>394</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">26370214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jat.3228</pub-id></element-citation></ref><ref id="CR163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frieke Kuper</surname><given-names>C</given-names></name><name name-style="western"><surname>Grollers-Mulderij</surname><given-names>M</given-names></name><name name-style="western"><surname>Maarschalkerweerd</surname><given-names>T</given-names></name><name name-style="western"><surname>Meulendijks</surname><given-names>NM</given-names></name><name name-style="western"><surname>Reus</surname><given-names>A</given-names></name><name name-style="western"><surname>van Acker</surname><given-names>F</given-names></name><etal/></person-group><article-title>Toxicity assessment of aggregated/agglomerated cerium oxide nanoparticles in an in vitro 3D airway model: the influence of mucociliary clearance</article-title><source>Toxicol In Vitro</source><year>2015</year><volume>29</volume><issue>2</issue><fpage>389</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">25448805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tiv.2014.10.017</pub-id></element-citation></ref><ref id="CR164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skuland</surname><given-names>T</given-names></name><name name-style="western"><surname>Ovrevik</surname><given-names>J</given-names></name><name name-style="western"><surname>Lag</surname><given-names>M</given-names></name><name name-style="western"><surname>Schwarze</surname><given-names>P</given-names></name><name name-style="western"><surname>Refsnes</surname><given-names>M</given-names></name></person-group><article-title>Silica nanoparticles induce cytokine responses in lung epithelial cells through activation of a p38/TACE/TGF-alpha/EGFR-pathway and NF-kappaBeta signalling</article-title><source>Toxicol Appl Pharmacol</source><year>2014</year><volume>279</volume><issue>1</issue><fpage>76</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">24844442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2014.05.006</pub-id></element-citation></ref><ref id="CR165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verstraelen</surname><given-names>S</given-names></name><name name-style="western"><surname>Remy</surname><given-names>S</given-names></name><name name-style="western"><surname>Casals</surname><given-names>E</given-names></name><name name-style="western"><surname>De Boever</surname><given-names>P</given-names></name><name name-style="western"><surname>Witters</surname><given-names>H</given-names></name><name name-style="western"><surname>Gatti</surname><given-names>A</given-names></name><etal/></person-group><article-title>Gene expression profiles reveal distinct immunological responses of cobalt and cerium dioxide nanoparticles in two in vitro lung epithelial cell models</article-title><source>Toxicol Lett</source><year>2014</year><volume>228</volume><issue>3</issue><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">24821434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2014.05.006</pub-id></element-citation></ref><ref id="CR166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jing</surname><given-names>X</given-names></name><name name-style="western"><surname>Park</surname><given-names>JH</given-names></name><name name-style="western"><surname>Peters</surname><given-names>TM</given-names></name><name name-style="western"><surname>Thorne</surname><given-names>PS</given-names></name></person-group><article-title>Toxicity of copper oxide nanoparticles in lung epithelial cells exposed at the air-liquid interface compared with in vivo assessment</article-title><source>Toxicol In Vitro</source><year>2015</year><volume>29</volume><issue>3</issue><fpage>502</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">25575782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tiv.2014.12.023</pub-id><pub-id pub-id-type="pmcid">PMC4373347</pub-id></element-citation></ref><ref id="CR167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name><name name-style="western"><surname>Samet</surname><given-names>JM</given-names></name><name name-style="western"><surname>Peden</surname><given-names>DB</given-names></name><name name-style="western"><surname>Bromberg</surname><given-names>PA</given-names></name></person-group><article-title>Phosphorylation of p65 is required for zinc oxide nanoparticle-induced interleukin 8 expression in human bronchial epithelial cells</article-title><source>Environ Health Perspect</source><year>2010</year><volume>118</volume><issue>7</issue><fpage>982</fpage><lpage>987</lpage><pub-id pub-id-type="pmid">20194077</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.0901635</pub-id><pub-id pub-id-type="pmcid">PMC2920919</pub-id></element-citation></ref><ref id="CR168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kraneveld</surname><given-names>AD</given-names></name><name name-style="western"><surname>van der Kleij</surname><given-names>HP</given-names></name><name name-style="western"><surname>Kool</surname><given-names>M</given-names></name><name name-style="western"><surname>van Houwelingen</surname><given-names>AH</given-names></name><name name-style="western"><surname>Weitenberg</surname><given-names>AC</given-names></name><name name-style="western"><surname>Redegeld</surname><given-names>FA</given-names></name><etal/></person-group><article-title>Key role for mast cells in nonatopic asthma</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><issue>4</issue><fpage>2044</fpage><lpage>2053</lpage><pub-id pub-id-type="pmid">12165531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.169.4.2044</pub-id></element-citation></ref><ref id="CR169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katwa</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Urankar</surname><given-names>RN</given-names></name><name name-style="western"><surname>Podila</surname><given-names>R</given-names></name><name name-style="western"><surname>Hilderbrand</surname><given-names>SC</given-names></name><name name-style="western"><surname>Fick</surname><given-names>RB</given-names></name><etal/></person-group><article-title>A carbon nanotube toxicity paradigm driven by mast cells and the IL-(3)(3)/ST(2) axis</article-title><source>Small.</source><year>2012</year><volume>8</volume><issue>18</issue><fpage>2904</fpage><lpage>2912</lpage><pub-id pub-id-type="pmid">22777948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.201200873</pub-id><pub-id pub-id-type="pmcid">PMC3445726</pub-id></element-citation></ref><ref id="CR170"><label>170.</label><mixed-citation publication-type="other">Moldaver DM, Larche M, Rudulier CD. An update on lymphocyte subtypes in Asthma and Airway Disease. Chest. 2016; doi:10.1016/j.chest.2016.10.038. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27818326">http://www.ncbi.nlm.nih.gov/pubmed/27818326</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2016.10.038</pub-id><pub-id pub-id-type="pmcid">PMC6026230</pub-id><pub-id pub-id-type="pmid">27818326</pub-id></mixed-citation></ref><ref id="CR171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Pichavant</surname><given-names>M</given-names></name><name name-style="western"><surname>Shore</surname><given-names>SA</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity</article-title><source>Nat Med</source><year>2014</year><volume>20</volume><issue>1</issue><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">24336249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nm.3423</pub-id><pub-id pub-id-type="pmcid">PMC3912313</pub-id></element-citation></ref><ref id="CR172"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>NW</given-names></name><name name-style="western"><surname>Sears</surname><given-names>MR</given-names></name></person-group><article-title>Asthma exacerbations.1: epidemiology</article-title><source>Thorax</source><year>2006</year><volume>61</volume><issue>8</issue><fpage>722</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">16877691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.2005.045161</pub-id><pub-id pub-id-type="pmcid">PMC2104697</pub-id></element-citation></ref><ref id="CR173"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gill</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bajwa</surname><given-names>G</given-names></name><name name-style="western"><surname>George</surname><given-names>TA</given-names></name><name name-style="western"><surname>Dong</surname><given-names>CC</given-names></name><name name-style="western"><surname>Dougherty</surname><given-names>II</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>N</given-names></name><etal/></person-group><article-title>Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><issue>11</issue><fpage>5999</fpage><lpage>6006</lpage><pub-id pub-id-type="pmid">20410486</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.0901194</pub-id><pub-id pub-id-type="pmcid">PMC4820019</pub-id></element-citation></ref><ref id="CR174"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durrani</surname><given-names>SR</given-names></name><name name-style="western"><surname>Montville</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Pratt</surname><given-names>AS</given-names></name><name name-style="western"><surname>Sahu</surname><given-names>S</given-names></name><name name-style="western"><surname>DeVries</surname><given-names>MK</given-names></name><name name-style="western"><surname>Rajamanickam</surname><given-names>V</given-names></name><etal/></person-group><article-title>Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children</article-title><source>J Allergy Clin Immunol</source><year>2012</year><volume>130</volume><issue>2</issue><fpage>489</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">22766097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2012.05.023</pub-id><pub-id pub-id-type="pmcid">PMC3437329</pub-id></element-citation></ref><ref id="CR175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>AL</given-names></name><name name-style="western"><surname>Trasti</surname><given-names>FS</given-names></name><name name-style="western"><surname>Mangum</surname><given-names>JB</given-names></name><name name-style="western"><surname>Everitt</surname><given-names>JI</given-names></name></person-group><article-title>Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice</article-title><source>Toxicol Sci</source><year>2003</year><volume>72</volume><issue>2</issue><fpage>331</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">12660365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfg031</pub-id></element-citation></ref><ref id="CR176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>AL</given-names></name><name name-style="western"><surname>Mangum</surname><given-names>JB</given-names></name><name name-style="western"><surname>DeLorme</surname><given-names>MP</given-names></name><name name-style="western"><surname>Everitt</surname><given-names>JI</given-names></name></person-group><article-title>Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression</article-title><source>Toxicol Sci</source><year>2003</year><volume>72</volume><issue>2</issue><fpage>339</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">12655033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfg032</pub-id></element-citation></ref><ref id="CR177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashiguchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H</given-names></name><name name-style="western"><surname>Akashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Komemoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name><name name-style="western"><surname>Ikarashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Titanium dioxide nanoparticles exacerbate pneumonia in respiratory syncytial virus (RSV)-infected mice</article-title><source>Environ Toxicol Pharmacol</source><year>2015</year><volume>39</volume><issue>2</issue><fpage>879</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">25795424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.etap.2015.02.017</pub-id></element-citation></ref><ref id="CR178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bawage</surname><given-names>SS</given-names></name><name name-style="western"><surname>Tiwari</surname><given-names>PM</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Dixit</surname><given-names>S</given-names></name><name name-style="western"><surname>Pillai</surname><given-names>SR</given-names></name><name name-style="western"><surname>Dennis</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response</article-title><source>Nanomedicine</source><year>2016</year><volume>12</volume><issue>8</issue><fpage>2299</fpage><lpage>2310</lpage><pub-id pub-id-type="pmid">27381068</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nano.2016.06.006</pub-id><pub-id pub-id-type="pmcid">PMC5116403</pub-id></element-citation></ref><ref id="CR179"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanpui</surname><given-names>P</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>JC</given-names></name><name name-style="western"><surname>Bisesi</surname><given-names>JH</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Khan</surname><given-names>IA</given-names></name><name name-style="western"><surname>Afrooz</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Single-walled carbon nanotubes increase pandemic influenza A H1N1 virus infectivity of lung epithelial cells</article-title><source>Part Fibre Toxicol</source><year>2014</year><volume>11</volume><fpage>66</fpage><pub-id pub-id-type="pmid">25497303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-014-0066-0</pub-id><pub-id pub-id-type="pmcid">PMC4318452</pub-id></element-citation></ref><ref id="CR180"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>L</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Patel</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name></person-group><article-title>Silver nanoparticles: synthesis, properties, and therapeutic applications</article-title><source>Drug Discov Today</source><year>2015</year><volume>20</volume><issue>5</issue><fpage>595</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">25543008</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drudis.2014.11.014</pub-id><pub-id pub-id-type="pmcid">PMC4433816</pub-id></element-citation></ref><ref id="CR181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKenzie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kendall</surname><given-names>M</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>RM</given-names></name><name name-style="western"><surname>Tetley</surname><given-names>TD</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>C</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2015</year><volume>370</volume><issue>1661</issue><fpage>20140049</fpage><pub-id pub-id-type="pmid">25533100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1098/rstb.2014.0049</pub-id><pub-id pub-id-type="pmcid">PMC4275912</pub-id></element-citation></ref><ref id="CR182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blank</surname><given-names>F</given-names></name><name name-style="western"><surname>Gerber</surname><given-names>P</given-names></name><name name-style="western"><surname>Rothen-Rutishauser</surname><given-names>B</given-names></name><name name-style="western"><surname>Sakulkhu</surname><given-names>U</given-names></name><name name-style="western"><surname>Salaklang</surname><given-names>J</given-names></name><name name-style="western"><surname>De Peyer</surname><given-names>K</given-names></name><etal/></person-group><article-title>Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells</article-title><source>Nanotoxicology.</source><year>2011</year><volume>5</volume><issue>4</issue><fpage>606</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">21231795</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2010.541293</pub-id></element-citation></ref><ref id="CR183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fromen</surname><given-names>CA</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>GR</given-names></name><name name-style="western"><surname>Shen</surname><given-names>TW</given-names></name><name name-style="western"><surname>Kai</surname><given-names>MP</given-names></name><name name-style="western"><surname>Ting</surname><given-names>JP</given-names></name><name name-style="western"><surname>DeSimone</surname><given-names>JM</given-names></name></person-group><article-title>Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2015</year><volume>112</volume><issue>2</issue><fpage>488</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">25548169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1422923112</pub-id><pub-id pub-id-type="pmcid">PMC4299250</pub-id></element-citation></ref><ref id="CR184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fromen</surname><given-names>CA</given-names></name><name name-style="western"><surname>Rahhal</surname><given-names>TB</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>GR</given-names></name><name name-style="western"><surname>Kai</surname><given-names>MP</given-names></name><name name-style="western"><surname>Shen</surname><given-names>TW</given-names></name><name name-style="western"><surname>Luft</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells</article-title><source>Nanomedicine</source><year>2016</year><volume>12</volume><issue>3</issue><fpage>677</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">26656533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nano.2015.11.002</pub-id><pub-id pub-id-type="pmcid">PMC4839472</pub-id></element-citation></ref><ref id="CR185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seydoux</surname><given-names>E</given-names></name><name name-style="western"><surname>Rodriguez-Lorenzo</surname><given-names>L</given-names></name><name name-style="western"><surname>Blom</surname><given-names>RA</given-names></name><name name-style="western"><surname>Stumbles</surname><given-names>PA</given-names></name><name name-style="western"><surname>Petri-Fink</surname><given-names>A</given-names></name><name name-style="western"><surname>Rothen-Rutishauser</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Pulmonary delivery of cationic gold nanoparticles boost antigen-specific CD4+ T Cell Proliferation</article-title><source>Nanomedicine</source><year>2016</year><volume>12</volume><issue>7</issue><fpage>1815</fpage><lpage>1826</lpage><pub-id pub-id-type="pmid">27013126</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nano.2016.02.020</pub-id></element-citation></ref><ref id="CR186"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>HS</given-names></name><name name-style="western"><surname>Ashitate</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Matsui</surname><given-names>A</given-names></name><name name-style="western"><surname>Insin</surname><given-names>N</given-names></name><etal/></person-group><article-title>Rapid translocation of nanoparticles from the lung airspaces to the body</article-title><source>Nat Biotechnol</source><year>2010</year><volume>28</volume><issue>12</issue><fpage>1300</fpage><lpage>1303</lpage><pub-id pub-id-type="pmid">21057497</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.1696</pub-id><pub-id pub-id-type="pmcid">PMC3058321</pub-id></element-citation></ref><ref id="CR187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blank</surname><given-names>F</given-names></name><name name-style="western"><surname>Stumbles</surname><given-names>PA</given-names></name><name name-style="western"><surname>Seydoux</surname><given-names>E</given-names></name><name name-style="western"><surname>Holt</surname><given-names>PG</given-names></name><name name-style="western"><surname>Fink</surname><given-names>A</given-names></name><name name-style="western"><surname>Rothen-Rutishauser</surname><given-names>B</given-names></name><etal/></person-group><article-title>Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes</article-title><source>Am J Respir Cell Mol Biol</source><year>2013</year><volume>49</volume><issue>1</issue><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">23492193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2012-0387OC</pub-id></element-citation></ref><ref id="CR188"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stano</surname><given-names>A</given-names></name><name name-style="western"><surname>Nembrini</surname><given-names>C</given-names></name><name name-style="western"><surname>Swartz</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hubbell</surname><given-names>JA</given-names></name><name name-style="western"><surname>Simeoni</surname><given-names>E</given-names></name></person-group><article-title>Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization</article-title><source>Vaccine.</source><year>2012</year><volume>30</volume><issue>52</issue><fpage>7541</fpage><lpage>7546</lpage><pub-id pub-id-type="pmid">23103199</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2012.10.050</pub-id></element-citation></ref><ref id="CR189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mottram</surname><given-names>PL</given-names></name><name name-style="western"><surname>Leong</surname><given-names>D</given-names></name><name name-style="western"><surname>Crimeen-Irwin</surname><given-names>B</given-names></name><name name-style="western"><surname>Gloster</surname><given-names>S</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>SD</given-names></name><name name-style="western"><surname>Meanger</surname><given-names>J</given-names></name><etal/></person-group><article-title>Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus</article-title><source>Mol Pharm</source><year>2007</year><volume>4</volume><issue>1</issue><fpage>73</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">17274665</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/mp060096p</pub-id></element-citation></ref><ref id="CR190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kundig</surname><given-names>TM</given-names></name><name name-style="western"><surname>Klimek</surname><given-names>L</given-names></name><name name-style="western"><surname>Schendzielorz</surname><given-names>P</given-names></name><name name-style="western"><surname>Renner</surname><given-names>WA</given-names></name><name name-style="western"><surname>Senti</surname><given-names>G</given-names></name><name name-style="western"><surname>Bachmann</surname><given-names>MF</given-names></name></person-group><article-title>Is The Allergen Really Needed in Allergy Immunotherapy?</article-title><source>Curr Treat Options Allergy</source><year>2015</year><volume>2</volume><issue>1</issue><fpage>72</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">25722959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40521-014-0038-5</pub-id><pub-id pub-id-type="pmcid">PMC4335088</pub-id></element-citation></ref><ref id="CR191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballester</surname><given-names>M</given-names></name><name name-style="western"><surname>Jeanbart</surname><given-names>L</given-names></name><name name-style="western"><surname>de Titta</surname><given-names>A</given-names></name><name name-style="western"><surname>Nembrini</surname><given-names>C</given-names></name><name name-style="western"><surname>Marsland</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Hubbell</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>14274</fpage><pub-id pub-id-type="pmid">26387548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep14274</pub-id><pub-id pub-id-type="pmcid">PMC4585708</pub-id></element-citation></ref><ref id="CR192"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirai</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshioka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Izumi</surname><given-names>N</given-names></name><name name-style="western"><surname>Ichihashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Handa</surname><given-names>T</given-names></name><name name-style="western"><surname>Nishijima</surname><given-names>N</given-names></name><etal/></person-group><article-title>Metal nanoparticles in the presence of lipopolysaccharides trigger the onset of metal allergy in mice</article-title><source>Nat Nanotechnol.</source><year>2016</year><volume>11</volume><issue>9</issue><fpage>808</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">27240418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nnano.2016.88</pub-id></element-citation></ref><ref id="CR193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mano</surname><given-names>SS</given-names></name><name name-style="western"><surname>Kanehira</surname><given-names>K</given-names></name><name name-style="western"><surname>Taniguchi</surname><given-names>A</given-names></name></person-group><article-title>Comparison of cellular uptake and inflammatory response via toll-like receptor 4 to lipopolysaccharide and titanium dioxide nanoparticles</article-title><source>Int J Mol Sci.</source><year>2013</year><volume>14</volume><issue>7</issue><fpage>13154</fpage><lpage>13170</lpage><pub-id pub-id-type="pmid">23803652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms140713154</pub-id><pub-id pub-id-type="pmcid">PMC3742180</pub-id></element-citation></ref><ref id="CR194"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>JK</given-names></name><name name-style="western"><surname>Ho</surname><given-names>CC</given-names></name><name name-style="western"><surname>Chang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lin</surname><given-names>JF</given-names></name><name name-style="western"><surname>Yang</surname><given-names>CS</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Particulate nature of inhaled zinc oxide nanoparticles determines systemic effects and mechanisms of pulmonary inflammation in mice</article-title><source>Nanotoxicol</source><year>2015</year><volume>9</volume><issue>1</issue><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2014.886740</pub-id><pub-id pub-id-type="pmid">24559390</pub-id></element-citation></ref><ref id="CR195"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lelieveld</surname><given-names>J</given-names></name><name name-style="western"><surname>Evans</surname><given-names>JS</given-names></name><name name-style="western"><surname>Fnais</surname><given-names>M</given-names></name><name name-style="western"><surname>Giannadaki</surname><given-names>D</given-names></name><name name-style="western"><surname>Pozzer</surname><given-names>A</given-names></name></person-group><article-title>The contribution of outdoor air pollution sources to premature mortality on a global scale</article-title><source>Nat</source><year>2015</year><volume>525</volume><issue>7569</issue><fpage>367</fpage><lpage>371</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature15371</pub-id><pub-id pub-id-type="pmid">26381985</pub-id></element-citation></ref><ref id="CR196"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guarnieri</surname><given-names>M</given-names></name><name name-style="western"><surname>Balmes</surname><given-names>JR</given-names></name></person-group><article-title>Outdoor air pollution and asthma</article-title><source>Lancet.</source><year>2014</year><volume>383</volume><issue>9928</issue><fpage>1581</fpage><lpage>1592</lpage><pub-id pub-id-type="pmid">24792855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(14)60617-6</pub-id><pub-id pub-id-type="pmcid">PMC4465283</pub-id></element-citation></ref><ref id="CR197"><label>197.</label><mixed-citation publication-type="other">Khreis H, Kelly C, Tate J, Parslow R, Lucas K, Nieuwenhuijsen M. Exposure to traffic-related air pollution and risk of development of childhood asthma: A systematic review and meta-analysis. Environ Int. 2016; doi:10.1016/j.envint.2016.11.012. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27881237">http://www.ncbi.nlm.nih.gov/pubmed/27881237</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envint.2016.11.012</pub-id><pub-id pub-id-type="pmid">27881237</pub-id></mixed-citation></ref><ref id="CR198"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>XY</given-names></name><name name-style="western"><surname>Ding</surname><given-names>H</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>LN</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SW</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>JP</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association between Air Pollutants and Asthma Emergency Room Visits and Hospital Admissions in Time Series Studies: A Systematic Review and Meta-Analysis</article-title><source>PloS One</source><year>2015</year><volume>10</volume><issue>9</issue><fpage>e0138146</fpage><pub-id pub-id-type="pmid">26382947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0138146</pub-id><pub-id pub-id-type="pmcid">PMC4575194</pub-id></element-citation></ref><ref id="CR199"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowatte</surname><given-names>G</given-names></name><name name-style="western"><surname>Lodge</surname><given-names>C</given-names></name><name name-style="western"><surname>Lowe</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Erbas</surname><given-names>B</given-names></name><name name-style="western"><surname>Perret</surname><given-names>J</given-names></name><name name-style="western"><surname>Abramson</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>The influence of childhood traffic-related air pollution exposure on asthma, allergy and sensitization: a systematic review and a meta-analysis of birth cohort studies</article-title><source>Allergy.</source><year>2015</year><volume>70</volume><issue>3</issue><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">25495759</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/all.12561</pub-id></element-citation></ref><ref id="CR200"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>A</given-names></name><name name-style="western"><surname>Wichmann</surname><given-names>HE</given-names></name><name name-style="western"><surname>Tuch</surname><given-names>T</given-names></name><name name-style="western"><surname>Heinrich</surname><given-names>J</given-names></name><name name-style="western"><surname>Heyder</surname><given-names>J</given-names></name></person-group><article-title>Respiratory effects are associated with the number of ultrafine particles</article-title><source>Am J Respir Crit Care Med.</source><year>1997</year><volume>155</volume><issue>4</issue><fpage>1376</fpage><lpage>1383</lpage><pub-id pub-id-type="pmid">9105082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm.155.4.9105082</pub-id></element-citation></ref><ref id="CR201"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Klot</surname><given-names>S</given-names></name><name name-style="western"><surname>Wolke</surname><given-names>G</given-names></name><name name-style="western"><surname>Tuch</surname><given-names>T</given-names></name><name name-style="western"><surname>Heinrich</surname><given-names>J</given-names></name><name name-style="western"><surname>Dockery</surname><given-names>DW</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Increased asthma medication use in association with ambient fine and ultrafine particles</article-title><source>Eur Respir J.</source><year>2002</year><volume>20</volume><issue>3</issue><fpage>691</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">12358349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.02.01402001</pub-id></element-citation></ref><ref id="CR202"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lwebuga-Mukasa</surname><given-names>JS</given-names></name><name name-style="western"><surname>Oyana</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name></person-group><article-title>Local ecological factors, ultrafine particulate concentrations, and asthma prevalence rates in Buffalo, New York, neighborhoods</article-title><source>J Asthma</source><year>2005</year><volume>42</volume><issue>5</issue><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">16036408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1081/JAS-62972</pub-id></element-citation></ref><ref id="CR203"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penttinen</surname><given-names>P</given-names></name><name name-style="western"><surname>Timonen</surname><given-names>KL</given-names></name><name name-style="western"><surname>Tiittanen</surname><given-names>P</given-names></name><name name-style="western"><surname>Mirme</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruuskanen</surname><given-names>J</given-names></name><name name-style="western"><surname>Pekkanen</surname><given-names>J</given-names></name></person-group><article-title>Ultrafine particles in urban air and respiratory health among adult asthmatics</article-title><source>Eur Respir J.</source><year>2001</year><volume>17</volume><issue>3</issue><fpage>428</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">11405521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.01.17304280</pub-id></element-citation></ref><ref id="CR204"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penttinen</surname><given-names>P</given-names></name><name name-style="western"><surname>Timonen</surname><given-names>KL</given-names></name><name name-style="western"><surname>Tiittanen</surname><given-names>P</given-names></name><name name-style="western"><surname>Mirme</surname><given-names>A</given-names></name><name name-style="western"><surname>Ruuskanen</surname><given-names>J</given-names></name><name name-style="western"><surname>Pekkanen</surname><given-names>J</given-names></name></person-group><article-title>Number concentration and size of particles in urban air: effects on spirometric lung function in adult asthmatic subjects</article-title><source>Environ Health Perspect.</source><year>2001</year><volume>109</volume><issue>4</issue><fpage>319</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">11335178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.01109319</pub-id><pub-id pub-id-type="pmcid">PMC1240270</pub-id></element-citation></ref><ref id="CR205"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCreanor</surname><given-names>J</given-names></name><name name-style="western"><surname>Cullinan</surname><given-names>P</given-names></name><name name-style="western"><surname>Nieuwenhuijsen</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Stewart-Evans</surname><given-names>J</given-names></name><name name-style="western"><surname>Malliarou</surname><given-names>E</given-names></name><name name-style="western"><surname>Jarup</surname><given-names>L</given-names></name><etal/></person-group><article-title>Respiratory effects of exposure to diesel traffic in persons with asthma</article-title><source>N Engl J Med.</source><year>2007</year><volume>357</volume><issue>23</issue><fpage>2348</fpage><lpage>2358</lpage><pub-id pub-id-type="pmid">18057337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa071535</pub-id></element-citation></ref><ref id="CR206"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>McCreanor</surname><given-names>JE</given-names></name><name name-style="western"><surname>Cullinan</surname><given-names>P</given-names></name><name name-style="western"><surname>Chung</surname><given-names>KF</given-names></name><name name-style="western"><surname>Ohman-Strickland</surname><given-names>P</given-names></name><name name-style="western"><surname>Han</surname><given-names>IK</given-names></name><etal/></person-group><article-title>Health effects of real-world exposure to diesel exhaust in persons with asthma</article-title><source>Res Rep Health Eff Inst</source><year>2009</year><volume>138</volume><fpage>5</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">19449765</pub-id></element-citation></ref><ref id="CR207"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pekkanen</surname><given-names>J</given-names></name><name name-style="western"><surname>Timonen</surname><given-names>KL</given-names></name><name name-style="western"><surname>Ruuskanen</surname><given-names>J</given-names></name><name name-style="western"><surname>Reponen</surname><given-names>A</given-names></name><name name-style="western"><surname>Mirme</surname><given-names>A</given-names></name></person-group><article-title>Effects of ultrafine and fine particles in urban air on peak expiratory flow among children with asthmatic symptoms</article-title><source>Environ Res.</source><year>1997</year><volume>74</volume><issue>1</issue><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9339211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/enrs.1997.3750</pub-id></element-citation></ref><ref id="CR208"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iskandar</surname><given-names>A</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Bonnelykke</surname><given-names>K</given-names></name><name name-style="western"><surname>Ellermann</surname><given-names>T</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>KK</given-names></name><name name-style="western"><surname>Bisgaard</surname><given-names>H</given-names></name></person-group><article-title>Coarse and fine particles but not ultrafine particles in urban air trigger hospital admission for asthma in children</article-title><source>Thorax.</source><year>2012</year><volume>67</volume><issue>3</issue><fpage>252</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">22156960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thoraxjnl-2011-200324</pub-id></element-citation></ref><ref id="CR209"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>KA</given-names></name><name name-style="western"><surname>Halterman</surname><given-names>JS</given-names></name><name name-style="western"><surname>Hopke</surname><given-names>PK</given-names></name><name name-style="western"><surname>Fagnano</surname><given-names>M</given-names></name><name name-style="western"><surname>Rich</surname><given-names>DQ</given-names></name></person-group><article-title>Increased ultrafine particles and carbon monoxide concentrations are associated with asthma exacerbation among urban children</article-title><source>Environ Res.</source><year>2014</year><volume>129</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">24528997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envres.2013.12.001</pub-id><pub-id pub-id-type="pmcid">PMC3947881</pub-id></element-citation></ref><ref id="CR210"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Wahlin</surname><given-names>P</given-names></name><name name-style="western"><surname>Raaschou-Nielsen</surname><given-names>O</given-names></name><name name-style="western"><surname>Ketzel</surname><given-names>M</given-names></name><name name-style="western"><surname>Scheike</surname><given-names>T</given-names></name><name name-style="western"><surname>Loft</surname><given-names>S</given-names></name></person-group><article-title>Size distribution and total number concentration of ultrafine and accumulation mode particles and hospital admissions in children and the elderly in Copenhagen, Denmark</article-title><source>Occup Environ Med.</source><year>2008</year><volume>65</volume><issue>7</issue><fpage>458</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">17989204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/oem.2007.033290</pub-id></element-citation></ref><ref id="CR211"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Loft</surname><given-names>S</given-names></name><name name-style="western"><surname>Ketzel</surname><given-names>M</given-names></name><name name-style="western"><surname>Stage</surname><given-names>M</given-names></name><name name-style="western"><surname>Scheike</surname><given-names>T</given-names></name><name name-style="western"><surname>Hermansen</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Ambient air pollution triggers wheezing symptoms in infants</article-title><source>Thorax.</source><year>2008</year><volume>63</volume><issue>8</issue><fpage>710</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">18267985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.2007.085480</pub-id></element-citation></ref><ref id="CR212"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benor</surname><given-names>S</given-names></name><name name-style="western"><surname>Alcalay</surname><given-names>Y</given-names></name><name name-style="western"><surname>Domany</surname><given-names>KA</given-names></name><name name-style="western"><surname>Gut</surname><given-names>G</given-names></name><name name-style="western"><surname>Soferman</surname><given-names>R</given-names></name><name name-style="western"><surname>Kivity</surname><given-names>S</given-names></name><etal/></person-group><article-title>Ultrafine particle content in exhaled breath condensate in airways of asthmatic children</article-title><source>J Breath Res</source><year>2015</year><volume>9</volume><issue>2</issue><fpage>026001</fpage><pub-id pub-id-type="pmid">25830607</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1088/1752-7155/9/2/026001</pub-id></element-citation></ref><ref id="CR213"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JL</given-names></name><name name-style="western"><surname>Elfman</surname><given-names>L</given-names></name><name name-style="western"><surname>Wieslander</surname><given-names>G</given-names></name><name name-style="western"><surname>Ferm</surname><given-names>M</given-names></name><name name-style="western"><surname>Toren</surname><given-names>K</given-names></name><name name-style="western"><surname>Norback</surname><given-names>D</given-names></name></person-group><article-title>Respiratory health among Korean pupils in relation to home, school and outdoor environment</article-title><source>J Korean Med Sci.</source><year>2011</year><volume>26</volume><issue>2</issue><fpage>166</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">21286005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3346/jkms.2011.26.2.166</pub-id><pub-id pub-id-type="pmcid">PMC3030998</pub-id></element-citation></ref><ref id="CR214"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delfino</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Tjoa</surname><given-names>T</given-names></name><name name-style="western"><surname>Gullesserian</surname><given-names>SK</given-names></name><name name-style="western"><surname>Nickerson</surname><given-names>B</given-names></name><name name-style="western"><surname>Gillen</surname><given-names>DL</given-names></name></person-group><article-title>Asthma morbidity and ambient air pollution: effect modification by residential traffic-related air pollution</article-title><source>Epidemiology.</source><year>2014</year><volume>25</volume><issue>1</issue><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">24240657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/EDE.0000000000000016</pub-id></element-citation></ref><ref id="CR215"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newcomb</surname><given-names>P</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>A</given-names></name><name name-style="western"><surname>Rast</surname><given-names>P</given-names></name><name name-style="western"><surname>Cauble</surname><given-names>D</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>N</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Acute effects of walking environment and GSTM1 variants in children with asthma</article-title><source>Biol Res Nurs.</source><year>2012</year><volume>14</volume><issue>1</issue><fpage>55</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">21196426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1099800410389167</pub-id></element-citation></ref><ref id="CR216"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adar</surname><given-names>SD</given-names></name><name name-style="western"><surname>D'Souza</surname><given-names>J</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>L</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>JD</given-names></name><name name-style="western"><surname>Hallstrand</surname><given-names>TS</given-names></name><name name-style="western"><surname>Davey</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Adopting Clean Fuels and Technologies on School Buses. Pollution and Health Impacts in Children</article-title><source>Am J Respir Crit Care Med</source><year>2015</year><volume>191</volume><issue>12</issue><fpage>1413</fpage><lpage>1421</lpage><pub-id pub-id-type="pmid">25867003</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201410-1924OC</pub-id><pub-id pub-id-type="pmcid">PMC4476560</pub-id></element-citation></ref><ref id="CR217"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>H</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Linn</surname><given-names>WS</given-names></name><name name-style="western"><surname>Clark</surname><given-names>KW</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>KR</given-names></name><name name-style="western"><surname>Sioutas</surname><given-names>C</given-names></name><name name-style="western"><surname>Alexis</surname><given-names>NE</given-names></name><etal/></person-group><article-title>Exposures of healthy and asthmatic volunteers to concentrated ambient ultrafine particles in Los Angeles</article-title><source>Inhal Toxicol.</source><year>2008</year><volume>20</volume><issue>6</issue><fpage>533</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">18444007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08958370801911340</pub-id></element-citation></ref><ref id="CR218"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaumann</surname><given-names>F</given-names></name><name name-style="western"><surname>Fromke</surname><given-names>C</given-names></name><name name-style="western"><surname>Dijkstra</surname><given-names>D</given-names></name><name name-style="western"><surname>Alessandrini</surname><given-names>F</given-names></name><name name-style="western"><surname>Windt</surname><given-names>H</given-names></name><name name-style="western"><surname>Karg</surname><given-names>E</given-names></name><etal/></person-group><article-title>Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study</article-title><source>Part Fibre Toxicol.</source><year>2014</year><volume>11</volume><fpage>39</fpage><pub-id pub-id-type="pmid">25204642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-014-0039-3</pub-id><pub-id pub-id-type="pmcid">PMC4354282</pub-id></element-citation></ref><ref id="CR219"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietropaoli</surname><given-names>AP</given-names></name><name name-style="western"><surname>Frampton</surname><given-names>MW</given-names></name><name name-style="western"><surname>Hyde</surname><given-names>RW</given-names></name><name name-style="western"><surname>Morrow</surname><given-names>PE</given-names></name><name name-style="western"><surname>Oberdorster</surname><given-names>G</given-names></name><name name-style="western"><surname>Cox</surname><given-names>C</given-names></name><etal/></person-group><article-title>Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles</article-title><source>Inhal Toxicol.</source><year>2004</year><volume>16</volume><issue>Suppl 1</issue><fpage>59</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15204794</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08958370490443079</pub-id></element-citation></ref><ref id="CR220"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frampton</surname><given-names>MW</given-names></name><name name-style="western"><surname>Utell</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Zareba</surname><given-names>W</given-names></name><name name-style="western"><surname>Oberdorster</surname><given-names>G</given-names></name><name name-style="western"><surname>Cox</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma</article-title><source>Res Rep Health Eff Inst.</source><year>2004</year><volume>126</volume><fpage>1</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">15768531</pub-id></element-citation></ref><ref id="CR221"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olvera</surname><given-names>HA</given-names></name><name name-style="western"><surname>Perez</surname><given-names>D</given-names></name><name name-style="western"><surname>Clague</surname><given-names>JW</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>YS</given-names></name><name name-style="western"><surname>Li</surname><given-names>WW</given-names></name><name name-style="western"><surname>Amaya</surname><given-names>MA</given-names></name><etal/></person-group><article-title>The effect of ventilation, age, and asthmatic condition on ultrafine particle deposition in children</article-title><source>Pulm Med.</source><year>2012</year><volume>2012</volume><fpage>736290</fpage><pub-id pub-id-type="pmid">22848818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2012/736290</pub-id><pub-id pub-id-type="pmcid">PMC3401531</pub-id></element-citation></ref><ref id="CR222"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalupa</surname><given-names>DC</given-names></name><name name-style="western"><surname>Morrow</surname><given-names>PE</given-names></name><name name-style="western"><surname>Oberdorster</surname><given-names>G</given-names></name><name name-style="western"><surname>Utell</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Frampton</surname><given-names>MW</given-names></name></person-group><article-title>Ultrafine particle deposition in subjects with asthma</article-title><source>Environ Health Perspect</source><year>2004</year><volume>112</volume><issue>8</issue><fpage>879</fpage><lpage>882</lpage><pub-id pub-id-type="pmid">15175176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.6851</pub-id><pub-id pub-id-type="pmcid">PMC1242016</pub-id></element-citation></ref><ref id="CR223"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shannahan</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kodavanti</surname><given-names>UP</given-names></name><name name-style="western"><surname>Brown</surname><given-names>JM</given-names></name></person-group><article-title>Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells</article-title><source>Inhalation toxicology.</source><year>2012</year><volume>24</volume><issue>5</issue><fpage>320</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">22486349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2012.668229</pub-id><pub-id pub-id-type="pmcid">PMC3768266</pub-id></element-citation></ref><ref id="CR224"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samet</surname><given-names>JM</given-names></name><name name-style="western"><surname>Rappold</surname><given-names>A</given-names></name><name name-style="western"><surname>Graff</surname><given-names>D</given-names></name><name name-style="western"><surname>Cascio</surname><given-names>WE</given-names></name><name name-style="western"><surname>Berntsen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>YC</given-names></name><etal/></person-group><article-title>Concentrated ambient ultrafine particle exposure induces cardiac changes in young healthy volunteers</article-title><source>Am J Respir Crit Care Med</source><year>2009</year><volume>179</volume><issue>11</issue><fpage>1034</fpage><lpage>1042</lpage><pub-id pub-id-type="pmid">19234105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200807-1043OC</pub-id></element-citation></ref><ref id="CR225"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stolzel</surname><given-names>M</given-names></name><name name-style="western"><surname>Breitner</surname><given-names>S</given-names></name><name name-style="western"><surname>Cyrys</surname><given-names>J</given-names></name><name name-style="western"><surname>Pitz</surname><given-names>M</given-names></name><name name-style="western"><surname>Wolke</surname><given-names>G</given-names></name><name name-style="western"><surname>Kreyling</surname><given-names>W</given-names></name><etal/></person-group><article-title>Daily mortality and particulate matter in different size classes in Erfurt, Germany</article-title><source>J Expo Sci Environ Epidemiol</source><year>2007</year><volume>17</volume><issue>5</issue><fpage>458</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">17108895</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.jes.7500538</pub-id></element-citation></ref><ref id="CR226"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demedts</surname><given-names>M</given-names></name><name name-style="western"><surname>Gyselen</surname><given-names>A</given-names></name></person-group><article-title>The cobalt lung in diamond cutters: a new disease</article-title><source>Verh K Acad Geneeskd Belg</source><year>1989</year><volume>51</volume><issue>6</issue><fpage>559</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">2561412</pub-id></element-citation></ref><ref id="CR227"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Journeay</surname><given-names>WS</given-names></name><name name-style="western"><surname>Goldman</surname><given-names>RH</given-names></name></person-group><article-title>Occupational handling of nickel nanoparticles: a case report</article-title><source>Am J Ind Med.</source><year>2014</year><volume>57</volume><issue>9</issue><fpage>1073</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">24809594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ajim.22344</pub-id></element-citation></ref><ref id="CR228"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>XY</given-names></name><name name-style="western"><surname>Gilmour</surname><given-names>PS</given-names></name><name name-style="western"><surname>Donaldson</surname><given-names>K</given-names></name><name name-style="western"><surname>MacNee</surname><given-names>W</given-names></name></person-group><article-title>Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro</article-title><source>Thorax.</source><year>1996</year><volume>51</volume><issue>12</issue><fpage>1216</fpage><lpage>1222</lpage><pub-id pub-id-type="pmid">8994518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.51.12.1216</pub-id><pub-id pub-id-type="pmcid">PMC472766</pub-id></element-citation></ref><ref id="CR229"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carosino</surname><given-names>CM</given-names></name><name name-style="western"><surname>Bein</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Plummer</surname><given-names>LE</given-names></name><name name-style="western"><surname>Castaneda</surname><given-names>AR</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wexler</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Allergic airway inflammation is differentially exacerbated by daytime and nighttime ultrafine and submicron fine ambient particles: heme oxygenase-1 as an indicator of PM-mediated allergic inflammation</article-title><source>J Toxicol Environ Health A.</source><year>2015</year><volume>78</volume><issue>4</issue><fpage>254</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">25679046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15287394.2014.959627</pub-id></element-citation></ref><ref id="CR230"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>S</given-names></name><name name-style="western"><surname>Soukup</surname><given-names>J</given-names></name></person-group><article-title>Coarse(PM(2.5-10)), fine(PM(2.5)), and ultrafine air pollution particles induce/increase immune costimulatory receptors on human blood-derived monocytes but not on alveolar macrophages</article-title><source>Journal of toxicology and environmental health Part A</source><year>2003</year><volume>66</volume><issue>9</issue><fpage>847</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">12746131</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15287390306381</pub-id></element-citation></ref><ref id="CR231"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Bramble</surname><given-names>LA</given-names></name><name name-style="western"><surname>Schmitz</surname><given-names>DA</given-names></name><name name-style="western"><surname>Schauer</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Sioutas</surname><given-names>C</given-names></name><etal/></person-group><article-title>The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential</article-title><source>Environ Health Perspect.</source><year>2009</year><volume>117</volume><issue>7</issue><fpage>1116</fpage><lpage>1123</lpage><pub-id pub-id-type="pmid">19654922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.0800319</pub-id><pub-id pub-id-type="pmcid">PMC2717139</pub-id></element-citation></ref><ref id="CR232"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Barajas</surname><given-names>B</given-names></name><name name-style="western"><surname>Sioutas</surname><given-names>C</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MA</given-names></name><name name-style="western"><surname>Nel</surname><given-names>AE</given-names></name></person-group><article-title>Nrf2 deficiency in dendritic cells enhances the adjuvant effect of ambient ultrafine particles on allergic sensitization</article-title><source>J Innate Immun.</source><year>2013</year><volume>5</volume><issue>6</issue><fpage>543</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">23595026</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000347060</pub-id><pub-id pub-id-type="pmcid">PMC3932311</pub-id></element-citation></ref><ref id="CR233"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>You</surname><given-names>D</given-names></name><name name-style="western"><surname>Saravia</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H</given-names></name><name name-style="western"><surname>Cormier</surname><given-names>SA</given-names></name></person-group><article-title>Maternal exposure to combustion generated PM inhibits pulmonary Th1 maturation and concomitantly enhances postnatal asthma development in offspring</article-title><source>Part Fibre Toxicol</source><year>2013</year><volume>10</volume><fpage>29</fpage><pub-id pub-id-type="pmid">23856009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-10-29</pub-id><pub-id pub-id-type="pmcid">PMC3717277</pub-id></element-citation></ref><ref id="CR234"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balakrishna</surname><given-names>S</given-names></name><name name-style="western"><surname>Saravia</surname><given-names>J</given-names></name><name name-style="western"><surname>Thevenot</surname><given-names>P</given-names></name><name name-style="western"><surname>Ahlert</surname><given-names>T</given-names></name><name name-style="western"><surname>Lominiki</surname><given-names>S</given-names></name><name name-style="western"><surname>Dellinger</surname><given-names>B</given-names></name><etal/></person-group><article-title>Environmentally persistent free radicals induce airway hyperresponsiveness in neonatal rat lungs</article-title><source>Part Fibre Toxicol</source><year>2011</year><volume>8</volume><fpage>11</fpage><pub-id pub-id-type="pmid">21388553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-8-11</pub-id><pub-id pub-id-type="pmcid">PMC3061909</pub-id></element-citation></ref><ref id="CR235"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thevenot</surname><given-names>PT</given-names></name><name name-style="western"><surname>Saravia</surname><given-names>J</given-names></name><name name-style="western"><surname>Jin</surname><given-names>N</given-names></name><name name-style="western"><surname>Giaimo</surname><given-names>JD</given-names></name><name name-style="western"><surname>Chustz</surname><given-names>RE</given-names></name><name name-style="western"><surname>Mahne</surname><given-names>S</given-names></name><etal/></person-group><article-title>Radical-containing ultrafine particulate matter initiates epithelial-to-mesenchymal transitions in airway epithelial cells</article-title><source>Am J Respir Cell Mol Biol</source><year>2013</year><volume>48</volume><issue>2</issue><fpage>188</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">23087054</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2012-0052OC</pub-id><pub-id pub-id-type="pmcid">PMC3604062</pub-id></element-citation></ref><ref id="CR236"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JK</given-names></name><name name-style="western"><surname>Fanucchi</surname><given-names>MV</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>DS</given-names></name><name name-style="western"><surname>Abid</surname><given-names>AD</given-names></name><name name-style="western"><surname>Wallis</surname><given-names>CD</given-names></name><name name-style="western"><surname>Dickinson</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Susceptibility to inhaled flame-generated ultrafine soot in neonatal and adult rat lungs</article-title><source>Toxicol Sci.</source><year>2011</year><volume>124</volume><issue>2</issue><fpage>472</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">21914721</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfr233</pub-id><pub-id pub-id-type="pmcid">PMC3216412</pub-id></element-citation></ref><ref id="CR237"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>A</given-names></name><name name-style="western"><surname>Timblin</surname><given-names>C</given-names></name><name name-style="western"><surname>BeruBe</surname><given-names>K</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>T</given-names></name><name name-style="western"><surname>McKinney</surname><given-names>W</given-names></name><name name-style="western"><surname>Driscoll</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inhaled particulate matter causes expression of nuclear factor (NF)-kappaB-related genes and oxidant-dependent NF-kappaB activation in vitro</article-title><source>Am J Respir Cell Mol Biol</source><year>2000</year><volume>23</volume><issue>2</issue><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">10919984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/ajrcmb.23.2.4035</pub-id></element-citation></ref><ref id="CR238"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Layachi</surname><given-names>S</given-names></name><name name-style="western"><surname>Rogerieux</surname><given-names>F</given-names></name><name name-style="western"><surname>Robidel</surname><given-names>F</given-names></name><name name-style="western"><surname>Lacroix</surname><given-names>G</given-names></name><name name-style="western"><surname>Bayat</surname><given-names>S</given-names></name></person-group><article-title>Effect of combined nitrogen dioxide and carbon nanoparticle exposure on lung function during ovalbumin sensitization in Brown Norway rat</article-title><source>PloS One</source><year>2012</year><volume>7</volume><issue>9</issue><fpage>e45687</fpage><pub-id pub-id-type="pmid">23029182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0045687</pub-id><pub-id pub-id-type="pmcid">PMC3461023</pub-id></element-citation></ref><ref id="CR239"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haland</surname><given-names>G</given-names></name><name name-style="western"><surname>Carlsen</surname><given-names>KC</given-names></name><name name-style="western"><surname>Sandvik</surname><given-names>L</given-names></name><name name-style="western"><surname>Devulapalli</surname><given-names>CS</given-names></name><name name-style="western"><surname>Munthe-Kaas</surname><given-names>MC</given-names></name><name name-style="western"><surname>Pettersen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Reduced lung function at birth and the risk of asthma at 10 years of age</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><issue>16</issue><fpage>1682</fpage><lpage>1689</lpage><pub-id pub-id-type="pmid">17050892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa052885</pub-id></element-citation></ref><ref id="CR240"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gauderman</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Avol</surname><given-names>E</given-names></name><name name-style="western"><surname>Gilliland</surname><given-names>F</given-names></name><name name-style="western"><surname>Vora</surname><given-names>H</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>D</given-names></name><name name-style="western"><surname>Berhane</surname><given-names>K</given-names></name><etal/></person-group><article-title>The effect of air pollution on lung development from 10 to 18 years of age</article-title><source>N Engl J Med .</source><year>2004</year><volume>351</volume><issue>11</issue><fpage>1057</fpage><lpage>1067</lpage><pub-id pub-id-type="pmid">15356303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa040610</pub-id></element-citation></ref><ref id="CR241"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gauderman</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Vora</surname><given-names>H</given-names></name><name name-style="western"><surname>McConnell</surname><given-names>R</given-names></name><name name-style="western"><surname>Berhane</surname><given-names>K</given-names></name><name name-style="western"><surname>Gilliland</surname><given-names>F</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>D</given-names></name><etal/></person-group><article-title>Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study</article-title><source>Lancet.</source><year>2007</year><volume>369</volume><issue>9561</issue><fpage>571</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">17307103</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(07)60037-3</pub-id></element-citation></ref><ref id="CR242"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reibman</surname><given-names>J</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LC</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Su</surname><given-names>WC</given-names></name><name name-style="western"><surname>Choy</surname><given-names>W</given-names></name><etal/></person-group><article-title>Size fractions of ambient particulate matter induce granulocyte macrophage colony-stimulating factor in human bronchial epithelial cells by mitogen-activated protein kinase pathways</article-title><source>Am J Respir Cell Mol Biol</source><year>2002</year><volume>27</volume><issue>4</issue><fpage>455</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">12356579</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2001-0005OC</pub-id></element-citation></ref><ref id="CR243"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramgolam</surname><given-names>K</given-names></name><name name-style="western"><surname>Chevaillier</surname><given-names>S</given-names></name><name name-style="western"><surname>Marano</surname><given-names>F</given-names></name><name name-style="western"><surname>Baeza-Squiban</surname><given-names>A</given-names></name><name name-style="western"><surname>Martinon</surname><given-names>L</given-names></name></person-group><article-title>Proinflammatory effect of fine and ultrafine particulate matter using size-resolved urban aerosols from Paris</article-title><source>Chemosphere.</source><year>2008</year><volume>72</volume><issue>9</issue><fpage>1340</fpage><lpage>1346</lpage><pub-id pub-id-type="pmid">18555515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2008.04.025</pub-id></element-citation></ref><ref id="CR244"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramgolam</surname><given-names>K</given-names></name><name name-style="western"><surname>Favez</surname><given-names>O</given-names></name><name name-style="western"><surname>Cachier</surname><given-names>H</given-names></name><name name-style="western"><surname>Gaudichet</surname><given-names>A</given-names></name><name name-style="western"><surname>Marano</surname><given-names>F</given-names></name><name name-style="western"><surname>Martinon</surname><given-names>L</given-names></name><etal/></person-group><article-title>Size-partitioning of an urban aerosol to identify particle determinants involved in the proinflammatory response induced in airway epithelial cells</article-title><source>Part Fibre Toxicol</source><year>2009</year><volume>6</volume><fpage>10</fpage><pub-id pub-id-type="pmid">19302717</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1743-8977-6-10</pub-id><pub-id pub-id-type="pmcid">PMC2667424</pub-id></element-citation></ref><ref id="CR245"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Val</surname><given-names>S</given-names></name><name name-style="western"><surname>Martinon</surname><given-names>L</given-names></name><name name-style="western"><surname>Cachier</surname><given-names>H</given-names></name><name name-style="western"><surname>Yahyaoui</surname><given-names>A</given-names></name><name name-style="western"><surname>Marfaing</surname><given-names>H</given-names></name><name name-style="western"><surname>Baeza-Squiban</surname><given-names>A</given-names></name></person-group><article-title>Role of size and composition of traffic and agricultural aerosols in the molecular responses triggered in airway epithelial cells</article-title><source>Inhal Toxicol</source><year>2011</year><volume>23</volume><issue>11</issue><fpage>627</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">21879948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2011.599445</pub-id></element-citation></ref><ref id="CR246"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borgie</surname><given-names>M</given-names></name><name name-style="western"><surname>Dagher</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ledoux</surname><given-names>F</given-names></name><name name-style="western"><surname>Verdin</surname><given-names>A</given-names></name><name name-style="western"><surname>Cazier</surname><given-names>F</given-names></name><name name-style="western"><surname>Martin</surname><given-names>P</given-names></name><etal/></person-group><article-title>Comparison between ultrafine and fine particulate matter collected in Lebanon: Chemical characterization, in vitro cytotoxic effects and metabolizing enzymes gene expression in human bronchial epithelial cells</article-title><source>Environ Pollut</source><year>2015</year><volume>205</volume><fpage>250</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">26093079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envpol.2015.05.027</pub-id></element-citation></ref><ref id="CR247"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Codispoti</surname><given-names>CD</given-names></name><name name-style="western"><surname>LeMasters</surname><given-names>GK</given-names></name><name name-style="western"><surname>Levin</surname><given-names>L</given-names></name><name name-style="western"><surname>Reponen</surname><given-names>T</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>PH</given-names></name><name name-style="western"><surname>Biagini Myers</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Traffic pollution is associated with early childhood aeroallergen sensitization</article-title><source>Ann Allergy Asthma Immunol</source><year>2015</year><volume>114</volume><issue>2</issue><fpage>126</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">25499550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.anai.2014.10.020</pub-id><pub-id pub-id-type="pmcid">PMC4308502</pub-id></element-citation></ref><ref id="CR248"><label>248.</label><mixed-citation publication-type="other">Brandt EB, Biagini Myers JM, Acciani TH, Ryan PH, Sivaprasad U, Ruff B, et al. Exposure to allergen and diesel exhaust particles potentiates secondary allergen-specific memory responses, promoting asthma susceptibility. J Allergy Clin Immunol. 2015;136(2):295&#8211;303 e7. doi:10.1016/j.jaci.2014.11.043. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25748065">http://www.ncbi.nlm.nih.gov/pubmed/25748065</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2014.11.043</pub-id><pub-id pub-id-type="pmcid">PMC4530081</pub-id><pub-id pub-id-type="pmid">25748065</pub-id></mixed-citation></ref><ref id="CR249"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diaz-Sanchez</surname><given-names>D</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>MP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Jyrala</surname><given-names>M</given-names></name><name name-style="western"><surname>Saxon</surname><given-names>A</given-names></name></person-group><article-title>Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in the human mucosa</article-title><source>J Allergy Clin Immunol</source><year>1999</year><volume>104</volume><issue>6</issue><fpage>1183</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">10588999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0091-6749(99)70011-4</pub-id></element-citation></ref><ref id="CR250"><label>250.</label><mixed-citation publication-type="other">Brandt EB, Kovacic MB, Lee GB, Gibson AM, Acciani TH, Le Cras TD, et al. Diesel exhaust particle induction of IL-17A contributes to severe asthma. J Allergy Clin Immunol. 2013;132(5):1194&#8211;1204 e2. doi:10.1016/j.jaci.2013.06.048. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/24060272">http://www.ncbi.nlm.nih.gov/pubmed/24060272</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2013.06.048</pub-id><pub-id pub-id-type="pmcid">PMC3845500</pub-id><pub-id pub-id-type="pmid">24060272</pub-id></mixed-citation></ref><ref id="CR251"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stevens</surname><given-names>T</given-names></name><name name-style="western"><surname>Cho</surname><given-names>SH</given-names></name><name name-style="western"><surname>Linak</surname><given-names>WP</given-names></name><name name-style="western"><surname>Gilmour</surname><given-names>MI</given-names></name></person-group><article-title>Differential potentiation of allergic lung disease in mice exposed to chemically distinct diesel samples</article-title><source>Toxicol Sci</source><year>2009</year><volume>107</volume><issue>2</issue><fpage>522</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">19074765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfn248</pub-id></element-citation></ref><ref id="CR252"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>M</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name><name name-style="western"><surname>Fujitani</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hirano</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effects of exposure to nanoparticle-rich or -depleted diesel exhaust on allergic pathophysiology in the murine lung</article-title><source>J Toxicol Sci</source><year>2013</year><volume>38</volume><issue>1</issue><fpage>35</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">23358138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2131/jts.38.35</pub-id></element-citation></ref><ref id="CR253"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alberg</surname><given-names>T</given-names></name><name name-style="western"><surname>Nilsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>JS</given-names></name><name name-style="western"><surname>Nygaard</surname><given-names>UC</given-names></name><name name-style="western"><surname>Lovik</surname><given-names>M</given-names></name></person-group><article-title>Nitrogen dioxide: no influence on allergic sensitization in an intranasal mouse model with ovalbumin and diesel exhaust particles</article-title><source>Inhal Toxicol</source><year>2011</year><volume>23</volume><issue>5</issue><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">21506877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08958378.2011.566898</pub-id></element-citation></ref><ref id="CR254"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>AS</given-names></name><name name-style="western"><surname>Choi</surname><given-names>IS</given-names></name><name name-style="western"><surname>Takizawa</surname><given-names>H</given-names></name><name name-style="western"><surname>Rhim</surname><given-names>T</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Additive effect of diesel exhaust particulates and ozone on airway hyperresponsiveness and inflammation in a mouse model of asthma</article-title><source>J Korean Med Sci</source><year>2005</year><volume>20</volume><issue>5</issue><fpage>759</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">16224148</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3346/jkms.2005.20.5.759</pub-id><pub-id pub-id-type="pmcid">PMC2779271</pub-id></element-citation></ref><ref id="CR255"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Moreno-Vinasco</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lang</surname><given-names>GD</given-names></name><name name-style="western"><surname>Linares</surname><given-names>JD</given-names></name><name name-style="western"><surname>Goonewardena</surname><given-names>SN</given-names></name><etal/></person-group><article-title>Murine lung responses to ambient particulate matter: genomic analysis and influence on airway hyperresponsiveness</article-title><source>Environ Health Perspect</source><year>2008</year><volume>116</volume><issue>11</issue><fpage>1500</fpage><lpage>1508</lpage><pub-id pub-id-type="pmid">19057703</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.11229</pub-id><pub-id pub-id-type="pmcid">PMC2592270</pub-id></element-citation></ref><ref id="CR256"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleinman</surname><given-names>MT</given-names></name><name name-style="western"><surname>Sioutas</surname><given-names>C</given-names></name><name name-style="western"><surname>Froines</surname><given-names>JR</given-names></name><name name-style="western"><surname>Fanning</surname><given-names>E</given-names></name><name name-style="western"><surname>Hamade</surname><given-names>A</given-names></name><name name-style="western"><surname>Mendez</surname><given-names>L</given-names></name><etal/></person-group><article-title>Inhalation of concentrated ambient particulate matter near a heavily trafficked road stimulates antigen-induced airway responses in mice</article-title><source>Inhal Toxicol</source><year>2007</year><volume>19</volume><issue>Suppl 1</issue><fpage>117</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">17886059</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08958370701495345</pub-id></element-citation></ref><ref id="CR257"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGee</surname><given-names>MA</given-names></name><name name-style="western"><surname>Kamal</surname><given-names>AS</given-names></name><name name-style="western"><surname>McGee</surname><given-names>JK</given-names></name><name name-style="western"><surname>Wood</surname><given-names>CE</given-names></name><name name-style="western"><surname>Dye</surname><given-names>JA</given-names></name><name name-style="western"><surname>Krantz</surname><given-names>QT</given-names></name><etal/></person-group><article-title>Differential effects of particulate matter upwind and downwind of an urban freeway in an allergic mouse model</article-title><source>Environ Sci Technol</source><year>2015</year><volume>49</volume><issue>6</issue><fpage>3930</fpage><lpage>3939</lpage><pub-id pub-id-type="pmid">25710269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/es506048k</pub-id></element-citation></ref><ref id="CR258"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Harkema</surname><given-names>JR</given-names></name><name name-style="western"><surname>Lewandowski</surname><given-names>RP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Bramble</surname><given-names>LA</given-names></name><name name-style="western"><surname>Gookin</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Ambient ultrafine particles provide a strong adjuvant effect in the secondary immune response: implication for traffic-related asthma flares</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2010</year><volume>299</volume><issue>3</issue><fpage>L374</fpage><lpage>L383</lpage><pub-id pub-id-type="pmid">20562226</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00115.2010</pub-id><pub-id pub-id-type="pmcid">PMC2951067</pub-id></element-citation></ref><ref id="CR259"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>M</given-names></name><name name-style="western"><surname>Viera-Hutchins</surname><given-names>L</given-names></name><name name-style="western"><surname>Garcia-Lloret</surname><given-names>M</given-names></name><name name-style="western"><surname>Noval Rivas</surname><given-names>M</given-names></name><name name-style="western"><surname>Wise</surname><given-names>P</given-names></name><name name-style="western"><surname>McGhee</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Vehicular exhaust particles promote allergic airway inflammation through an aryl hydrocarbon receptor-notch signaling cascade</article-title><source>J Allergy Clin Immunol.</source><year>2015</year><volume>136</volume><issue>2</issue><fpage>441</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">25825216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2015.02.014</pub-id><pub-id pub-id-type="pmcid">PMC4530027</pub-id></element-citation></ref><ref id="CR260"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lundborg</surname><given-names>M</given-names></name><name name-style="western"><surname>Dahlen</surname><given-names>SE</given-names></name><name name-style="western"><surname>Johard</surname><given-names>U</given-names></name><name name-style="western"><surname>Gerde</surname><given-names>P</given-names></name><name name-style="western"><surname>Jarstrand</surname><given-names>C</given-names></name><name name-style="western"><surname>Camner</surname><given-names>P</given-names></name><etal/></person-group><article-title>Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages</article-title><source>Environ Res.</source><year>2006</year><volume>100</volume><issue>2</issue><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">16171796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envres.2005.08.007</pub-id></element-citation></ref><ref id="CR261"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>GI</given-names></name><name name-style="western"><surname>Saravia</surname><given-names>J</given-names></name><name name-style="western"><surname>You</surname><given-names>D</given-names></name><name name-style="western"><surname>Shrestha</surname><given-names>B</given-names></name><name name-style="western"><surname>Jaligama</surname><given-names>S</given-names></name><name name-style="western"><surname>Hebert</surname><given-names>VY</given-names></name><etal/></person-group><article-title>Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection</article-title><source>Part Fibre Toxicol</source><year>2014</year><volume>11</volume><fpage>57</fpage><pub-id pub-id-type="pmid">25358535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-014-0057-1</pub-id><pub-id pub-id-type="pmcid">PMC4222384</pub-id></element-citation></ref><ref id="CR262"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pettitt</surname><given-names>ME</given-names></name><name name-style="western"><surname>Lead</surname><given-names>JR</given-names></name></person-group><article-title>Minimum physicochemical characterisation requirements for nanomaterial regulation</article-title><source>Environ Int</source><year>2013</year><volume>52</volume><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">23280375</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.envint.2012.11.009</pub-id></element-citation></ref><ref id="CR263"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laborda</surname><given-names>F</given-names></name><name name-style="western"><surname>Bolea</surname><given-names>E</given-names></name><name name-style="western"><surname>Cepria</surname><given-names>G</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>MT</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>MS</given-names></name><name name-style="western"><surname>Perez-Arantegui</surname><given-names>J</given-names></name><etal/></person-group><article-title>Detection, characterization and quantification of inorganic engineered nanomaterials: A review of techniques and methodological approaches for the analysis of complex samples</article-title><source>Anal Chim Acta</source><year>2016</year><volume>904</volume><fpage>10</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">26724760</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aca.2015.11.008</pub-id></element-citation></ref><ref id="CR264"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Monopoli</surname><given-names>MP</given-names></name><name name-style="western"><surname>Aberg</surname><given-names>C</given-names></name><name name-style="western"><surname>Salvati</surname><given-names>A</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>KA</given-names></name></person-group><article-title>Biomolecular coronas provide the biological identity of nanosized materials</article-title><source>Nat Nanotechnol</source><year>2012</year><volume>7</volume><issue>12</issue><fpage>779</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">23212421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nnano.2012.207</pub-id></element-citation></ref><ref id="CR265"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitwell</surname><given-names>H</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>RM</given-names></name><name name-style="western"><surname>Elgy</surname><given-names>C</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>C</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>M</given-names></name><name name-style="western"><surname>Clark</surname><given-names>H</given-names></name><etal/></person-group><article-title>Nanoparticles in the lung and their protein corona: the few proteins that count</article-title><source>Nanotoxicol</source><year>2016</year><volume>10</volume><issue>9</issue><fpage>1385</fpage><lpage>1394</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/17435390.2016.1218080</pub-id><pub-id pub-id-type="pmid">27465202</pub-id></element-citation></ref><ref id="CR266"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Djurisic</surname><given-names>AB</given-names></name><name name-style="western"><surname>Leung</surname><given-names>YH</given-names></name><name name-style="western"><surname>Ng</surname><given-names>AM</given-names></name><name name-style="western"><surname>Xu</surname><given-names>XY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>PK</given-names></name><name name-style="western"><surname>Degger</surname><given-names>N</given-names></name><etal/></person-group><article-title>Toxicity of metal oxide nanoparticles: mechanisms, characterization, and avoiding experimental artefacts</article-title><source>Small</source><year>2015</year><volume>11</volume><issue>1</issue><fpage>26</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">25303765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.201303947</pub-id></element-citation></ref><ref id="CR267"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hwang</surname><given-names>BF</given-names></name><name name-style="western"><surname>Young</surname><given-names>LH</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>CH</given-names></name><name name-style="western"><surname>Tung</surname><given-names>KY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>PC</given-names></name><name name-style="western"><surname>Su</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Fine particle, ozone exposure, and asthma/wheezing: effect modification by glutathione S-transferase P1 polymorphisms</article-title><source>PloS One</source><year>2013</year><volume>8</volume><issue>1</issue><fpage>e52715</fpage><pub-id pub-id-type="pmid">23357926</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0052715</pub-id><pub-id pub-id-type="pmcid">PMC3554722</pub-id></element-citation></ref><ref id="CR268"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castro-Giner</surname><given-names>F</given-names></name><name name-style="western"><surname>Kunzli</surname><given-names>N</given-names></name><name name-style="western"><surname>Jacquemin</surname><given-names>B</given-names></name><name name-style="western"><surname>Forsberg</surname><given-names>B</given-names></name><name name-style="western"><surname>de Cid</surname><given-names>R</given-names></name><name name-style="western"><surname>Sunyer</surname><given-names>J</given-names></name><etal/></person-group><article-title>Traffic-related air pollution, oxidative stress genes, and asthma (ECHRS)</article-title><source>Environ Health Perspect</source><year>2009</year><volume>117</volume><issue>12</issue><fpage>1919</fpage><lpage>1924</lpage><pub-id pub-id-type="pmid">20049212</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.0900589</pub-id><pub-id pub-id-type="pmcid">PMC2799467</pub-id></element-citation></ref><ref id="CR269"><label>269.</label><mixed-citation publication-type="other">Bowatte G, Lodge CJ, Knibbs LD, Lowe AJ, Erbas B, Dennekamp M, et al. Traffic-related air pollution exposure is associated with allergic sensitization, asthma, and poor lung function in middle age. J Allergy Clin Immunol. 2016; doi:10.1016/j.jaci.2016.05.008. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27372567">http://www.ncbi.nlm.nih.gov/pubmed/27372567</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2016.05.008</pub-id><pub-id pub-id-type="pmid">27372567</pub-id></mixed-citation></ref><ref id="CR270"><label>270.</label><mixed-citation publication-type="other">Gordon T, Halzack N, Blaustein M, Galdanes K, Chen L. The toxicity of fresh versus aged nanoparticles.Annual Meeting Abstract Supplement, Society of Toxicology. 2008;Abstract No. 1508.</mixed-citation></ref><ref id="CR271"><label>271.</label><mixed-citation publication-type="other">Botta D, Schmuck S, Scoville D, White C, Carosino C, Schaupp C, et al. Nanosilver-Induced Lung Inflammation Is Mouse Strain Dependent. Annual Meeting Abstract Supplement, Society of Toxicology. 2013;Abstract No. 1364.</mixed-citation></ref><ref id="CR272"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Inoue</surname><given-names>K</given-names></name><name name-style="western"><surname>Takano</surname><given-names>H</given-names></name><name name-style="western"><surname>Yanagisawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Koike</surname><given-names>E</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>A</given-names></name></person-group><article-title>Size effects of latex nanomaterials on lung inflammation in mice</article-title><source>Toxicol Appl Pharmacol</source><year>2009</year><volume>234</volume><issue>1</issue><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">18938192</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2008.09.012</pub-id></element-citation></ref><ref id="CR273"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mishra</surname><given-names>V</given-names></name><name name-style="western"><surname>Baranwal</surname><given-names>V</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>RK</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Paul</surname><given-names>B</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>AC</given-names></name></person-group><article-title>Titanium dioxide nanoparticles augment allergic airway inflammation and Socs3 expression via NF-kappaB pathway in murine model of asthma</article-title><source>Biomaterials.</source><year>2016</year><volume>92</volume><fpage>90</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">27057692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2016.03.016</pub-id></element-citation></ref><ref id="CR274"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>CL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>TT</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>CK</given-names></name><name name-style="western"><surname>Liu</surname><given-names>WT</given-names></name><etal/></person-group><article-title>Comparative proteomics of inhaled silver nanoparticles in healthy and allergen provoked mice</article-title><source>Int J Nanomedicine</source><year>2013</year><volume>8</volume><fpage>2783</fpage><lpage>2799</lpage><pub-id pub-id-type="pmid">23946650</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S46997</pub-id><pub-id pub-id-type="pmcid">PMC3742529</pub-id></element-citation></ref><ref id="CR275"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gustafsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Bergstrom</surname><given-names>U</given-names></name><name name-style="western"><surname>Agren</surname><given-names>L</given-names></name><name name-style="western"><surname>Osterlund</surname><given-names>L</given-names></name><name name-style="western"><surname>Sandstrom</surname><given-names>T</given-names></name><name name-style="western"><surname>Bucht</surname><given-names>A</given-names></name></person-group><article-title>Differential cellular responses in healthy mice and in mice with established airway inflammation when exposed to hematite nanoparticles</article-title><source>Toxicol Appl Pharmacol</source><year>2015</year><volume>288</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">26163175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2015.07.001</pub-id></element-citation></ref><ref id="CR276"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Park</surname><given-names>YH</given-names></name><name name-style="western"><surname>Han</surname><given-names>H</given-names></name><name name-style="western"><surname>Park</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics</article-title><source>Experimental &amp; molecular medicine.</source><year>2015</year><volume>47</volume><fpage>e173</fpage><pub-id pub-id-type="pmid">26183169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/emm.2015.50</pub-id><pub-id pub-id-type="pmcid">PMC4525300</pub-id></element-citation></ref><ref id="CR277"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganguly</surname><given-names>K</given-names></name><name name-style="western"><surname>Upadhyay</surname><given-names>S</given-names></name><name name-style="western"><surname>Irmler</surname><given-names>M</given-names></name><name name-style="western"><surname>Takenaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Pukelsheim</surname><given-names>K</given-names></name><name name-style="western"><surname>Beckers</surname><given-names>J</given-names></name><etal/></person-group><article-title>Impaired resolution of inflammatory response in the lungs of JF1/Msf mice following carbon nanoparticle instillation</article-title><source>Respir Res</source><year>2011</year><volume>12</volume><fpage>94</fpage><pub-id pub-id-type="pmid">21756372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1465-9921-12-94</pub-id><pub-id pub-id-type="pmcid">PMC3145576</pub-id></element-citation></ref><ref id="CR278"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Cho</surname><given-names>WS</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>J</given-names></name><name name-style="western"><surname>Yi</surname><given-names>J</given-names></name><name name-style="western"><surname>Choi</surname><given-names>K</given-names></name><name name-style="western"><surname>Park</surname><given-names>K</given-names></name></person-group><article-title>Pro-inflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation</article-title><source>Toxicology.</source><year>2009</year><volume>259</volume><issue>3</issue><fpage>113</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">19428951</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tox.2009.02.009</pub-id></element-citation></ref><ref id="CR279"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>WS</given-names></name><name name-style="western"><surname>Duffin</surname><given-names>R</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>M</given-names></name><name name-style="western"><surname>Megson</surname><given-names>IL</given-names></name><name name-style="western"><surname>Macnee</surname><given-names>W</given-names></name><name name-style="western"><surname>Howie</surname><given-names>SE</given-names></name><etal/></person-group><article-title>NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis</article-title><source>Eur Respir J</source><year>2012</year><volume>39</volume><issue>3</issue><fpage>546</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">21828028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.00047111</pub-id></element-citation></ref><ref id="CR280"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>WS</given-names></name><name name-style="western"><surname>Duffin</surname><given-names>R</given-names></name><name name-style="western"><surname>Poland</surname><given-names>CA</given-names></name><name name-style="western"><surname>Duschl</surname><given-names>A</given-names></name><name name-style="western"><surname>Oostingh</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Macnee</surname><given-names>W</given-names></name><etal/></person-group><article-title>Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs</article-title><source>Nanotoxicology.</source><year>2012</year><volume>6</volume><issue>1</issue><fpage>22</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">21332300</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390.2011.552810</pub-id></element-citation></ref><ref id="CR281"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>J</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Nickel oxide nanoparticles can recruit eosinophils in the lungs of rats by the direct release of intracellular eotaxin</article-title><source>Part Fibre Toxicol</source><year>2016</year><volume>13</volume><issue>1</issue><fpage>30</fpage><pub-id pub-id-type="pmid">27283431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-016-0142-8</pub-id><pub-id pub-id-type="pmcid">PMC4899890</pub-id></element-citation></ref><ref id="CR282"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ogami</surname><given-names>A</given-names></name><name name-style="western"><surname>Todoroki</surname><given-names>M</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>M</given-names></name><name name-style="western"><surname>Hirohashi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expression of inflammation-related cytokines following intratracheal instillation of nickel oxide nanoparticles</article-title><source>Nanotoxicology.</source><year>2010</year><volume>4</volume><issue>2</issue><fpage>161</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">20795893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/17435390903518479</pub-id></element-citation></ref><ref id="CR283"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gustafsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Lindstedt</surname><given-names>E</given-names></name><name name-style="western"><surname>Elfsmark</surname><given-names>LS</given-names></name><name name-style="western"><surname>Bucht</surname><given-names>A</given-names></name></person-group><article-title>Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat</article-title><source>J Immunotoxicol</source><year>2011</year><volume>8</volume><issue>2</issue><fpage>111</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">21309687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/1547691X.2010.546382</pub-id><pub-id pub-id-type="pmcid">PMC3104284</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>